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ABSTRACT
TRANSCRIPTIONAL SILENCING AND ANTI-SILENCING OF VIRULENCE
GENES IN THE BACTERIAL PATHOGEN SHIGELLA FLEXNERI: VIRB,
DNA SUPERCOILING, AND THE HISTONE-LIKE NUCLEOID
STRUCTURING PROTEIN
By
Michael Picker
Helen J. Wing, Ph.D., Committee Chair
Professor of Biology
University of Nevada Las Vegas

Transcriptional silencing and anti-silencing affect many aspects of bacterial physiology,
including virulence in bacterial pathogens. In Shigella species, a group of gram-negative
pathogens that cause bacillary dysentery in humans, the histone-like nucleoid
structuring protein (H-NS) transcriptionally silences virulence genes found on the large
virulence plasmid while VirB anti-silences these genes. However, the mechanistic
details of their interplay are not fully understood. To elucidate their regulatory
mechanisms, I use the icsP virulence locus, which shares a long intergenic region with
the divergently transcribed ospZ gene (1535 bp from TSS to TSS). Prior to this work,
two discrete H-NS binding regions had been identified, suggesting H-NS-mediated
bridging of these two regions as the mechanism of silencing. However, I show that
changes to the spacing and helical phasing designed to disrupt the potential bridging
were tolerated, suggesting an alternate mechanism of silencing is at play. In addition to
H-NS, two other H-NS homologs found in S. flexneri, StpA and Sfh, can also silence the
iii

icsP promoter. Interestingly, VirB counters transcriptional silencing mediated by these
other H-NS homologs. The site required for VirB-dependent anti-silencing of the icsP
promoter is located over 1 kb upstream of the TSS, and nearly 500 bp upstream of the
ospZ promoter, but exactly how VirB accomplishes this long-range regulation is not
known. I show that VirB docks to this recognition site in vitro and has a high specificity
for this site in vivo. Using a combination of 1D and 2D chloroquine-based agarose gel
electrophoresis, I demonstrate that, upon docking to its recognition site, VirB triggers a
loss of negative supercoiling of our VirB-dependent PicsP-lacZ reporter; importantly,
this phenomenon occurs with native VirB levels in S. flexneri. Because H-NS is
sensitive to DNA topology at some promoters, it is tantalizing to envision that VirBmediated changes in supercoiling alleviate H-NS-mediated silencing of virulence genes
in Shigella. Although anti-silencing proteins in other bacteria, including related
pathogens, bear little sequence homology to VirB, the possibility that changes to DNA
supercoiling mechanistically unite this group of proteins requires further consideration
when studying transcriptional silencing and anti-silencing processes in bacteria.
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CHAPTER 1

INTRODUCTION

1.1 OVERVIEW OF THE GENERAL INFORMATION FLOW IN BIOLOGICAL
SYSTEMS
Deoxyribonucleic acid (DNA), termed the blueprint of life, is comprised of four
nitrogenous bases, adenine (A), guanine (G), thymine (T), and cytosine (C). A threeletter code made up of 64 possible (43) combinations of each base, is deciphered by
intricate molecular machinery that work together to produce proteins, the primary
functional units of the cell. One set of machinery converts DNA into ribonucleic acid
(RNA) through a process called transcription while another set of machinery converts
RNA into a chain of amino acids, in a process called translation, which then fold into
their functional, three-dimensional structure. This forward flowing conversion of DNA to
RNA to protein constitute the general information flow in biological systems (Crick,
1970).
A wide array of protein types exists, including those involved in cell structuring, cell
signaling, and various enzymatic processes. It is the regulatory proteins that underlie
intra- and interspecies diversity (Reviewed in Carroll, 2000; Wang et al., 2015), through
the adaptation of cells to diverse and dynamic environments. In bacteria, transcriptional
regulation, among other forms of gene regulation, allows for this dynamic adaptability,
especially in bacterial pathogens (Will et al., 2015). Canonical transcriptional regulation
1

involves activation or repression of gene expression typically through interactions of
transcription factors with RNA polymerase and/or promoter elements (Collado-Vides et
al., 1991). However, a relatively new and understudied area of gene regulation in
bacteria is the process of transcriptional silencing and anti-silencing. These processes
involve the formation and remodeling of extensive nucleoprotein complexes by nucleoid
structuring proteins and control the expression of a wide variety virulence phenotypes in
many human pathogens, including Shigella spp. (reviewed in Stoebel et al., 2008).
This introduction has five sections. Section 1.2 discusses the structure and
composition of the bacterial nucleoid from the perspective of the Escherichia coli
nucleoid because this system has been studied in great detail. These studies are likely
applicable to Shigella because Shigella spp. are close phylogenetic relatives of E. coli,
sharing a nearly identical (~85% identity) chromosome (Jin et al., 2002). Section 1.3
reviews the histone-like nucleoid structuring protein H-NS and mechanisms of
transcriptional silencing and anti-silencing. Section 1.4 reviews Shigella pathogenesis,
including an overview of virulence gene regulation and the molecular interplay between
the silencing and anti-silencing proteins H-NS and VirB, respectively. Section 1.5
outlines the objectives of this dissertation.

2

1.2 THE BACTERIAL NUCLEOID, ITS STRUCTURE, AND COMPOSITION
All living organisms are confronted with the challenge of packaging DNA about 103 –
104 times its length inside each cell. Accordingly, organisms in all three domains of life
have evolved a set of DNA binding proteins that aid in this process (reviewed in Dillon &
Dorman, 2010). In eukaryotes, the most basic form of nuclear DNA packaging is the
wrapping of DNA around a histone core, which then forms into nucleosome arrays and,
ultimately, higher order, functional domains (reviewed in Polo & Almouzni, 2006). In
bacteria, while not completely understood, the bridging, bending, and wrapping of
cytoplasmic DNA by nucleoid associated proteins (NAPs) contributes to DNA packaging
(reviewed in Dillon & Dorman, 2010). Archaea have either eukaryotic homologs of
histone proteins or bacterial homologs of NAPs, which are less studied than their
eukaryotic and bacterial counterparts (reviewed in Dillon & Dorman, 2010, reviewed in
Peeters, Driessen, Werner, & Dame, 2015). Thus, histones and NAPs are of

A)

Circular Map of E. coli
Chromosome

B)

Isolated nucleoid

C)

Domain barriers

H-NS

Figure 1.1 The bacterial chromosome. A) Circular map of the E. coli K-12 strain MG1655 (Blattner et
al., 1997). B) Electron micrograph of gently isolated nucleoid from E. coli showing topologically isolated
DNA domains (Postow et al., 2004). C) Simplified schematic of isolated nucleoid showing the
involvement of H-NS in forming topologically isolated domains (adapted from Hardy & Cozzarelli,
2005).
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fundamental importance in organizing DNA found inside eukaryotic and prokaryotic cells,
respectively. As a result of DNA packaging, these DNA binding proteins impact DNAcentric processes, including DNA replication (Katayama, Takata, & Sekimizu, 1996,
reviewed in MacAlpine & Almouzni, 2013) and transcription (Singh et al., 2014, reviewed
in Zhang & Reinberg, 2001).
For over a century, the bacterial nucleoid was thought to be simple and unorganized
compared to the DNA found in the nucleus of eukaryotic organisms, owing in large part to
the small genome size of bacteria and the lack of appropriate resolution with early
microscopy techniques (reviewed in Thanbichler, Wang, & Shapiro, 2005). While it has
long been known that many bacterial chromosomes are circular (Cairns, 1963; Figure
1.1A), with the advent of newer technologies, this rather simplistic view of the bacterial
chromosome is rapidly changing into one that is more sophisticated. For example,
nucleoids isolated from E. coli reveal that the chromosome is organized into hundreds of
topologically isolated domains of variable length (average ~11 kb) emanating from a
highly condensed center (Postow et al., 2004; Hacker et al., 2017); Figure 1.1B). The
presence of these topologically isolated domains has also been confirmed in vivo (Postow
et al., 2004), and H-NS, a highly abundant and well-studied NAP, was found to act as a
domain barrier, contributing to the formation of these domains (Hardy and Cozzarelli,
2005; Noom et al., 2007); Figure 1.1C).
The complexity of the bacterial nucleoid is further compounded by the presence of
other NAPs. Including H-NS, the E. coli nucleoid contains 12 NAPs in total (CbpA,
CbpB, DnaA, Dps, FIS, Hfq, HU, IciA, IHF, Lrp, and StpA), where the relative amounts
of each varies by growth phase (Azam et al., 1999); only a subset of these NAPs (H4

NS, StpA, Lrp, IHF, HU, FIS, and Dps) have been studied in great detail (reviewed in
(Luijsterburg et al., 2006; Lim, Whang, et al., 2012; Lim et al., 2014). These NAPs have
the ability to either wrap or bend DNA, form long nucleoprotein filaments or
intermolecular bridges, and some of these DNA binding proteins are capable of more
than one of these DNA topology-altering activities (Luijsterburg et al., 2006; Liu et al.,
2010; Lim, Whang, et al., 2012). While these studies have been useful in understanding
how individual NAPs affect nucleoid architecture, a more global view of how these
NAPs function coordinately to compact, condense, and ultimately package the bacterial
nucleoid is not known.
In addition to a role in nucleoid structuring, these NAPs also have roles in various
fundamental cellular processes. These processes include DNA replication and RNA
stability (Fuller and Kornberg, 1983; Almirón et al., 1992; Hwang et al., 1992; Bird et al.,
2006), but a majority of these NAPs, such as the well-studied H-NS, affect
transcriptional regulation (Freundlich et al., 1992; Aki et al., 1996; Hommais et al., 2001;
Brinkman et al., 2003; Bradley et al., 2007). To counteract the negative transcriptional
regulation imparted by NAPs such as H-NS, bacteria have also evolved a set of proteins
specific for this function (reviewed in (Stoebel et al., 2008). These two opposing
functions (i.e. H-NS-mediated transcriptional downregulation and counter-regulatory
proteins) allow for precise control of gene expression in many bacteria, affecting biofilm
formation, temperature adaptability and virulence (Maurelli and Sansonetti, 1988;
Stoebel et al., 2008; Will et al., 2015), among other phenotypes. Consequently, H-NS is
central not only to nucleoid structuring, but also to the fine-tuned regulatory control of
many aspects of bacterial physiology.
5

1.3

THE HISTONE-LIKE NUCLEOID STUCTURING PROTEIN

1.3.1 H-NS IS WIDESPREAD AMONG PHYLOGENETICALLY SIMILAR AND
DIVERSE BACTERIA
H-NS is one of the best studied NAPs both in its role in nucleoid structuring and in
transcriptional regulation. Orthologs of E. coli H-NS bearing structural and sequence
similarity are widespread amongst the γ-proteobacteria, including many related human
pathogens such as Salmonella enterica, Vibrio cholera, and Shigella species (Maurelli
and Sansonetti, 1988; Nye et al., 2000; Tendeng and Bertin, 2003; Brunet et al., 2015).
The more distant relatives of E. coli such as Pseudomonas spp. also encode two
functional H-NS orthologs, MvaT and MvaU (Tendeng and Bertin, 2003; Castang et al.,
2008; Castang and Dove, 2012), and others are also found in many a- and bproteobacteria (Tendeng and Bertin, 2003). More recently, functional H-NS homologs
have even been discovered in the gram-positive soil bacterium Bacillus subtilis (Albano
et al., 2010) and the gram-variable, acid-fast positive pathogen Mycobacterium
tuberculosis (Gordon et al., 2008). In the last two examples, these H-NS orthologs have
been shown to function in transcriptional silencing (Gordon et al., 2008; Albano et al.,
2010). Clearly, H-NS and its homologs are present in many non-pathogenic and
pathogenic bacteria alike, strongly suggesting that, like the E. coli H-NS protein, these
orthologs play key roles in bacterial physiology, most likely through gene regulation and
nucleoid structuring.

1.3.2 THE H-NS PROTEIN

6

In E. coli, H-NS is present at up to 20,000 copies per cell (Azam et al., 1999),
equivalent to an average of 1 H-NS dimer per 460 bp on the E. coli chromosome. The
E. coli H-NS protein is small (15.5 kDa), has an overall neutral isoelectric point
(Spassky et al., 1984), and contains two functional domains separated by a flexible
linker (Figure 1.2). The N-terminus is dedicated to the formation of dimers and higher
order oligomers (Ueguchi et al., 1996), while the C-terminus is dedicated to DNA
binding (Dorman et al., 1999). Although H-NS can also bind RNA, H-NS does so at a
~3-fold lower affinity relative to DNA (Brescia et al., 2004). H-NS preferentially binds ATrich DNA (Carrera and Azorin, 1994) that is intrinsically curved (Owen-Hughes et al.,
1992). While an AT-rich consensus binding site has been proposed for H-NS
(Bouffartigues et al., 2007), a subsequent study revealed that narrow minor groove
widths typically associated with AT-rich DNA largely determines H-NS

Dimerization Domain
Dimerization Interface I
2 – 44 aa

Flexible Linker

Dimerization Interface II
53 – 83 aa

Nucleic Acid Binding Domain
DNA Binding Domain
108 – 116 aa

Figure 1.2 Domains of the H-NS Protein. The N-terminus of H-NS is involved in the formation of dimers
(2 – 44 amino acids) and higher order oligomers (53 – 83 amino acids). The C-terminus functions in
nucleic acid binding (DNA binding motif, 108 – 116 amino acids, (Dorman et al., 1999).

binding affinity (Gordon et al., 2011). As such, a role for H-NS and its homologs has
been described in the transcriptional silencing of horizontally acquired genes, which
tend to be more AT-rich than ancestral DNA, in a process called xenogeneic silencing
(Navarre et al., 2006; Navarre et al., 2007; Ali et al., 2012). Lsr2 from Actinobacteria
and MvaT from Pseudomonaceae represent distinct members of xenogeneic silencers
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and, like H-NS, render horizontally acquired genes transcriptionally silent (reviewed in
Ali et al., 2012). Silencing of horizontally acquired genes helps protect against
potentially deleterious effects that may arise from uncontrolled expression of these
recently acquired genes, and consequently, is thought to facilitate the acquisition and
eventual incorporation of horizontally acquired genes into existing gene networks
(reviewed in Dorman, 2009). H-NS and its homologs are thought to have facilitated the
initial acquisition of pathogenicity islands and virulence plasmids in Salmonella enterica
(reviewed in Ali et al., 2014) and Shigella spp. (reviewed in Picker & Wing, 2016),
respectively. Thus, the involvement of H-NS, and other xenogeneic silencers (Will et al.,
2015; Singh et al., 2016), in transcriptional silencing of horizontally acquired genes has
played an integral role in the evolution of bacterial pathogens.

1.3.3 TRANSCRIPTIONAL SILENCING BY H-NS
In E. coli, H-NS controls the expression of ~5% of genes (Hommais et al., 2001).
Although this study revealed that at some loci, H-NS appears to function as an activator
(Hommais et al., 2001), this effect is likely indirect, because, in combination with the
overwhelming number of examples in which H-NS has been shown to function directly
as a transcriptional silencer (Falconi et al., 1998; Beloin and Dorman, 2003; Shin et al.,
2005; Bouffartigues et al., 2007), evidence for a direct role of H-NS in gene activation is
still lacking. H-NS functions through transcriptional silencing, a process in which the
access of sequence-specific DNA binding proteins, such as RNA polymerase (RNAP)
and transcriptional activators to promoter DNA, is prevented by extended nucleoprotein
complexes (Stoebel et al., 2008; Liu et al., 2010). This process is analogous to
8

transcriptional silencing mediated by histones in eukaryotic cells but differs from
classical transcriptional repression by transcriptional repressors. Transcriptional
repressors are sequence-specific DNA binding proteins that lower the amount of
transcription by blocking the initiation of transcription through various mechanisms,
including those that prevent RNAP binding to the promoter, the transition from closed to
open complex, and promoter clearance (reviewed in Rojo, 1999). These repression
mechanisms can occur through occupancy of sequences bound by RNA polymerase,
altered promoter topology, or a direct interaction with RNAP, respectively (reviewed in
Rojo, 1999).
In contrast, H-NS forms two distinct, nucleoprotein conformations involved in
transcriptional silencing. The first is a nucleoprotein filament where H-NS coats long,
contiguous stretches of DNA that can exceed 1 kb (Figure 1.3A), and the second is a
nucleoprotein bridge formed by H-NS-mediated bridging of two discrete DNA regions
(Figure 1.3C); both of these complexes have been visualized by atomic force
microscopy (Remus Thei Dame, Wyman, & Goosen, 2000; Liu, Chen, Kenney, & Yan,
2010 ; Figures 1.3B and D).Depending on their location, these two nucleoprotein
complexes can silence gene promoters through different mechanisms. A nucleoprotein
H-NS filament formed over the core promoter elements likely occludes RNAP from the
promoter (Figure 1.4A), whereas a nucleoprotein filament formed downstream of the
transcription start site (TSS) prevents transcription elongation (Kotlajich et al., 2015;
Figure 1.4B). Bridging of two discrete DNA regions by H-NS may block transcription in
two ways. First, if one binding region includes the promoter elements and is brought
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A

C

B

D

Figure 1.3 H-NS nucleoprotein complexes. A) H-NS forms nucleoprotein filament B) Atomic force
microscopy image of H-NS nucleoprotein filament. C) H-NS forms nucleoprotein bridge. D) Atomic
force microscopy image of H-NS bridging complexes (white arrows). (B) and (D) are adapted from (Liu
et al., 2010).

together with another discrete region upstream or downstream, access of RNAP to the
promoter is likely blocked (Figure 1.4C). In contrast, if two regions upstream and
downstream of the promoter elements are bridged by H-NS, RNAP may still engage the
promoter elements, but promoter clearance will be blocked (Figure 1.4D).
More recently, two other mechanisms of transcriptional silencing involving changes to
DNA topology were proposed based on the ability of H-NS bridges to promote the
formation of plectonemes and H-NS filaments to suppress their formation (Lim et al.,
2014). Thus, it is possible that an H-NS bridge bound downstream of the promoter leads
to the formation of plectonemic DNA, which may become non-permissive for RNAP
elongation (Figure 1.4E). With the H-NS filament bound upstream of the promoter,
torque may be placed on the core promoter elements such that RNAP binding or open
10

complex formation is blocked (Figure 1.4F). However, these theoretical mechanisms
have not been experimentally verified.

A

C

B
RNAP

RNAP
RNAP

H-NS nucleoprotein filament
excludes RNAP from the promoter.

H-NS bridging excludes RNAP
from the promoter.

plectoneme

D

H-NS nucleoprotein filament
directly blocks transcription
elongation.

E

F
RNAP

torque

H-NS bridging entraps RNAP to
prevent transcription elongation.

H-NS bridging leads to plectoneme formation which
blocks the diffusion of transient DNA supercoils (+) to
prevent transcription elongation.

H-NS nucleoprotein filament places torque
on core promoter elements, which is nonpermissive for open complex formation or
RNAP binding.

Figure 1.4 Proposed and theoretical mechanisms of H-NS-mediated silencing. Four proposed
mechanisms are depicted which can occur through two distinct H-NS binding modes: filament
formation (A), (B), and (F) or DNA bridging (C), (D), and (E). These result in either the exclusion of
RNAP from the promoter, (A), (C), and (F), or blocking transcription elongation (B), (D), and (E).
RNAP represents RNA Polymerase. Small, white circles represent H-NS monomers. Line with arrow
represents the transcription start site. The "+” symbol represents positive supercoils generated from
an elongating RNAP (Liu and Wang, 1987). Adapted from (Weatherspoon-Griffin et al., 2016).

1.3.4 TRANSCRIPTIONAL ANTI-SILENCING OF H-NS-MEDIATED SILENCING
Typically associated with eukaryotes (Adkins, Howar, & Tyler, 2004; reviewed in
Morse, 2007; Schermer, Korber, & Hörz, 2005), transcriptional anti-silencing in bacteria
is the process in which transcriptional silencing by NAPs is countered, leading to an
increase in transcription of the silenced gene (reviewed in Stoebel et al., 2008).
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Although histone-like proteins and NAPs have been discovered in Archaea (reviewed in
Dillon & Dorman, 2010; Henneman & Dame, 2015), examples of transcriptional antisilencing in this domain of life have not yet been described. Transcriptional antisilencing is typically achieved by removal or remodeling of DNA architectural proteins,
allowing access of transcriptional machinery to promoters. In contrast, canonical

A

D

B

Silenced promoter

C

Figure 1.5 Anti-silencing mechanisms of countering H-NS. A) DNA topology-mediated changes in the
promoter region disrupts H-NS (white circles) bridging. B) Truncated H-NS protein (gray circle)
weakens or disrupts H-NS bridging. C) DNA binding protein (gray object) blocks H-NS oligomerization
along DNA. D) Altered promoter conformation (gray TSS) is permissive for transcription. Adapted from
(Stoebel et al., 2008).

transcription activation typically involves an increase in transcription in the presence of
RNAP through direct or indirect means (reviewed in Barnard et al., 2004). Various
examples of transcriptional anti-silencing of genes silenced by H-NS have been
described, largely in the context of bacterial pathogens (Stoebel et al., 2008).
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Generally speaking, anti-silencing can occur through protein-independent and
protein-dependent means. At the virF and proU promoters in Shigella flexneri and E.
coli, respectively, transcriptional anti-silencing of the H-NS silencing complex occurs
through an induced change in DNA topology in response to specific environmental
conditions (Prosseda et al., 2004; Bouffartigues et al., 2007; Figure 1.5A). On the other
hand, protein-dependent transcriptional anti-silencing can occur in a variety of ways,
including weakening the H-NS:DNA complex through protein-protein interactions of
truncated versions of H-NS (Figure 1.5B), blocking H-NS oligomerization along DNA
(Figure 1.5C), and alteration of promoter conformation (Figure 1.5D) (reviewed in
Stoebel, Free, & Dorman, 2008). Clearly, there are many ways in which H-NS-mediated
silencing can be alleviated. As more studies on NAPs like H-NS emerge, it is anticipated
that many more examples of transcriptional anti-silencing proteins and their diverse
mechanisms will emerge.
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1.4

SHIGELLA SPECIES AND THEIR PATHOGENESIS
Shigella species are a group of gram-negative, intracellular bacterial pathogens that

cause bacillary dysentery in humans. Symptoms of the disease are characterized by
abdominal cramping, tenesmus, diarrhea, mucus, and sometimes blood in the stool
(Dupont et al., 1969). Originally named Bacillus dysenterie, S. dysenteriae was first
isolated from patients suffering from non-amoebic dysentery by Dr. Kiyoshi Shiga in
1897 (reviewed in Trofa et al., 1999). Over 30 years later, the genus was renamed
Shigella in honor of Dr. Shiga, and today, there are four species belonging to the
Shigella genus; S. dysenteriae, S. flexneri, S. boydii, and S. sonnei. Despite the
discovery of Shigella 120 years ago (reviewed in Trofa et al., 1999), cases of shigellosis
persist worldwide, with recent estimates reaching more than 88 million cases (Lamberti
et al., 2014) and 40,000 deaths each year (GBD 2013 Mortality and Causes of Death
Collaborators, 2015). While all four species contribute to these statistics, the burden of
disease is largely attributed to S. flexneri in underdeveloped countries (60%; Kotloff et
al., 1999). Fluoroquinolones and other antibiotics have traditionally been used to treat
Shigella infections, but this has led to an increase in the prevalence of antibiotic
resistant Shigellae (Horiuchi et al., 1993; Hirose et al., 2005; Toro et al., 2005; Nandy et
al., 2010). Hence, a detailed understanding of the molecular pathogenesis of Shigella
spp. is needed so that novel antimicrobial treatments against key virulence
determinants can be developed to prevent or treat Shigella infections.
Despite Shigella spp. being close phylogenetic relatives of Escherichia coli, (Jin et
al., 2002), some phenotypic differences exist. For example, Shigella spp. have lost the
ability to utilize lactose or mucate, lack lysine decarboxylation, and are non-motile (Pupo
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et al., 2000). Perhaps the biggest difference is the presence of a large virulence plasmid
(~180 – 220 kb) found in all Shigella spp. (Lan et al., 2001). Interestingly, the virulence
plasmid is thought to have been acquired up to seven times, leading to the convergent
evolution of the Shigella phenotype (Pupo et al., 2000). As mentioned earlier, the NAP
H-NS and its paralog StpA are hypothesized to have aided in the initial acquisition and
subsequent maintenance of the virulence plasmid (reviewed in Picker & Wing, 2016). A
third H-NS family member, Sfh, was also found in S. flexneri 2a strain 2457T, and is
encoded by an accessory plasmid (Beloin et al., 2003). Interestingly, Sfh is thought to
have aided in the silent acquisition of this accessory plasmid (Doyle et al., 2007). While
the role of StpA in Shigella virulence has not yet been defined (Beloin et al., 2003;
Picker and Wing, 2016), recently, a role for Sfh in acid resistance has been described
(Niu et al., 2017).

1.4.1 SHIGELLA INFECTION
Shigellosis is contracted primarily via the fecal-oral route, and the ease of which
Shigella is contracted and causes disease is likely due to its high resistance to acid
(Weatherspoon-Griffin and Wing, 2016) allowing for a very low infectious dose, where
only 101 – 102 cells are required for infection (DuPont et al., 1989). An overview of the
Shigella infection cycle is described and summarized in Figure 1.6 below (Steps 1 – 10).
After ingestion of Shigellae and access to the lumen of the colon or small intestine has
been gained, the M-cells (Giannasca et al., 1999) sample Shigellae (Step 1),
transporting them to the Peyer’s patch. Shigellae then actively invade macrophages
(Step 2) (reviewed in Sasakawa, 2010), degrade the phagosome, and replicate inside
15

Apical side
1

Shigella
M cell

Actin tail

9

2

8

7

Macrophage

6
10

4
Invasion

Enterocyte

5

3

Proinflammatory
cytokines

Basolateral
side

Polymorphonuclear leukocytes

Figure 1.6 Shigella infection of enterocytes. Shigellae are sampled by M cells (1) and transported to
the Peyer’s patch where they actively invade macrophages (2). Shigellae escape the phagosome and
actively replicate in the cytoplasm (3), which induces apoptosis as well as the production of
proinflammatory cytokines (4). Once released from the macrophage, Shigellae invade enterocytes
from the basolateral surface (5), dissolve the vacuolar membrane (6) and replicate (7). Shigellae then
spread intracellularly and intercellularly using actin-based motility (8). Intercellular spread disrupts
tight junctions (9), compromising the integrity of the intestinal wall. These processes are also
proinflammatory, leading to a release of cytokines that activate polymorphonuclear leukocytes (10).
These processes aid in the clearance of Shigellae, but also their subsequent release to the external
environment. Adapted from (Sasakawa, 2010)

the cytoplasm of the macrophage (Step 3). This process induces macrophage apoptosis
(Zychlinsky et al., 1992) and triggers a large inflammatory response (Step 4). Once
released from the macrophage, Shigellae invade intestinal epithelial cells through the
basolateral membrane (Step 5), break free of the membrane vacuoles (Step 6), multiply
(Step 7), and spread intra- and intercellularly via through actin-based motility (Step 8).
Intercellular spread disrupts tight junctions between adjacent enterocytes (Step 9),
compromising the integrity of the colonic epithelium. Further disruption of the intestinal
epithelial integrity occurs due to the large, triggered inflammatory response (Step 10),
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resulting in the recruitment of polymorphic neutrophils, a diarrheaogenic process.
Subsequently, in healthy adults, Shigellae that remain in the host are likely cleared by
the recruited polymorphic neutrophils (Mandic-Mulec et al., 1997), while Shigellae that
exit the host into the external environment are ready to infect the next host.

1.4.2 TRANSCRIPTIONAL REGULATION OF THE SHIGELLA VIRULENCE GENE
CASCADE
The large virulence plasmid present in all Shigella species encodes many of the
determinants required for Shigella pathogenicity, including those required for host cell
invasion, intra- and intercellular spread, and host cell manipulation via the type III
secretion system (Venkatesan et al., 2001). Many of these virulence determinants are
tightly regulated at the level of transcription and are expressed in a hierarchical manner
(Figure 1.7). The two main positive transcriptional regulators involved in Shigella
virulence gene expression are VirF and VirB, while the main negative transcriptional
regulator is the chromosomally encoded NAP, H-NS. Interestingly, all Shigella species
harbor an additional H-NS paralog, StpA (Dorman and Porter, 1998; Beloin et al., 2003;
Picker and Wing, 2016), while a routinely used S. flexneri 2a strain 2457T harbors yet a
third H-NS paralog, Sfh (Deighan et al., 2003; Beloin et al., 2003) The role of these
paralogs in Shigella appears to be as a backup for H-NS (Beloin et al., 2003), although,
recently, a role for Sfh in acid resistance has been described (Niu et al., 2017).
At temperatures non-permissive for virulence (£ 30 °C), H-NS transcriptionally silences
many virulence genes found on the large virulence plasmid (Maurelli and Sansonetti,
1988), including virF (Falconi et al., 1998), which encodes VirF, the first positive
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transcriptional regulator of the virulence gene cascade. Silencing of the virF promoter
occurs through H-NS-mediated bridging of a promoter-distal (upstream) and promoterproximal binding region (Falconi et al., 1998; Prosseda et al., 2004); Figure 1.7). A
transition to the host temperature of 37 °C leads to a structural change in the
conformation of the H-NS nucleoprotein complex formed at the virF promoter, resulting
in the loss of H-NS-mediated silencing and subsequent expression of VirF (Prosseda et
al., 2004; Figure 1.7). VirF, an AraC-like transcriptional activator (Sakai et al., 1986),
then activates the expression of virB (Tobe et al., 1993; Figure 1.7); the role of H-NS at
the virB promoter is not clear. The virB gene encodes VirB, the second positive
transcriptional of the virulence gene cascade (Adler et al., 1989). However, rather than
functioning as a transcriptional activator like VirF, VirB functions to counter H-NSmediated silencing (Wing et al., 2004; Turner and Dorman, 2007; Basta et al., 2013) of
many virulence genes where temperature alone is not sufficient to overcome the
silencing effects of H-NS (Figure 1.7). These virulence genes include those found within
the 30 kb ipa-mxi-spa invasion locus and those found outside of this region, including,
ospC2-4, ospD1, ospD2, ospZ, and icsP (Wing et al., 2004; Le Gall et al., 2005; Basta
et al., 2013). Upon activation of the type III secretion system, MxiE, encoded by the ipamxi-spa locus, activates the expression of the remaining effector molecules required for
successful host cell invasion (Kane et al., 2002). Overall, the step-wise expression of
virulence genes allows for the precise and fine-tuned control of Shigella pathogenicity
for a coordinated, adaptive response to a dynamic host environment.
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Figure 1.7 The Shigella virulence gene cascade. H-NS transcriptionally silences the virF promoter
through bridging of two discrete binding regions (Prosseda et al., 1998; Falconi et al., 1998). A
temperature-mediated change in the topology of the virF promoter disrupts H-NS bridging, leading to
the production of VirF (Prosseda et al., 2004). VirF then activates the virB promoter in a supercoilingdependent manner (Tobe et al., 1993; Tobe et al., 1995). Although an H-NS binding region at the virB
promoter has been described, the in vivo role of H-NS in silencing virB is questionable (Tobe et al.,
1993) VirB then counters transcriptional silencing of virulence genes mediated by H-NS at 37 °C (Wing
et al., 2004; Turner and Dorman, 2007; Basta et al., 2013). Adapted from (Weatherspoon-Griffin et al.,
2016).

1.4.3 THE TRANSCRIPTIONAL ANTI-SILENCING PROTEIN VIRB
The VirB protein (35.4 kDa) is essential for Shigella virulence, as Shigellae lacking virB
are avirulent (Schuch and Maurelli, 1997). VirB functions to offset transcriptional
silencing mediated by H-NS that is not relieved by temperature-induced changes in
DNA topology, as demonstrated by its ability to upregulate virulence gene promoters
solely in the presence of H-NS, but not in its absence (Wing et al., 2004; Turner and
Dorman, 2007; Basta et al., 2013). Despite this process being critical for Shigella
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virulence, the mechanism of anti-silencing by VirB is not fully understood. In order to
gain insight into the mechanism of VirB-dependent anti-silencing, VirB has been
compared to its closest homolog. Interestingly, VirB is not related to known
transcriptional regulators, but instead, is related to the ParB superfamily of plasmid and
chromosomal partitioning proteins, bearing the most homology to ParB of P1 phage
(42.8% amino acid identity) (Taniya et al., 2003; Figure 1.8A). Although VirB does not
participate in plasmid partitioning (Venkatesan et al., 2001; Taniya et al., 2003),
comparisons of VirB to ParB have been crucial in dissecting how VirB might function to
counter H-NS-mediated silencing. There are two characteristics of VirB that are similar
to ParB. First, VirB contains a centrally located helix-turn-helix DNA binding domain
(148 – 171 amino acids; Figure 1.8B) that is required for binding to a ParB-like DNA
recognition sequence (Beloin et al., 2002; McKenna et al., 2003; Turner and Dorman,
2007; Gao et al., 2013). VirB binds its recognition site, likely as a dimer (WeatherspoonGriffin et al., 2018), as does ParB (Lobocka and Yarmolinsky, 1996; Bouet et al., 2000;
Taylor et al., 2015b). In addition to the formation of VirB dimers, VirB also forms higher
order oligomers both in vitro and in vivo (Beloin et al., 2002), a process dependent on
the C-terminus (Figure 1.8B). Second, the formation of oligomers and non-discrete
nucleoprotein complexes suggest that VirB may also oligomerize along DNA (Beloin et
al., 2002; Gao et al., 2013; Weatherspoon-Griffin et al., 2018), a well-described activity
of ParB homologs (Lynch and Wang, 1995; Rodionov et al., 1999; Funnell, 2016).
Together, these DNA binding activities of VirB are thought to be critical for its role in
transcriptional anti-silencing, as VirB proteins containing amino acid substitutions to the
HTH DNA binding domain or truncations of the C-terminus are unable to regulate
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virulence genes (Beloin et al., 2002; Gao et al., 2013; Weatherspoon-Griffin et al.,
2018). The N-terminus is also required for VirB-dependent regulation and may contain
an additional determinant for DNA binding (Gao et al., 2013; Figure 1.8B).
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1 – 147 aa
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Figure 1.8 VirB alignment with ParB and VirB domain organization. A) Alignment of VirB protein from
S. flexneri with ParB of P1 phage. B) Schematic of the VirB protein from Shigella flexneri. The
function of the N-terminus is not well-defined, but may have a minor contribution to cooperative DNA
binding dimerization (Gao et al., 2013). The DNA binding domain is a centrally located helix-turn-helix
(HTH) motif (Beloin et al., 2002). The C-terminus is involved in dimerization, the formation of higher
order oligomers, and cooperative DNA binding (Beloin et al., 2002; Gao et al., 2013). All three
domains are essential for VirB-dependent regulation (Beloin et al., 2002; Gao et al., 2013).

1.4.4 THE INTERPLAY BETWEEN H-NS AND VIRB
Without VirB, Shigella is avirulent (Schuch and Maurelli, 1997). Despite this, the
mechanism by which VirB anti-silences virulence gene promoters that are
transcriptionally silenced by H-NS remains poorly understood. Insight into these
mechanisms may yield knowledge that can lead to the development of novel
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therapeutics for the treatment or prevention of Shigella infections. Perhaps the best
example where the interplay between H-NS and VirB has been studied is at the icsB
promoter, which controls the expression of the icsB-ipg-ipa operon, which is located in
the 30 kb invasion region. At this locus, H-NS silences the expression of the icsB
promoter in vivo (Beloin and Dorman, 2003), protecting sequences located between 110 to +56 relative to the transcription start site (Beloin and Dorman, 2003; Turner and
Dorman, 2007). H-NS silences the icsB promoter by blocking open complex formation
(Turner and Dorman, 2007), but the exact step in which open complex formation is
blocked is unknown. The DNA sequence required for VirB-dependent anti-silencing of
the icsB promoter was initially described as a 15 bp sequence (centrally located -115
relative to TSS) organized as an inverted repeat of 7 bp each (called boxes 1 and 2)
and separated by a single nucleotide (Turner and Dorman, 2007). However, only the
promoter-distal box 2 was found to be required for VirB-dependent regulation of the icsB
promoter in vivo (Turner and Dorman, 2007). Based on these studies and those using a
heavily truncated VirB protein, it is thought that VirB docks to its recognition site,
oligomerizes along DNA, and this oligomerization destabilizes the H-NS silencing
complex (Turner and Dorman, 2007; Gao et al., 2013). However, the precise
mechanistic details of by which the H-NS nucleoprotein silencing complex is altered is
unknown.
Even though there are over 30 virulence genes controlled by VirB (Le Gall et al.,
2005), our understanding of silencing and anti-silencing mechanisms is based largely
on data collected at only one locus, icsB. Thus, there is a pressing need to study these
mechanisms at other virulence loci. To begin this task, our lab has chosen to
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characterize the regulation of another violence locus, the monocistronic icsP located
~100 kb away from the 30 kb invasion locus. The icsP promoter is transcriptionally
silenced and anti-silenced by H-NS and VirB, respectively (Wing et al., 2004), and like
the icsB promoter (Turner and Dorman, 2007), VirB acts as a true anti-silencing protein,
functioning to upregulate the icsP promoter only in the presence of H-NS (Wing et al.,
2004). VirB boxes 1 and 2 found at the icsB promoter are also found at the icsP
promoter and are organized as an inverted repeat. Strikingly, and in contrast to the icsB
promoter, these boxes are located over 1 kb away from the icsP TSS (Castellanos et
al., 2009; Figure 1.9). Strikingly, VirB-dependent regulation of the icsP promoter
requires both boxes 1 and 2 (Castellanos et al., 2009; Hensley et al., 2011), suggesting
that a VirB dimer engages both sites. Interestingly, this same site (centered -397
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Figure 1.9 Schematic of the icsP/ospZ intergenic region and identified regulatory elements. The icsP
promoter has two transcription start sites (TSSs) (Hensley et al., 2011), while the ospZ promoter has
only one (Basta et al., 2013). VirB boxes 1 and 2 are both required for VirB-dependent anti-silencing
of the icsP (Castellanos et al., 2009) and ospZ promoters (Basta et al., 2013). 5’ truncation analysis
revealed that sequences located from -893 to -351 relative to the primary TSS is required for
transcriptional silencing of the icsP promoter (Castellanos et al., 2009). A similar analysis revealed
that sequences located between -703 and -384 relative to the ospZ TSS are required for H-NSmediated silencing of the ospZ promoter (Basta et al., 2013).
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upstream of the ospZ TSS) is required for regulation of the divergently transcribed ospZ
promoter by VirB (Basta et al., 2013). A 5’ truncation analysis of the icsP promoter
revealed that sequences between -893 and -351 relative to the primary icsP TSS are
required for complete silencing (Castellanos et al., 2009). Because the analysis was
done at a broad scale, finer truncations are required for more precise mapping. The
mechanisms of silencing and anti-silencing by H-NS and VirB, respectively, at the icsP
promoter are not known.
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1.5 OBJECTIVES OF THIS STUDY
Because of the integral role that both VirB and H-NS play in the regulation of
Shigella virulence genes, my doctoral dissertation work has focused primarily on
elucidating their mechanisms of transcriptional control, using the regulation of the icsP
and divergent ospZ promoters as a model. In Chapter 2, I seek to characterize the
mechanism of H-NS-mediated silencing of the icsP promoter by first mapping the DNA
sequences required and then testing which H-NS nucleoprotein complex is likely to
form. In chapter 3, I study the ability of VirB to alter DNA supercoiling of our PicsP-lacZ
reporter plasmid, a process that may underpin the mechanism of transcriptional antisilencing of virulence genes by VirB in Shigella. In chapter 4, I aim to better understand
VirB:DNA interactions by further characterizing VirB boxes 1 and 2, which are required
for VirB-dependent regulation of the icsP and ospZ promoters, using in vivo and in vitro
methods. The significance of my findings is discussed in Chapter 5.
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CHAPTER 2

THE REGULATION OF VIRULENCE GENES BY H-NS FAMILY MEMBERS IN
SHIGELLA FLEXNERI

2.1 FOREWORD
This chapter is composed of empirical data, some of which is published in a review
article in Genes (Picker & Wing, 2016; Section 2.4.1) as well as Molecular Microbiology
(Weatherspoon-Griffin et al., 2018; Section 2.4.2). A previous research technician, Hiro
S. Park, constructed pHS06 through pHS13 used in my assays.
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2.2 ABSTRACT
The histone-like nucleoid structuring protein transcriptionally silences many virulence
genes found on the large virulence plasmid harbored by all Shigella spp. However, the
mechanism of transcriptional silencing by H-NS has not been elucidated at each
virulence locus. Here, I present evidence in favor of the formation of a H-NS
nucleoprotein filament at the icsP promoter, a known repression mechanism of H-NS.
The genome of each Shigella spp. also encodes another H-NS family member, StpA,
while S. flexneri strain 2457T, a routinely used laboratory strain, has a third H-NS family
member, Sfh. While these proteins can functionally substitute for H-NS at one virulence
locus, the ability of these H-NS-like proteins to regulate other virulence genes has not
been tested. I show that StpA and Sfh can transcriptionally silence the icsP promoter,
and that VirB, an H-NS antagonist, can also alleviate silencing mediated by these two
H-NS family members. The implications for all of these findings for transcriptional
silencing and anti-silencing are discussed.
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2.3 INTRODUCTION
Relative to other H-NS-regulated virulence gene promoters in S. flexneri (Falconi et al.,
1998; Beloin and Dorman, 2003), at the icsP promoter, remote DNA sequences (-893 to
-351 relative to the primary TSS) are required for H-NS-mediated transcriptional
silencing in vivo (Castellanos et al., 2009; Harrison, 2010). A direct, high affinity
interaction of H-NS with fragments of the icsP promoter (Figure 2.1) containing this ATrich region was detected using electrophoretic mobility shift assays (EMSAs) (Harrison,
2010). Interestingly, binding to another discrete, high-affinity DNA target (-214 to +24
relative to the TSS) was also identified (Harrison, 2010; Figure 2.1), but the role of these
sequences in H-NS-mediated silencing remains unclear. The presence of two discrete
H-NS binding regions suggests the formation of a H-NS bridging complex between the
upstream and downstream binding regions (Figure 1.4C) to silence the icsP promoter,
analogous to the H-NS-mediated bridging mechanism of silencing at the virF promoter
(Falconi et al., 1998; Prosseda et al., 2004).

Site required for VirBdependent regulation

Region required for H-NSmediated silencing

+28

icsP
-1137
Regions bound
by H-NS in vitro -1058

-900

+1

-351
-523

-213

+24

Figure 2.1 Target map of the icsP promoter used for electrophoretic mobility shift assays and DNase
I protection assays. The icsP promoter/intergenic region was divided into 6 overlapping DNA targets.
The two block arrows represent the inverted repeat centered at -1137 relative to the primary icsP TSS
that is required for VirB-dependent anti-silencing of the icsP promoter (Castellanos et al., 2009).
Sequences -900 to -351 represent the region required for H-NS-mediated silencing in vivo (Harrison,
2010).
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In addition to H-NS, S. flexneri 2a strain 2457T contains two other H-NS family
members, StpA and Sfh, which share significant homology with H-NS (56.2 and 59.2%
amino acid identity, respectively). Because each H-NS paralog can complement a
number of hns mutant phenotypes in E. coli, and deletion of either alone does not have
any observable effects on the growth of S. flexneri, these proteins have been
hypothesized to function as backups for H-NS (Deighan et al., 2003; Beloin et al.,
2003). When overexpressed, both of these paralogs decrease expression of the
mxiC::lacZ virulence gene present in S. flexneri strain BS184, a derivative of 2457T
(Maurelli and Sansonetti, 1988; Beloin et al., 2003). However, it is not clear if these HNS paralogs silence the VirB-dependent mxiC::lacZ directly, as VirB protein levels are
also reduced when each H-NS family member is expressed (Beloin et al., 2003). While
these data demonstrate that StpA and Sfh can affect virulence gene expression in S.
flexneri, the extent to which each paralog is involved at other virulence gene promoters,
such as the icsP promoter, remains untested.
The overarching aim of this chapter was to investigate H-NS, its family members,
and their role in the regulation of the icsP promoter in S. flexneri. Section 2.4.1 contains
a published review article that seeks to understand the role of H-NS, StpA, and Sfh in
virulence gene regulation in S. flexneri. Section 2.4.2 contains a co-first author
publication in which I probe the mechanism of H-NS-mediated silencing of the icsP
promoter. My other contributions are detailed below.
In Appendix A, I present DNase I protection assay data of recombinant H-NS with
two regions of the icsP promoter. I also present preliminary data of the sequences
required for StpA-mediated silencing of the icsP promoter. In light of these data, I
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reanalyze previously collected data on helical-face dependency on transcriptional
silencing of the icsP promoter in the absence of hns, which suggests that the
mechanism of StpA-mediated silencing is different from the one employed by H-NS.
Together, these sections highlight the complexity of virulence gene regulation by H-NS
and its family members in Shigella, transcriptional regulation from remote regions by
H-NS and StpA, and possible mechanisms of transcriptional silencing of the icsP
promoter by H-NS and StpA.
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2.4 RESULTS
2.4.1 H-NS, ITS FAMILY MEMBERS AND THEIR REGULATION OF VIRULENCE
GENES IN SHIGELLA SPECIES
The original format of this review article published in Genes (2016) was not used in
order to fulfill the formatting requirements of the dissertation. The writing is presented as
published except: the font was changed to Arial, italics have been added to “in vitro, in
vivo, and ex vivo”, figure numbers have been changed for continuity within the
dissertation, in-text citations have been modified. Both authors contributed equally to
the writing of this manuscript and the writing of our response to the reviewers’
comments. I also collected the data presented. The copyright information allowing the
use of this manuscript in my dissertation can be found in Appendix A.
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Abstract: The histone-like nucleoid structuring protein (H-NS) has played a key role in
shaping the evolution of Shigella spp. and provides the backdrop to the regulatory
cascade that controls virulence by silencing many genes found on the large virulence
plasmid. H-NS and its paralogue StpA are present in all four Shigella spp., but a
second H-NS paralogue, Sfh, is found in the Shigella flexneri type strain 2457T, which
is routinely used in studies of Shigella pathogenesis. While StpA and Sfh have been
proposed to serve as “molecular backups” for H-NS, the apparent redundancy of these
proteins is questioned by in vitro studies and work done in Escherichia coli. In this
review, we describe the current understanding of the regulatory activities of the H-NS
family members, the challenges associated with studying these proteins and their role
in the regulation of virulence genes in Shigella.
Keywords: H-NS; Shigella; transcription; xenogeneic silencing; virulence gene
expression; silencing mechanisms; anti-silencing mechanisms.

1. Introduction
Shigella spp. are gram-negative, intracellular bacterial pathogens in the γproteobacteria that cause bacillary dysentery in humans. Four Shigella species have
been described: S. dysenteriae, S. flexneri, S. boydii and S. sonnei. Each of these
species is primarily transmitted by the fecal–oral route and invades cells of the colonic
epithelium. The destruction of the colonic epithelial barrier and the severe inflammation
that follows causes the symptoms of this disease (shigellosis, also known as Marlow
syndrome). Shigella spp. are estimated to cause more than 88 million cases of
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shigellosis each year (Lamberti et al., 2014), and more than 40,000 deaths worldwide
(GBD 2013 Mortality and Causes of Death Collaborators, 2015). These statistics, the
rise of antibiotic resistant strains and the absence of approved vaccines underscore the
need for an improved understanding of the molecular biology of this pathogen so that
novel antibacterial strategies can be found and implemented.
Shigella spp. are close phylogenetic relatives of Escherichia coli. All four Shigella
species harbor a large virulence plasmid (~180–220 kb) (Lan et al., 2001), which is
essential for their pathogenicity. Genes encoded by the virulence plasmid are necessary
for host cell invasion, intra- and intercellular spread and host cell manipulation via the
type III secretion system (Venkatesan et al., 2001). Evidence suggests that the
acquisition and maintenance of the virulence plasmid, its subsequent evolution and the
present day transcriptional regulation of these virulence genes is tied to the
chromosomally-encoded histone-like nucleoid structuring protein, H-NS (Marteyn et al.,
2012; Dorman, 2014; Will et al., 2015).
As a nucleoid structuring protein, H-NS organizes and compacts DNA, but it also
globally regulates the expression of ~5% of all genes in E. coli, many of which are
involved in the transcription, translation and the production of cell envelope components
needed for adaptation to varying environments (Hommais et al., 2001). H-NS
preferentially binds AT-rich DNA, rendering it transcriptionally inactive or silent (Navarre
et al., 2006; Navarre et al., 2007). The silencing of the horizontally acquired AT-rich
DNA has been termed xenogeneic silencing (Navarre et al., 2006). In Shigella, this HNS-dependent process is thought to have allowed the initial acquisition and long-term
maintenance of the large AT-rich (up to 70% in many ORFs) virulence plasmid without
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the newly acquired genes compromising the organism′s fitness. The eventual
integration of these genes into existing transcriptional networks is also predicted to have
been aided by H-NS-mediated silencing (reviewed in Navarre et al., 2007; Ali et al.,
2012; Ali et al., 2014; Will et al., 2015). Today, the ecological fitness of Shigella spp.
both ex vivo and in vivo is tightly connected to the silencing of virulence genes by H-NS.
Outside of the host, transcriptional silencing avoids the costly production of proteins that
provide no benefit to Shigella in the external environment (Dorman, 2014). In contrast,
within the host, silencing mediated by H-NS provides the backdrop for the precise and
hierarchical expression of virulence genes that occurs in response to environmental
cues and signals encountered within the host environment (Stoebel et al., 2008;
Marteyn et al., 2012). Consequently, H-NS has had a profound effect on the evolution of
Shigella spp. and continues to play a central role in the regulation of virulence genes in
this group of important human pathogens.
In addition to H-NS, Shigella spp. contain up to two H-NS paralogues. The first
paralogue, StpA, is chromosomally encoded and found in all Shigella spp. (Dorman and
Porter, 1998). In contrast, the second paralogue, Sfh, is carried by an R27-like plasmid
that is found exclusively in S. flexneri type strain, 2457T (Deighan et al., 2003)—a
clinical isolate that is commonly used in studies that focus on the molecular basis of an
infection. Both StpA and Sfh have been proposed to serve as “molecular backups” for
H-NS because these proteins can transcriptionally silence virulence genes in Shigella in
mutants that lack hns. However, different nucleic acid binding activities and expression
profiles of these proteins (described in more detail later; (Zhang et al., 1996; Deighan et
al., 2003; Doyle and Dorman, 2006)) raise questions about the apparent redundancy of
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StpA and Sfh, their respective and combined activities and their interplay with other
transcriptional regulators of the Shigella virulence gene cascade. Here, we review our
current understanding of H-NS, its two paralogues and their role in the regulation of
virulence genes in Shigella species.
2. H-NS and Its Role in the Regulatory Cascade Controlling the Transcription of
Virulence Genes in Shigella
2.1. The H-NS Protein and Its Interactions with DNA
The H-NS protein is encoded by a gene located in the ter macrodomain of the
chromosome of both E. coli and Shigella spp. In these two closely related organisms, HNS is 100% identical, making in vitro studies on the E. coli H-NS protein directly
applicable to the Shigella protein. H-NS is small (15.4 kDa), highly abundant (20,000
copies per cell in stationary phase cultures (Spassky et al., 1984) and functions as a
dimer or as a larger multimer (Ceschini et al., 2000). Each protein monomer is
comprised of two structural domains separated by a flexible linker: the N-terminal
domain is directly responsible for dimerization/oligomerization, and the C-terminal
domain confers DNA binding activity (Williams et al., 1996; Arold et al., 2010; Renault et
al., 2013; Figure 2.2).
The ability of H-NS to transcriptionally silence genes can be explained by its DNA
binding preference and the nucleoprotein complexes that form. High-affinity binding
sites for H-NS have been found in E. coli (Bouffartigues et al., 2007; Lang et al., 2007),
leading to a proposed consensus binding site (5′-AATTTATCGA-3′; Lang et al., 2007).
More recently however, the width of the DNA minor groove has been demonstrated to
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primarily govern the DNA binding preference of H-NS, with H-NS preferentially binding
to DNA with narrow minor groove widths (Gordon et al., 2011). Interestingly, an
ATATAT motif (Gordon et al., 2011), which is present in the two identical high affinity
binding sites found in the E. coli proU operon, 5′ AATATATCGA 3′ (Bouffartigues et al.,
2007; Lang et al., 2007), is predicted to narrow the minor groove to 3.5 Å (compared to
5.7 Å expected in B-DNA; (Yoon et al., 1988), explaining why these high-affinity sites
bind H-NS so well (Bouffartigues et al., 2007).

Figure 2.2 Alignment of the primary protein sequence of histone-like nucleoid structuring protein
(H-NS), StpA, and Sfh from S. flexneri strain 2457T. Functional domains of H-NS are indicated.
Two thick black bars represent discrete interfaces involved in dimerization that are needed for
the formation of higher order oligomers (Renault et al., 2013). The thick grey bar indicates the
nucleic acid binding domain. Boxed regions represent either the flexible linker region (black) or
the DNA binding motif (grey) (Dorman et al., 1999). Conserved residues are indicated by
asterisks, and similar residues are indicated by colons. Percent amino acid identity: H-NS and StpA
(56.2%), H-NS and Sfh (59.1%), StpA and Sfh (61.9%).

Once bound to a high-affinity region, H-NS oligomerizes along DNA into regions
with lower affinity (Lang et al., 2007; Fang and Rimsky, 2008), leading to the formation
of large H-NS:DNA complexes. Two H-NS nucleoprotein structures have been
visualized and studied using atomic force microscopy (Dame et al., 2000; Dame et al.,
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2005) and single molecule experiments (Dame et al., 2006; Arold et al., 2010). H-NS
bridges form when two discrete DNA regions are brought together by H-NS. In contrast,
nucleoprotein filaments form when H-NS oligomers coat long, contiguous stretches of
DNA. Both of these H-NS:DNA structural complexes are predicted to be involved in the
silencing of virulence genes in Shigella (Tobe et al., 1993; Falconi et al., 1998; Turner
and Dorman, 2007).
2.2. The Role of H-NS in Shigella Virulence Gene Regulation
Under non-physiological conditions (osmolarities lower than physiological, pH below
7.4 and temperatures below 37 °C), H-NS silences many genes encoded by the
Shigella virulence plasmid, including those encoding the transcriptional regulators of the
virulence gene cascade (Maurelli, Blackmon, Curtiss, 1984; Maurelli and Sansonetti, 1988;
Hromockyj et al., 1992; Porter and Dorman, 1994; Porter and Dorman, 1997; Figure 2.3).
Upon a switch to 37 °C, a temperature-dependent remodeling of the H-NS:DNA
complex located within the virF promoter region triggers the production of VirF, the
master regulator of this regulatory cascade (Falconi et al., 1998; Prosseda et al., 2004;
Figure 2.3). Consequently, the thermally-induced modulation of a H-NS:DNA complex
can be considered the key event that triggers the regulatory cascade controlling
Shigella virulence.
At the virF promoter, two discrete H-NS binding regions, centered at -250 and -1
relative to the virF transcription start site, flank a temperature-dependent DNA “hinge”
region (Falconi et al., 1998; Prosseda et al., 2004; Ulissi et al., 2014). At temperatures
below 32 °C, the relative bending and rotational orientation of the two H-NS binding
regions are optimized for H-NS bridging (Prosseda et al., 2004; Figure 2.4A). Since one
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of the H-NS binding regions overlaps the core promoter elements, the formation of the
H-NS bridging complex is thought to occlude RNA polymerase (RNAP) from the virF
promoter (Prosseda et al., 2004). As the temperature increases to 37 °C, movement of
the curvature center disrupts the H-NS-silencing complex, allowing the promoter to
become accessible and virF transcription to proceed (Falconi et al., 2001; Prosseda et
al., 2004; Figure 2.4A). These regulatory events showcase how temperature can induce
changes in DNA topology and cause H-NS bridging structures to be remodeled, leading
to the relief of H-NS-mediated silencing.

Figure 2.3 Overview of the regulatory virulence cascade in Shigella spp. H-NS silences
virulence genes at each step of the virulence cascade. H-NS-mediated silencing of the virF
promoter is alleviated upon a switch to 37 °C. VirF subsequently directly activates the icsA
promoter as well as the virB promoter. Next, many genes on the virulence plasmid are
upregulated by VirB via a counter-silencing mechanism.

Once VirF, an AraC family member, reaches threshold levels, it up-regulates the
transcription of icsA (Sakai et al., 1988) and virB (Tobe et al., 1993; Figure 2). The icsA
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gene encodes the determinant for Shigella actin-based motility (Bernardini et al., 1989;
Goldberg, 2001), whereas virB encodes the next transcriptional regulator of the
regulatory cascade (Tobe et al., 1991; Tobe et al., 1993). While H-NS appears to
silence transcription of both of these genes (Tobe et al., 1993; Porter and Dorman,
1997; Tran et al., 2011; Figure 2.3), we focus on the regulation of virB because of its
integral role in the virulence gene cascade. At the virB promoter, only a single H-NS
binding region has been identified that overlaps the core promoter elements (Tobe et
al., 1993), suggesting that transcription of virB is silenced by an H-NS nucleoprotein
filament that occludes RNAP from this promoter. Indeed, H-NS-dependent silencing of
virB can be observed using in vitro transcription assays. While VirF increases virB
transcription in these in vitro assays, it does so only in the absence of H-NS (Tobe et
al., 1993). Consequently, the authors conclude that VirF does not function to counter HNS-mediated repression, but rather serves as an essential transcriptional activator of
the virB gene once H-NS-mediated repression has been relieved (Tobe et al., 1993). To
date, the event that relieves H-NS-mediated silencing of the virB gene remains unclear.
The production of VirB is a critical step in the Shigella virulence gene cascade
because it relieves H-NS-mediated silencing of virulence genes that has not been
alleviated by temperature alone. VirB up-regulates greater than thirty virulence plasmid
genes (Uchiya et al., 1995; Santapaola et al., 2002; Wing et al., 2004; Le Gall et al.,
2005; Castellanos et al., 2009; Kane and Dorman, 2012; Basta et al., 2013), including
those found within the 30 kb ipa-mxi-spa region, which encode structural components of
the type III secretion system and their effectors, the MxiE transcriptional regulator
(Figure 2.3) as well as several other genes outside of this region. The activity of VirB as
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a transcriptional anti-silencing protein is demonstrated by work at the icsB, icsP and
ospZ promoters, where VirB has no effect on promoter activity in the absence of
functional H-NS (Wing et al., 2004; Turner and Dorman, 2007; Basta et al., 2013). If
VirB solely functions to relieve transcriptional silencing by H-NS, as predicted by the
experiments described above, then any gene found to be directly regulated by VirB will
be silenced by H-NS.

Figure 2.4 Temperature- and protein-dependent mechanisms of counter-silencing in Shigella. (A) At
30 °C, the virF promoter is silenced through H-NS-mediated bridging of two discrete binding
regions separated by a region of DNA curvature. As the temperature increases to 37 °C,
movement of the curvature remodels the H-NS bridging complex leading to virF expression
(Prosseda et al., 1998; Prosseda et al., 2004); (B) H-NS directly silences the icsB promoter.
VirB binds DNA, induces a local DNA bend and oligomerizes along the DNA, which destabilizes
the downstream H-NS silencing complex (Gao et al., 2013).

Indeed, all three VirB-regulated promoters found within the ipa-mxi-spa region are
silenced by H-NS at 30 °C (Beloin and Dorman, 2003), but the silencing and antisilencing of the two divergent promoters that control the ipa (PicsB) and mxi (PipgD)
operons have been more thoroughly characterized (Beloin and Dorman, 2003; Turner
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and Dorman, 2007). The icsB promoter was initially found to be H-NS-responsive using
a PicsB-lacZ transcriptional reporter in an E. coli background. Subsequently,
electrophoretic mobility shift assays (EMSAs) and DNase I footprints revealed that HNS binds the icsB-ipgD intergenic region, protecting sequences between +60 to −220
relative to the icsB transcription start site (TSS) (Turner and Dorman, 2007). Other
analyses in this study suggest that the precise step of transcription initiation to be
inhibited by H-NS is open complex formation, but because binding of RNA polymerase
to the promoter was not demonstrated in the presence of H-NS, it remains unclear if
RNA polymerase binding itself or the formation of the transcriptional bubble is actually
the step inhibited by H-NS (Turner and Dorman, 2007). The transcriptional anti-silencing
of PicsB requires a VirB-binding site centered 120 bp upstream of the icsB TSS. Based
on biochemical and structural studies (Beloin et al., 2002; McKenna et al., 2003; Gao et
al., 2013), a counter-silencing mechanism has been proposed in which VirB binds to its
site, induces a local bend, and oligomerizes along the DNA, thus destabilizing the
downstream H-NS silencing complex (Gao et al., 2013; Figure 3B). At the divergent
promoter ipgD, evidence for H-NS-mediated silencing comes from two different lacZ
transcriptional reporters: an ipgD-lacZ reporter in E. coli (Beloin and Dorman, 2003) and
a lacZ reporter located in the second to last gene of this fifteen gene operon in S.
flexneri (Hromockyj et al., 1992), as well as Northern analysis in S. flexneri (Porter and
Dorman, 1997). While it remains unclear if the same sequences required for H-NSmediated silencing and VirB-dependent anti-silencing of the icsB promoter are also
required for the regulation of the ipgD promoter, this does seem likely given the close
proximity of these two promoters.
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An example of a VirB–-regulated gene that lies outside of the ipa-mxi-spa region is
icsP. Promoter activity of this gene was measured using a plasmid-borne PicsP-lacZ
reporter in both E. coli and Shigella backgrounds (Wing et al., 2004; Castellanos et al.,
2009). While 5′ truncation analyses of the icsP promoter reveal that the DNA sequences
located between 800 and 350 bp upstream of the primary icsP TSS are required for HNS-mediated repression (Harrison, 2010), the VirB binding site required for
transcriptional anti-silencing of this promoter lies over 1 kb upstream of the primary icsP
TSS (Castellanos et al., 2009; Hensley et al., 2011). To date, it remains unclear how
silencing and anti-silencing of the icsP promoter occurs from such remote sites.
The final step of the virulence gene cascade is triggered by the VirB-dependent upregulation of the mxi operon because mxiE encodes the last transcriptional regulator of
this cascade (Figure 2.3). In response to activation of the type III secretion system,
MxiE and its co-activator IpgC transcriptionally activate a suite of genes encoding type
III secretion effector molecules. While some of these genes are also regulated by VirB
(Le Gall et al., 2005), to the best of our knowledge, the regulatory interplay of MxiE and
IpgC, VirB and H-NS at these promoters has not been studied.
In summary, the effect of H-NS on Shigella virulence gene expression is pervasive
(Figure 2.3). A switch to 37 °C is absolutely required to alleviate H-NS-mediated
silencing and is caused either by a temperature-induced change in DNA topology
(Figure 2.4A) or through the temperature-dependent production of VirB, a countersilencing protein (Figure 3B). Mechanistically, H-NS-mediated silencing appears to rely
on the occlusion of promoter elements by H-NS (Figure 2.4A & B). Importantly however,
with the exception of work done at the virF promoter (Falconi et al., 1998) where an in
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vivo dimethyl sulfate footprint was employed, most evidence in the Shigella literature
supporting H-NS-mediated promoter occlusion comes from in vitro DNase I protection
assays (Tobe et al., 1993; Beloin and Dorman, 2003; Turner and Dorman, 2007).
Importantly, these studies do not show promoter occlusion per se, but simply show HNS occupying promoter regions in the absence of all other proteins. Given that promoter
regions are AT-rich, perhaps it is not surprising to find that H-NS binds to promoter
regions in vitro. At other virulence plasmid loci, including the icsP region, the region
required for H-NS-mediated silencing does not overlap promoter elements (Harrison,
2010). This raises the possibility that other H-NS binding regions have yet to be
identified or that other mechanisms of H-NS-mediated silencing exist. In fact, other
models of silencing have been proposed that suggest H-NS may interfere with
transcription elongation rather than transcription initiation (Schröder and Wagner, 2000;
Lim, et al., 2012; Lim et al., 2014). Furthermore, the recent finding that H-NS is tyrosine
phosphorylated in S. flexneri 2457T (Standish et al., 2016), raises the possibility that
post-translational modification of H-NS may regulate H-NS:DNA interactions and cause
changes in H-NS-mediated silencing of virulence genes in this bacterium. Clearly, there
is still much to be learned about the role of H-NS in this important human pathogen.
3. Activities of the H-NS Paralogues StpA and Sfh and Their Possible Roles in
Virulence Gene Regulation
The two other H-NS family members found in Shigella spp., —StpA (58% identical
to H-NS and 100% identical to StpA in E. coli) and Sfh (59% identical H-NS), —share a
similar domain organization to H-NS (Deighan et al., 2003; Figure 2.2). As a
consequence, all three proteins have the ability to interact with one another to form
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heteromeric complexes (Deighan et al., 2003). In addition, StpA and Sfh can
complement various H-NS-dependent phenotypes in E. coli, restoring Bgl (ability to use
β-glucosides) and mucoidy phenotypes to those exhibited by wild type (Beloin et al.,
2003), leading to the proposal that StpA and Sfh primarily serve as a backup system for
H-NS in Shigella (Deighan et al., 2003; Beloin et al., 2003; Müller et al., 2010). In
support of this, stpA and sfh transcripts are significantly elevated in an hns mutant
background, whereas hns transcript levels are not significantly altered in stpA or sfh null
mutants (Deighan et al., 2003). As “molecular backups” for H-NS, these proteins may
mitigate potentially harmful effects caused by either the occasional loss of a functional
hns gene or the acquisition of AT-rich DNA by horizontal gene transfer (Müller et al.,
2010; Ali et al., 2014; Hüttener et al., 2014). Although only two studies have examined
the regulatory activities of the H-NS paralogues in Shigella (Deighan et al., 2003; Beloin
et al., 2003), the activities of these proteins have been studied more extensively in E.
coli or Salmonella (Zhang et al., 1996; Dame et al., 2005; Doyle et al., 2007; Dillon et
al., 2010). Since some of these reported activities may influence virulence gene
regulation in Shigella spp., we will review these activities before describing our current
understanding of the role that StpA and Sfh play in Shigella virulence gene regulation.
3.1. Reported Activities of StpA and Sfh in E. coli and Salmonella
In E. coli, StpA serves to supplement the H-NS pool through its transient expression
during exponential growth (Free and Dorman, 1997; Dorman, 2014). The routine
presence and conserved location of stpA in E. coli, Salmonella and Shigella strains
strongly suggests that this paralogue arose through an hns gene duplication event that
predates the divergence of these bacterial clades from one another (Tendeng and
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Bertin, 2003). Like H-NS, StpA constrains DNA supercoils and forms bridges and
nucleoprotein filaments on AT-rich DNA exhibiting planar curvature (Zhang et al., 1996;
Azam et al., 1999; Dame et al., 2001; Dame et al., 2005). Interestingly, StpA filaments
are more stable than H-NS filaments when measured in vitro (Lim, et al., 2012),
suggesting the regulatory activities of StpA and H-NS may differ. While initial
identification of StpA was as a protein that suppresses a splicing defective td- intron
mutant from bacteriophage T4 when overexpressed in vivo (Zhang and Belfort, 1992),
subsequent in vitro studies revealed that its RNA chaperone activity was responsible for
this phenotype, promoting proper RNA folding and the formation of a competent, selfsplicing intron (Zhang et al., 1995; Zhang et al., 1996; Cusick and Belfort, 1998).
Indeed, StpA binds RNA more strongly than H-NS, an activity that is demonstrated to
promote intra-strand RNA annealing or strand displacement (Rajkowitsch and
Schroeder, 2007). Another example of StpA serving as a regulator of RNA activity can
be seen in E. coli, where StpA destabilizes the sRNA MicF. Since MicF functions to
block translation of the OmpF porin, the actions of StpA make it a negative posttranscriptional regulator of MicF. Interestingly, H-NS also negatively regulates MicF
levels but does so by repressing transcription and hence the production of this sRNA
(Suzuki et al., 1996; Deighan et al., 2000). Thus, it is clear that at certain genetic loci,
StpA and H-NS are not functionally redundant, but instead, serve independent and
distinct roles as regulators of gene expression.
In contrast to StpA, much less is known about the Sfh protein. Sfh shares higher
amino acid identity with StpA than H-NS (62% versus 59%, respectively). Unlike StpA,
Sfh is encoded by the R27-like conjugative plasmid found exclusively in S. flexneri
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strain serotype 2a, 2457T (Deighan et al., 2003). While it remains unclear how or when
this plasmid was acquired by 2457T, evidence from Salmonella enterica Typhimurium
suggests that Sfh facilitated the acquisition of this AT-rich plasmid by preventing native
pools of H-NS being titrated away from AT-rich sequences located on both the Shigella
chromosome and virulence plasmid (Doyle et al., 2007; Dillon et al., 2010). In support of
this hypothesis, when a copy of the R27-like plasmid lacking sfh was introduced into S.
enterica Typhimurium, the expression of over 300 genes was altered when compared to
the wild type plasmid (Doyle et al., 2007; Dillon et al., 2010). Doubts about this titration
hypothesis, however, have been raised because many of the genes showing altered
expression were not identified as H-NS-regulated in previous studies and multiple bona
fide H-NS-regulated genes were not affected by the introduction of the Δsfh plasmid
(Navarre, 2010). Regardless, it does appear that the presence of Sfh has enabled
2457T to acquire the R27-like conjugative plasmid by minimizing fitness defects,
suggesting more broadly that the presence of H-NS-like proteins on conjugative
plasmids may facilitate their dissemination to a variety of different bacterial populations
(Navarre, 2010).
3.2. Important Considerations When Studying Virulence Gene Regulation by the H-NS
Family
The presence of three H-NS family members in S. flexneri strain 2457T raises
questions about their expression profiles. Protein levels of each H-NS family member
found in 2457T have been measured in wild type cultures grown in LB broth at 37 °C
(Deighan et al., 2003; Doyle and Dorman, 2006). While H-NS levels remain relatively
constant throughout growth, StpA protein levels peak in early exponential phase and
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drop precipitously to undetectable levels in stationary phase cultures. In contrast, Sfh
protein levels follow an opposite pattern, where they are very low in exponential growth
and increase about 2.5-fold as cultures enter stationary phase. These different
expression profiles support the idea that each member of the H-NS family may serve a
discrete, physiological role in Shigella. Furthermore, they allow hypotheses to be
generated about when heteromeric interactions between family members are most likely
to occur (if they occur), and when Shigella virulence gene expression is likely regulated
by individual proteins or combinations thereof, at least under the conditions tested.
Another important consideration when studying virulence gene regulation by the HNS family in Shigella is the nature of the hns mutant being used. The hns mutant alleles
used in Shigella studies (hns::Tn10; Maurelli and Sansonetti, 1988 & hns::Knr; Tobe et
al., 1993) are not true null mutants, but rather encode heavily truncated proteins
comprised of the N terminal oligomerization domain or part of it (1–93 or 1–37 amino
acids, respectively) (Yamada et al., 1991; Williams et al., 1996; Beloin et al., 2003; Wing
et al., 2004; Figure 2.2). Since H-NS, StpA and Sfh are known to oligomerize with
themselves as well as with each other (Deighan et al., 2003; Beloin et al., 2003), these
truncated derivatives of H-NS are capable of interacting with StpA and Sfh and partially
disrupting their nucleic acid binding activity in a dominant-negative manner (Williams et
al., 1996). Consequently, use of dominant-negative hns mutant alleles is likely to mask
the activities of these proteins. This is supported by data collected at the icsP promoter
where promoter activity was measured in a wild type E. coli background or in isogenic
derivatives containing either an hns dominant-negative allele or hns or stpA nulls. In the
hns or stpA null backgrounds, activity of the icsP promoter was repressed similar to wild
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type, but was significantly higher in the hns dominant-negative mutant background
(Figure 2.5). These findings are consistent with previous studies that have characterized
these mutant alleles (Battesti et al., 2012). The data presented in Figure 2.5 demonstrate a
clear phenotypic difference between the hns dominant-negative mutant and null alleles,
which may explain why dominant-negative alleles rather than hns null mutants have
been used in studies of Shigella virulence. Interestingly though, when hns or its family
members were induced from pBAD plasmids in the hns dominant-negative background,
icsP promoter activity decreased significantly (Figure 2.6; compare the white bars).
These data and those presented in Figure 2.5 are consistent with the hns dominantnegative allele masking the activity of native H-NS family members, but demonstrate
that any of the hns paralogues can overcome this dominant-negative effect when they
are overexpressed. These findings clearly highlight the importance of understanding the
type of hns mutant allele being used in an experiment so that the resulting data can be

Figure 2.5 StpA and Sfh can silence the icsP promoter in the absence of H-NS. Activity of the
PicsP-lacZ reporter was measured in the absence of H-NS or StpA in E. coli MC4100 and its
isogenic derivatives. β-galactosidase activity was measured after cells had been grown at 37 °C, as
described previously (Wing et al., 2004). Strains denoted hns and stpA are true null mutants,
whereas hns::Knr carries a dominant-negative allele. Representative data of three independent
trials are shown. A Student’s T-test was performed for statistical significance, * p < 0.05.
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interpreted appropriately.
3.3. The Role of StpA and Sfh in Shigella Virulence Gene Regulation
Our understanding of the involvement of StpA and Sfh in virulence gene regulation
in Shigella is relatively rudimentary compared to H-NS and is limited to analyses of the
H-NS-silenced and VirB-anti-silenced mxi operon. These analyses were carried out in a
2457T derivative named BS184 (Maurelli and Sansonetti, 1988), which contains a
mxiC::lacZ transcriptional fusion in the large mxi operon located on the virulence
plasmid. As expected for an H-NS-regulated locus, lacZ production in BS184 is low at
30 °C, but elevated at 37 °C in stationary phase cultures, consistent with the wellcharacterized temperature-dependent regulation of virulence genes in Shigella (Maurelli
and Sansonetti, 1988). Furthermore, a BS184 derivative carrying an hns dominantnegative mutant allele showed elevated levels of lacZ activity at 30 °C (Beloin et al.,
2003), consistent with loss of H-NS-mediated silencing (Maurelli and Sansonetti, 1988)
and data collected at the icsP promoter (Figure 2.5). This phenotype is likely caused by
both the loss of functional H-NS and the partial negative effect that the heavily truncated
H-NS protein has on the activities of StpA and Sfh because BS185 carries an hns
dominant-negative allele. In contrast, lacZ production in BS184 derivatives carrying
clean deletions of sfh, stpA or both was similar to that observed in the BS184 wild type
background at 30 °C and 37 °C. This finding strongly suggests that StpA and Sfh do not
play a regulatory role at this locus in the presence of H-NS (Beloin et al., 2003).
Interestingly, when the hns dominant-negative allele was combined with the sfh
deletion, lacZ activity increased at 30 °C above levels observed in the hns mutant,
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suggesting that Sfh may participate in the regulation of the mxi locus, but only in the
absence of functional H-NS.
In the same study, overexpression of either stpA or sfh in the BS184 background
led to a decrease in lacZ expression at 37 °C (Beloin et al., 2003). Under these
experimental conditions, VirB protein levels were dramatically decreased, most likely
because overexpression of the paralogues had led to the silencing of the virB promoter,
the virF promoter or both. This decrease in ipgD promoter activity may have been
caused by the paralogues themselves or through a loss of VirB anti-silencing. Support
for the indirect modulation of the mxi operon by StpA and Sfh was provided by EMSAs
using DNA fragments taken from the virB and virF promoters. Recombinant H-NS, StpA
and Sfh proteins were shown to bind to these DNA sequences in a concentrationdependent manner. It is surprising that DNA fragments taken from the ipgD promoter
were not used in this experiment because this promoter controls the mxiC::lacZ
transcriptional reporter in BS184. It is also unfortunate that the stability of the >9 kb mxi
transcript generated prior to the lacZ fusion was not examined in the presence and
absence of the paralogues because StpA, at least, has been shown to modulate RNA
stability (Deighan et al., 2000; Rajkowitsch and Schroeder, 2007).
In summary, it is clear that StpA and Sfh can be a substitute for H-NS, but it is not
known whether the silencing imparted by these proteins is mechanistically identical to
that mediated by H-NS. Furthermore, it remains unclear if the backup role exhibited by
StpA and Sfh in these assays is the only regulatory effect that these proteins impart in
the context of Shigella virulence gene expression.
4. Can VirB Alleviate StpA- and Sfh-Mediated Silencing?
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The observation that StpA and Sfh can silence virulence genes, albeit in the
absence of H-NS, not only raises questions about the silencing activities of these
proteins, but also about their interplay with the Shigella counter-silencing protein VirB.
To address this, we tested whether VirB can alleviate silencing mediated by either of the
two H-NS paralogues StpA and Sfh at the icsP promoter. To do this, an E. coli hns
dominant-negative background was used to avoid some of the complications that arise
when using similar mutant alleles in Shigella, including artifacts caused by the instability
of the virulence plasmid and indirect effects caused by the up-regulation of both virF
and virB genes. In the E. coli hns dominant-negative mutant background,
overexpression of hns, stpA or sfh leads to silencing of the icsP promoter (Figure 2.6;
compare the white bars). Moreover, expression of virB from an inducible promoter

Figure 2.6 VirB can alleviate silencing mediated by H-NS family members at the icsP promoter.
Activity of the PicsP-lacZ reporter was measured in an E. coli MC4100 hns dominant-negative
mutant carrying two additional inducible plasmids (pCA24N or its derivatives bearing an hns
family member and pBAD or its derivative bearing virB). Each hns family member was induced
(0.2 mM IPTG) from the pCA24N series throughout growth in Luria-Bertani broth at 37 °C for 5
h. In the last hour of growth, virB was induced with L-arabinose (0.2% w/v). Assays were
conducted in triplicate and representative data of three independent trials are shown. A
Student’s T-test was performed for statistical significance, * p < 0.05.
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relieved this silencing (Figure 2.6; compare the black bars to the white bars).
Consequently, these data show that in addition to H-NS, VirB can alleviate
transcriptional silencing mediated by StpA or Sfh. While the relevance of this finding in
the context of Shigella physiology remains unclear, evidently VirB does have the ability
to relieve silencing mediated by StpA or Sfh if required to do so.
5. Conclusions and Perspectives
Over 25 years ago, the importance of H-NS as a regulator of Shigella virulence was
established (Maurelli and Sansonetti, 1988). Despite this, questions remain about the
underlying mechanisms of H-NS-mediated silencing of virulence genes. While a
mechanism of promoter occlusion appears to be fairly common, conclusive
experimental support has been collected at only a few genetic loci. The finding that
some regions on the Shigella virulence plasmid do not overlap promoter elements (Tran
et al., 2011) may indicate that alternative mechanisms are at play. Indeed, alternative
mechanisms of H-NS-mediated silencing have been proposed, including those that
result in H-NS interfering with other steps of transcription initiation (Schröder and
Wagner, 2000; Lim, Whang, et al., 2012; Lim et al., 2014) or the process of
transcriptional elongation (Kotlajich et al., 2015). Consequently, it seems likely that
more than one mechanism of H-NS-mediated silencing may be involved in the
regulation of Shigella virulence genes.
In this regard, if we are to more thoroughly understand H-NS-mediated silencing in
Shigella, a global in vivo approach will be required. Indeed, the identification of sites
bound by H-NS in vivo at 30 °C and 37 °C and in the presence and absence of virB
would provide valuable insight into virulence gene regulation in Shigella and provide a
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foundation for studies that seek to clarify mechanisms of silencing and anti-silencing.
On a separate but related topic, the recent finding that H-NS family members are
phosphorylated in S. flexneri (Standish et al., 2016) and E. coli (Hansen et al., 2013)
raises the possibility that post-translational modification of H-NS family members may
also regulate interactions with DNA, triggering changes in the silencing of virulence
genes. Clearly, it is an exciting time to be studying the H-NS family of proteins and their
role in virulence gene regulation.
The observation that Shigella spp. contain one and sometimes two H-NS
paralogues adds another layer of complexity to virulence gene regulation in this
pathogen. Most of the evidence gathered in Shigella suggests that the paralogues act
as a functional substitute for H-NS, a finding that is further supported by VirB alleviating
either StpA- or Sfh-mediated silencing of the icsP promoter (Figure 2.6). In contrast,
other lines of evidence support the possibility that the paralogues exhibit additional
regulatory roles. These include the observations that StpA can regulate RNA stability
(Deighan et al., 2000; Rajkowitsch and Schroeder, 2007), the in vitro properties of StpA
and H-NS filaments differ from one another (Lim, et al., 2012) and all three H-NS family
members display distinct expression profiles in S. flexneri strain 2457T (Deighan et al.,
2003). It is possible that some of these additional regulatory activities have been
obscured by the exclusive use of hns mutants bearing dominant-negative alleles in
Shigella research. Nevertheless, through careful experimentation, additional roles of
StpA and Sfh and their regulatory effects on virulence gene expression may be
identified in Shigella.

53

In order to get a clear view of the role of each H-NS family member, it will be
important to study each protein in the absence of the other family members. The use of
null mutants, alone or combination, may elucidate how these proteins function
independently and coordinately to regulate virulence genes. The risk of these studies is
that the remaining protein may or may not be present at levels found in wild type cells
due to the fact that H-NS family members are capable of negative auto- and crossregulation (Deighan et al., 2003). This would need to be investigated because elevated
or diminished levels of protein could lead to phenotypic artifacts. An alternative
approach would be to delete all genes encoding the family members and to reintroduce
each gene independently in trans. The downside of this approach is that, at least in E.
coli, mutants lacking all genes encoding H-NS family members are prohibitively sick
(Sondén and Uhlin, 1996; Müller et al., 2006). Nevertheless, with careful planning and
the use of multiple approaches to validate observed activities, it seems likely that a
clearer understanding of the roles exhibited by the H-NS paralogues found in Shigella
will be achieved.
A further layer of complexity arises from the finding that all three H-NS family
members are capable of forming heteromers with each other, at least in a yeast twohybrid assay (Deighan et al., 2003). Currently, evidence to support the natural formation
of H-NS family heteromers in Shigella is lacking. The tendency of these proteins to form
heteromers, however, is an important consideration for investigators because
heteromeric complexes may form when two or more H-NS family members are
expressed together at high levels. Furthermore, it is possible that the resulting
heteromers will have different activities than their homomeric counterparts.
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To conclude, Shigella presents a fascinating opportunity to study the relationship
between H-NS, StpA and Sfh and their role in the regulation of virulence gene
expression in this important human pathogen. The presence of two or more of these
nucleoid structuring proteins in all Shigella species, pathogenic E. coli and Salmonella
strains and many other bacterial pathogens elevates interest in this family of proteins
that are intricately tied to bacterial physiology and virulence. Since loss of H-NS family
members causes severe growth defects in some bacteria, H-NS and its paralogues may
constitute prime molecular targets for novel antibacterial therapies.
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2.4.2 INSIGHTS INTO TRANSCRIPTIONAL SILENCING AND ANTI-SILENCING IN
SHIGELLA FLENXERI: A DETAILED MOLECULAR ANALYSIS OF THE ICSP
VIRULENCE LOCUS
The goal of this publication was to better understand transcriptional silencing and
anti-silencing of the icsP promoter by H-NS and VirB, respectively. This goal was
achieved by first defining the DNA regulatory sequences required for each protein.
Defining this region is a required first step because it allows hypotheses to be generated
for how H-NS silences the icsP promoter. Next, we then probed the physical, spatial,
and helical relationship between the identified sequences. My contributions are listed at
the end of the publication. I purified the H-NS protein used in the EMSAs conducted by
Dr. Weatherspoon-Griffin. I also created the graphical abstract and contributed to the
writing and editing of the manuscript as well as the response to the reviewers’
comments.
The manuscript has been modified to fulfill the formatting requirements of the
dissertation guidelines: the figure numbers were altered for continuity, “Figure 2.7
Graphical Abstract” was added, a space was added between value and “°C”, “Fig.” was
changed to “Figure”, and in-text citations were modified to fit with rest of dissertation.
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Summary
Transcriptional silencing and anti-silencing mechanisms modulate bacterial physiology
and virulence in many human pathogens. In Shigella species, many virulence plasmid
genes are silenced by the histone-like nucleoid structuring protein H-NS and antisilenced by the virulence gene regulator VirB. Despite the key role that these regulatory
proteins play in Shigella virulence, their mechanisms of transcriptional control remain
poorly understood. Here, we characterize the regulatory elements and their relative
spacing requirements needed for the transcriptional silencing and anti-silencing of icsP,
a locus that requires remotely located regulatory elements for both types of
transcriptional control. Our findings highlight the flexibility of the regulatory elements’
positions with respect to each other, and yet, a molecular roadblock docked between
the VirB binding site and the upstream H-NS binding region abolishes transcriptional
anti-silencing by VirB, providing insight into transcriptional anti-silencing. Our study also
raises the need to re-evaluate the currently proposed VirB binding site. Models of
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transcriptional silencing and anti-silencing at this genetic locus are presented, and the
implications for understanding these regulatory mechanisms in bacteria are discussed.
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Introduction
Nucleoid structuring proteins (NSPs) mediate transcriptional silencing of bacterial
genes by binding, compacting and organizing DNA, activities that frequently render
58

promoter regions inaccessible (Dorman and Deighan, 2003; Turner and Dorman, 2007).
Transcriptional anti-silencing proteins relieve this repression through poorly
characterized mechanisms, although it is clear that remodeling of the NSP-DNA
complex is involved (reviewed in Stoebel et al., 2008). Using the human bacterial
pathogen Shigella flexneri as a model, our goal is to further characterize mechanisms of
transcriptional silencing and anti-silencing of target genes found on the large (222 kb)
virulence plasmid. At temperatures below 37 °C, many of these target genes are
transcriptionally silenced by the NSP H-NS (Hromockyj and Maurelli, 1989; Beloin and
Dorman, 2003). Upon a switch to 37 °C, VirF, the master activator of virulence genes,
triggers the production of the anti-silencing protein VirB (Tobe et al., 1991), which
subsequently functions to relieve H-NS-mediated silencing of virulence genes that is not
relieved by the temperature increase alone (Wing et al., 2004). Despite the importance
of the interplay between H-NS and VirB for Shigella virulence, mechanistic insight into
transcriptional silencing and anti-silencing of virulence genes in Shigella is limited
(Beloin et al., 2002; Turner and Dorman, 2007; Gao et al., 2013).
The transcriptional silencing activity of H-NS can be explained by its DNA binding
preference and the resulting nucleoprotein complexes that form (reviewed in Picker and
Wing, 2016). H-NS preferentially binds AT-rich DNA (Williams and Rimsky, 1997;
Navarre et al., 2006; Bouffartigues et al., 2007), which is a common feature of bacterial
promoters (Landick et al., 2015) and horizontally acquired genetic loci (Navarre et al.,
2007), including virulence genes. Although a high-affinity binding site for H-NS has been
proposed (Bouffartigues et al., 2007; Lang et al., 2007), AT-rich DNA tracts that produce
narrow minor groove widths primarily govern the DNA binding preference of H-NS
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(Gordon et al., 2011). Once bound to DNA, H-NS oligomerizes along the helix into
regions with lower binding affinities (Lang et al., 2007; Fang and Rimsky, 2008), leading
to the formation of large H-NS-DNA complexes. Two H-NS-DNA complexes have been
described: H-NS nucleoprotein filaments that coat long, contiguous stretches of DNA,
and H-NS bridging complexes that bring two discrete regions together by direct H-NSH-NS interactions (Dame et al., 2000; Dame et al., 2005; Dame et al., 2006; Arold et al.,
2010). Both of these nucleoprotein complexes have been implicated in the silencing of
virulence genes in Shigella (Tobe et al., 1993; Falconi et al., 1998; Prosseda et al.,
2004; Turner and Dorman, 2007).
The anti-silencing protein VirB belongs to the ParB protein superfamily (Taniya et al.,
2003; Turner and Dorman, 2007) that contains both chromosomal and plasmid
partitioning factors, including SopB and Spo0J. Consequently, VirB appears to have
been co-opted to a new role in Shigella where it serves to relieve transcriptional
silencing mediated by H-NS and its family members (Turner and Dorman, 2007; Stoebel
et al., 2008; Picker and Wing, 2016). VirB is a bona fide anti-silencing protein because it
up-regulates transcription of its target genes in the presence of H-NS, but has little to no
effect on these genes in its absence (Wing et al., 2004; Turner and Dorman, 2007;
Basta et al., 2013 and reviewed in Stoebel et al., 2008). The DNA binding activity of
VirB is necessary for its role as a transcriptional regulator (Beloin et al., 2002; Gao et
al., 2013). Even though a DNA recognition site for VirB, 5’-RWG(G)AAAT-3’, has been
proposed (Taniya et al., 2003), this site is only loosely supported by in vitro assays
(Taniya et al., 2003), making the validity of the proposed site uncertain.
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To date, the best studied example of a transcriptionally silenced and anti-silenced
virulence gene locus in Shigella is the icsB promoter, which controls the ipa operon
located within the invasion locus on the large virulence plasmid (Taniya et al., 2003;
Turner and Dorman, 2007). Here, DNA sequences required for both transcriptional
silencing by H-NS and anti-silencing by VirB are promoter-proximal, located within 150
bp upstream of the icsB transcription start site (TSS; Turner and Dorman, 2007). The
VirB binding site at this genetic locus is organized as a near-perfect inverted repeat
separated by a single base pair. Interestingly, only the upstream half (known as Box 2)
is reported to be necessary for VirB-dependent regulation of the icsB promoter in vivo
and VirB binding in vitro (Taniya et al., 2003). As such, this site appears to be consistent
with the currently proposed VirB binding site (Taniya et al., 2003).
To improve our understanding of transcriptional silencing and anti-silencing and how
this process regulates virulence gene expression in Shigella, our work has focused on
characterizing another H-NS and VirB- regulated gene, icsP (Wing et al., 2004;
Castellanos et al., 2009; Africa et al., 2011; Hensley et al., 2011), which encodes the
IcsA-specific outer membrane protease (Shere et al., 1997; Egile et al., 1997;
Steinhauer et al., 1999; Wing et al., 2005). Several features of the icsP locus make it
different from the icsB locus and justify our interest in characterizing its silencing and
anti- silencing. These include its regulation by two promoters (Hensley et al., 2011), its
location outside of the invasion locus (100 kb away) and the unusually long, 1.5 kb
intergenic region upstream of the icsP gene (Castellanos et al., 2009). Our previous
studies of icsP reveal that H-NS silences the transcription of icsP at 37 °C in the
absence of VirB (Wing et al., 2004). Consistent with its role as an anti-silencing protein,
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VirB has little to no effect on icsP promoter activity in the absence of a functional hns
gene (Wing et al., 2004). VirB-dependent anti-silencing of icsP relies on a DNA
sequence (Castellanos et al., 2009) resembling that found at the icsB promoter: a nearperfect inverted repeat, with each half bearing similarity to the proposed VirB binding
site (Taniya et al., 2003). Unlike the VirB regulatory site at the icsB promoter, however,
both halves of the inverted repeat are required for VirB-dependent regulation of icsP
(Castellanos et al., 2009). Strikingly, and in contrast to the icsB promoter, these sites
are remotely located, centered 1137 bp upstream of the primary icsP TSS (Castellanos
et al., 2009). These differences raise questions about the mechanism of transcriptional
anti-silencing mediated by VirB.
Here, we focus on the detailed characterization of the remotely located regulatory
elements controlling the expression of icsP and their relative spacing requirements to
improve our understanding of the mechanisms of transcriptional silencing and antisilencing of virulence gene expression in Shigella (Wing et al., 2004; Stoebel et al.,
2008; Picker and Wing, 2016). We present a model of transcriptional regulation by HNS and VirB at the icsP locus and discuss the implications of our findings for those
studying mechanisms of transcriptional silencing and anti-silencing in other bacteria.

Results
Remote DNA sequences located between -900 and -436 are required for H-NSmediated silencing of the icsP promoter
Previous studies revealed that sequences located between -1232 (full-length icsP
intergenic region) and -351 relative to the primary TSS (+1) of icsP were required for full
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silencing of the icsP promoter, with partial silencing observed when sequences up to 665 were present (Castellanos et al., 2009). However, it was unclear if this silencing
was mediated by H-NS, and the sequences involved needed to be more precisely
mapped. To address this, a 5’ truncation series of the icsP intergenic region was
constructed, extending as far as -92 (Egile et al., 1997; Hensley et al., 2011).

Figure 2.8 Precise mapping of DNA sequences required for H-NS-mediated silencing of PicsP are
capable of binding H-NS. A. Activities of the PicsP-lacZ and 5’ truncation derivatives in wild-type E. coli
MC4100 and its isogenic hns::Knr mutant. β-Galactosidase activities are expressed as a percentage of
repression exhibited by the full-length PicsP-lacZ in wild-type MC4100. Upstream boundary of constructs
relative to the primary TSS (+1) (Hensley et al., 2011) are listed from left to right: -1232 (full-length), -1056
bp, -900 bp, -893 bp, -874 bp, -838 bp, -683 bp, -665 bp, -637 bp, -601 bp, -550 bp, -436 bp, -351 bp, 254 bp and -92 bp. All data generated in the wild-type (MC4100) background, except those annotated ns,
are statistically different from the full-length promoter (P < 0.001). All data generated in the hns::Knr
mutant, except those annotated NS, are statistically different from the identical construct measured in the
wild-type strain (P < 0.05). B. Schematic of the six DNA targets (T1–T6) used in EMSAs to identify H-NS
binding regions. All coordinates given are relative to the primary icsP TSS (Hensley et al., 2011). Inverted
arrows represent the VirB boxes essential for VirB-dependent regulation (Castellanos et al., 2009). C. In
vitro binding of purified, recombinant H-NS-His6 to six DNA targets (T1–T6) as determined by EMSAs.
Each radiolabeled target was incubated with final concentrations of 0, 10.7, 13.4 or 16.1 µM (for each
panel, lanes 1–4, respectively) of H-NS-His6. DNA and the resulting nucleoprotein complexes were
separated by polyacrylamide gel electrophoresis.
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Subsequently, each DNA fragment was introduced into our PicsP-lacZ transcriptional
reporter pAFW04 (Basta et al., 2013), and the resulting constructs were assayed for βgalactosidase activity in the Escherichia coli strain MC4100 and an isogenic mutant
lacking a functional hns allele (MC4100 hns::Knr). These strains have been routinely
used to investigate the role of H-NS in the regulation of Shigella promoters (Beloin et
al., 2003; Wing et al., 2004; Basta et al., 2013; Picker and Wing, 2016) because they
avoid the genetic instability routinely exhibited by Shigella hns mutants (Schuch and
Maurelli, 1997) and eliminate interference arising from the dysregulation of virB in the
absence of hns (Tobe et al., 1993; Falconi et al., 1998). Our data show that DNA
sequences located between -900 and -436 are needed for H-NS-mediated silencing of
the icsP promoter in vivo (Figure 2.8A). In wild-type cells, 90% repression was observed
when this region is present in its entirety, and 5΄ truncations from -436 to -92 displayed
repression levels similar to those observed in the hns mutant. These data raise the
possibility that H-NS binds throughout this remote region to confer direct H-NSmediated silencing of the icsP promoter.
H-NS directly binds to two discrete regions upstream of the icsP gene
To determine if H-NS binds directly to the DNA located upstream of the icsP gene,
electrophoretic mobility shift assays (EMSAs) were used. The full intergenic region
upstream of icsP (1.2 kb) was divided into six nearly equal length DNA targets (Figure
2.8B). Each radiolabeled target was incubated with increasing concentrations of
purified, His-tagged H-NS, and the resulting DNA-protein complexes were resolved by
polyacrylamide gel electrophoresis (Figure 2.8C). Because H-NS oligomerizes along
DNA (Lang et al., 2007), H-NS-DNA complexes do not appear as discrete shifted bands
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in EMSAs, but instead, appear more diffuse (Azam et al., 1999; Doyle et al., 2007).
Nonetheless, we fully expected that H-NS would interact with some of the six DNA
fragments at lower concentrations than others.
H-NS caused pronounced shifts of T4 and T5 at the lowest concentration used (10.7
µM; Fig. 2.8C), although moderate shifts of T1, T3 and T6 were also observed with this
concentration. The only targets, however, to solely exhibit discrete shifts at the highest
concentration of H-NS (16.1 µM) were T1, T4 and T5 (T3 showed a mixture of discrete

Figure 2.9 Helical phasing and spacing requirements between H-NS binding regions at the icsP
promoter. A. Schematic showing the size and location of deletions made in the icsP promoter region
relative to key regulatory elements and regions (not drawn to scale). B. Effect of deletions between the
two regions binding H-NS in vitro. Fold change in promoter activity of the PicsP-lacZ reporter and deletion
derivatives when compared in the hns::Knr mutant and wild-type backgrounds. The asterisk represents
data that are statistically different from the fold change observed with full-length PicsP-lacZ, (P < 0.05).

and non-discrete shifts). In contrast, T2 failed to shift even in the presence of the
highest H-NS concentration used (16.1 µM). Taken together, these data are consistent
with our 5’ truncation analysis because the sequences bound by H-NS in vitro (Figure
2.8B and C; T3–T5) overlap with those required for H-NS- mediated silencing in vivo
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(Figure 2.8A; -900 to -436), thus supporting our hypothesis that H-NS directly binds to
the icsP intergenic region to silence the icsP promoter. Strikingly, these data also reveal
that T1 displays high affinity for H-NS in vitro, a region demonstrated not to be sufficient
for H-NS mediated silencing of icsP (Figure 2.8A). Notably, this DNA target contains
icsP promoter elements and has the highest AT content of all six targets used in our
EMSAs (70% AT-rich), which likely contributes to its affinity for H-NS (Williams and
Rimsky, 1997; Navarre et al., 2006; Bouffartigues et al., 2007).
Spacing and helical phasing requirements between the two discrete regions displaying
high affinity for H-NS in vitro
The presence of two discrete H-NS binding regions (T5–T3 and T1) identified by our
EMSAs suggests that H-NS silences the icsP promoter by bridging these two regions of
DNA, a demonstrated activity of H-NS (Dame et al., 2005). A similar arrangement of HNS binding regions at the virF promoter is crucial for the bridging of two regions by HNS, resulting in transcriptional silencing (Falconi et al., 1998; Prosseda et al., 2004). At
this locus, bridging can be disrupted by changing the helical phasing of the two H-NS
binding regions with respect to each other (Prosseda et al., 2004). To determine if HNS-mediated silencing of the icsP promoter is also affected by the spacing between
and/or helical orientation of the regions bound by H-NS, four derivatives of the PicsPlacZ construct (pAFW04) were created. Each construct, containing either a change in a
half helical turn (5 or 100 bp deletion) or full helical turn (10 or 105 bp deletion)
immediately downstream of the AflII site at position -425 (Figure 2.9A), was introduced
into MC4100 and the isogenic MC4100 hns mutant strain, and β-galactosidase activities
were measured.
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Regardless of the deletion tested, the average fold change in β-galactosidase
activity between the hns mutant strain and wild-type remained approximately 12-fold
(Figure 2.9B), demonstrating that none of these deletions affected H-NS-mediated
silencing of the icsP promoter. Thus, we conclude that, unlike the virF promoter, the
spacing and helical phasing of the icsP regulatory elements with respect to each other
can be altered without affecting H-NS-mediated silencing.

Seven sites matching the proposed VirB binding site do not significantly contribute to
VirB-dependent regulation in vivo
Having mapped the DNA sequences required for H-NS-mediated silencing of the
icsP promoter, we next turned our attention to the sequences required for VirBdependent regulation. Two putative VirB binding sites (known as boxes 1 and 2), each
matching the proposed recognition site (Taniya et al., 2003; Turner and Dorman, 2007),
are required for the regulation of the icsP promoter by VirB in vivo (Castellanos et al.,
2009). Notably, these boxes are organized as an inverted repeat and are positioned
over 1 kb upstream of the primary icsP TSS (Egile et al., 1997; Hensley et al., 2011).
Interestingly, seven other putative binding sites with at least a 6/7 match to the
proposed recognition site were also identified in the intergenic region immediately
upstream of the icsP gene (Castellanos et al., 2009; Figure 2.10A), but their contribution
to VirB-dependent regulation had not been tested.
To assess the involvement of these seven sites in VirB-dependent regulation of the
icsP promoter, each site was subjected to site-directed mutagenesis using transversion
mutations. The eight resulting promoter fragments carrying mutations of each of the
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seven putative binding sites, or a combination of all seven mutated sites, were cloned
upstream of the lacZ gene in our transcriptional reporter, pHJW20 (Supporting
Information Table A.1). The resulting reporter constructs were then introduced into wild-

Figure 2.10 Investigating the role of seven sites that closely match the proposed VirB binding site in vivo.
A. Schematic showing the location of seven sites displaying at least a 6/7 or 7/8 match to the proposed
VirB binding site 5’- RWG(G)AAAT-3’ (Taniya et al., 2003). The central base pair of each site is indicated.
B. Activities of PicsP-lacZ reporter and derivatives carrying transversion mutations made in each of the
seven sites, all seven sites and the previously characterized box 1, box 2 or both. Average βgalactosidase activities are expressed as percentage activity relative to the full-length PicsP-lacZ in wildtype S. flexneri (2457T). Average fold changes between S. flexneri wild-type and isogenic virB mutant are
also provided. The asterisk represents data that are statistically different from the average relative activity
observed in wild-type S. flexneri carrying PicsP-lacZ. ^, represents data that are statistically different from
the fold change observed with full-length PicsP-lacZ, (P < 0.05).
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type S. flexneri strain 2457T or a virB mutant derivative, and β-galactosidase activities
were measured.
Mutagenesis of these putative binding sites alone or in combination did not
significantly alter the VirB-dependent regulation of the icsP promoter (Figure 2.10B). In
contrast, mutagenesis of either or both of the required boxes 1 and 2 completely
abolished VirB-dependent regulation (Figure 2.10B), as demonstrated previously
(Castellanos et al., 2009). Based on these data, we conclude that the seven sites
displaying at least a 6/7 match to the proposed VirB-binding site do not contribute
significantly to VirB- dependent regulation of the icsP promoter. Interestingly, none of
these seven sites were organized as an inverted repeat separated by a single base pair.
VirB binds DNA sites required for VirB-dependent regulation
Next, we chose to study the direct interaction of VirB with the remotely located VirB
boxes. To do this, a combination of in vitro electrophoretic mobility shift assays and
DNase I protection assays were used to test binding of purified His-tagged VirB to
radiolabeled DNA products of the icsP promoter containing either wild-type or mutated
boxes 1 and 2. A 54 bp DNA fragment containing wild-type boxes was retarded when
VirB was added at the lowest concentration (0.94 µM), while retardation of an identically
sized DNA fragment containing mutated boxes began at the second lowest
concentration (1.88 µM) (Figure 2.11A). With increasing concentrations of VirB, the
formation of discrete VirB-DNA complexes in the middle of the gel, as well as higher
order complexes in the gel wells, are evident on the DNA bearing wild-type boxes
(Figure 2.11A and B panel i). In contrast, only higher order VirB-DNA complexes form
with the DNA fragment containing mutated boxes (Fig. 2.11A and B, panel ii). These
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Figure 2.11 In vitro binding of VirB to DNA sites required for VirB-dependent regulation. A. EMSA of
recombinant VirB-His6 with 54 bp DNA targets carrying either centrally located wild-type boxes or mutated
boxes. Increasing amounts of purified recombinant VirB-His6 at final concentrations of 0, 0.94, 1.88, 3.75
and 5.00 µM (from left to right) were incubated with radiolabeled DNA. B. Densitometric trace analysis of
each lane in (A). Panels i and ii show traces of DNA targets containing wild-type and mutated boxes
respectively. Concentrations of recombinant VirB-His6 are indicated. C. DNase I protection analysis of
VirB-His6 bound to a 250 bp DNA fragment carrying either wild-type boxes or mutated boxes (coding
strand radiolabeled). Panels i and ii show sequencing gels of DNA products after DNase I cleavage of
complexes formed with increasing final concentrations of VirB-His6 (0, 0.31, 0.62 and 1.2 µM) on DNA
bearing wild-type boxes and mutated boxes respectively. Panel iii shows a similar gel of DNA products
after DNase I cleavage of complexes formed on DNA bearing wild-type boxes with increasing final
concentrations of VirB-His6 (0, 0.77, 1.54, 3.08 and 4.62 µM). A Maxam-Gilbert ladder (GA) was used to
identify coordinates relative to the primary icsP TSS. The solid bars indicate initial regions of protection by
VirB, the open bar highlights lack of protection observed on DNA bearing mutated boxes, and the dotted
line represents an extended region of protection observed.
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data suggest that the wild-type boxes are required for the formation of specific, discrete
VirB- DNA complexes and that higher order complexes form through non-specific
interactions. We therefore conclude that VirB displays higher binding affinity and
specificity for the DNA fragment containing the wild-type boxes than the mutated boxes.
Next, to precisely map sequences protected by VirB at the icsP promoter, DNase I
protection assays were used. VirB protection was observed between positions -1154 to
-1122 (relative to the primary TSS of icsP) at the two highest protein concentrations
used, 0.62 and 1.2 μM (Figure 4C, panel i and Supporting Information Figure 2.14,
panel i). This protection is consistent with the region that contains the VirB boxes
required for VirB-dependent regulation of the icsP promoter. In contrast, VirB was
unable to protect the DNA fragment containing mutated boxes at the concentrations
needed to protect the wild-type VirB binding site (Figure 2.11C, compare panels i and ii,
and Supporting Information Figure 2.14). Interestingly, with just a two-fold increase in
the concentration of VirB needed to protect the wild-type boxes (0.77–1.54 µM), an
extended region of protection was observed in both directions away from the initially
protected site (Figure 2.11C, panel iii). These findings are consistent with the
oligomerization of VirB along the DNA. Cumulatively, these data indicate that VirB
specifically binds to the remote boxes required for VirB-dependent regulation of the icsP
promoter, and may oligomerize along DNA bi-directionally from these sites.

The remote VirB binding sites are cis-acting elements needed for VirB-dependent
regulation
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Since it is unusual for bacterial transcriptional regulators to modulate transcription
from remotely located DNA sites (>1 kb upstream of the regulated promoter), we next
chose to investigate how these remote VirB binding sites were used to modulate icsP
promoter activity. To start, we sought to determine if the binding sites function as bona
fide, remote cis-acting elements necessary for the transcriptional regulation of icsP or if
these sites function in trans by controlling the production of a small protein or sRNA that
subsequently regulates icsP promoter activity.
Two existing full-length PicsP-lacZ reporter constructs (Supporting Information Table
A.1) bearing either wild-type VirB binding sites (pHJW20) or mutated sites (pMIC18)
(Castellanos et al., 2009) were introduced into wild-type S. flexneri and an isogenic virB
mutant. Subsequently, pBR322 or derivatives carrying either DNA sequences upstream
of -665 (pKLP09) or upstream of -255 (pADK05) relative to the primary TSS of the icsP
promoter was also introduced. The activities of the lacZ reporters were then measured
using b-galactosidase assays, and data were expressed as fold change in the VirBdependent regulation of the lacZ reporter (Supporting Information Figure 2.15). Our data
show that the VirB binding sites and the downstream sequences contained in pKLP09
or pADK05 do not significantly influence VirB-dependent regulation of the PicsP-lacZ
reporter bearing mutated sites when placed in trans (Supporting Information Figure
2.15). Consequently, we conclude that the VirB binding sites found in the icsP intergenic
region function as remote, cis-acting elements that are required for VirB- dependent
regulation of icsP.
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Table 2.1 Effect of inserting base pairs between the two halves of the VirB binding site.
Average Relative b-Galactosidase
Activity (%)
Wild-type
S. flexneri (2457T)
100

virB mutant
(AWY3)
6 ± 1*

2 bp insertion

8 ± 1*

6 ± 1*

3 bp insertion

7 ± 1*

6 ± 1*

4 bp insertion

7 ± 1*

7 ± 1*

Promoterless lacZ

3 ± 0*

6 ± 1*

PicsP-lacZ

All data are statistically different (t-test) from the average relative activity observed in wild-type S. flexneri
carrying PicsP-lacZ, (P < 0.05).

The VirB boxes function as a single cis-acting element
The finding that mutagenesis of either box 1 or box 2 resulted in a complete loss of
VirB-dependent regulation (Castellanos et al., 2009; Figure 2.10B) raised the possibility
that, rather than functioning as two distinct binding sites, the two boxes actually function
together as a single cis-acting element. To test this, base pair insertions (2, 3 and 4 bp)
were made in between the two binding sites ordinarily organized as a near-perfect
inverted repeat separated by a single base pair. Three promoter fragments bearing
these insertions were then introduced into the PicsP-lacZ transcriptional reporter
(pHJW20), and β-galactosidase activities were measured in wild-type S. flexneri and an
isogenic virB mutant (Table 2.1).
Insertion of two, three or four base pairs between the two sites abolished VirBdependent activity of the icsP promoter (Table 2.1). Thus, in combination with the
previous data presented in this work (Figure 2.11, Supporting Information Figures 2.14
and 2.15), and in contrast to the site that regulates the icsB promoter (Turner and
Dorman, 2007), we conclude that the remote VirB binding site that regulates the icsP
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promoter functions as a single cis-acting element comprised of a near-perfect inverted
repeat separated by a single base pair. Based on these findings, it is likely that VirB
binds to this site as a dimer.

Plasticity of the spacing and helical phasing of the VirB binding site with respect to the
promoter-distal H-NS binding region
An earlier study revealed that a DNA fragment carrying a VirB binding site
transplanted upstream of a H-NS binding region in the E. coli proU promoter allowed
VirB to relieve silencing of this promoter by H-NS (Kane and Dorman, 2011). This was
striking not only because VirB is not naturally produced by E. coli, but also because
changes in the spacing of the VirB binding site relative to the H-NS binding region did
not alter VirB-dependent regulation at this artificial proU promoter construct. To
investigate these requirements at the naturally occurring icsP promoter, three deletions
of increasing size (Δ5, Δ10 and Δ50 bp) were created (upstream of -1038) between the
VirB binding site and downstream sequences, including the promoter-distal region
required for H-NS-mediated silencing and the promoter elements (Supporting
Information Figure 2.16A). Each of the resulting constructs were then introduced into
wild-type S. flexneri and an isogenic virB mutant, and β-galactosidase activities were
measured (Supporting Information Figure 2.16B). None of the deletions compromised
VirB-dependent regulation of the icsP promoter (Supporting Information Figure 2.16B).
Furthermore, because the 5 bp deletion places the VirB binding site on the opposite
face of the DNA helix with respect to the downstream H-NS binding region and
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promoter elements, we conclude that the helical phasing of the VirB binding site relative
to these features is not critical for its role as a transcriptional anti-silencer of this locus.

A molecular roadblock, LacI, placed between the VirB binding site and the upstream
region bound by H-NS blocks VirB-mediated anti-silencing
To further probe the relationship between the VirB binding site and the promoterdistal H-NS binding region, we took inspiration from a study that investigated the
oligomerization along DNA of ParB, the closest homologue of VirB, at the P1 plasmid
centromere (Rodionov et al., 1999). In that study, oligomerization of ParB along DNA
was blocked by docking a DNA binding protein to its introduced binding site, which was
positioned close to, but not overlapping, the initial ParB binding site. Like ParB, VirB is
known to form oligomers in vivo (Beloin et al., 2002) and in addition, our DNase I
protection assays suggest VirB oligomerizes bi-directionally from the VirB binding site
(Figure 2.11B, panel iii). We therefore reasoned that VirB binding to its recognition site
is likely followed by its oligomerization along DNA, and that VirB oligomerization
towards the promoter-distal H-NS binding region may be key for the transcriptional antisilencing of the icsP promoter.
To test this hypothesis, two constructs were created that placed two tandem lacO
sites approximately 80 bp either upstream or downstream of the cis-acting VirB binding
site (Figure 2.12A). The use of pQE2, a medium-copy plasmid that expresses lacIq,
ensured LacI production and LacI binding to the lacO recognition sites in the absence of
IPTG and its dissociation in the presence of IPTG. With these constructs, the effect of a
DNA binding protein acting as a molecular roadblock, positioned either on the upstream
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or downstream flank of the VirB binding site, was tested in the context of our PicsP-lacZ
reporter, pAFW04.

Figure 2.12 A LacI molecular roadblock placed downstream, but not upstream, of the essential VirB
binding site abolishes VirB-dependent anti-silencing of the icsP promoter. A. Schematic showing the
inserts bearing tandem lacO sites located either 87 bp upstream or 80 bp downstream of the VirB binding
site (not drawn to scale). Double forward slashes represent intergenic sequences not drawn. B. Effect of
lacO sites in the presence or absence of LacI on VirB-dependent regulation of the icsP promoter.
Average β-galactosidase activities are expressed as percent activity relative to the full-length PicsP-lacZ
in wild-type S. flexneri (2457T). All data, except those labeled ns, are statistically significant from the
average relative activity observed in wild-type S. flexneri carrying the wild-type PicsP-lacZ reporter in the
absence of IPTG (P < 0.05).

VirB-dependent regulation of the icsP promoter was not affected when the tandem
lacO sites were positioned upstream of the remote VirB binding site, regardless of
76

whether IPTG was present or absent from the growth medium (Figure 2.12B). These
data indicate that VirB-dependent regulation of the icsP promoter is neither impacted by
the inserted lacO sites nor LacI binding to these sites. Because VirB-dependent
regulation was still observed in the absence of IPTG, conditions supporting LacI
binding, we conclude that the 87 bp between the LacI binding sites and the VirB binding
site provides sufficient room for both proteins to simultaneously dock at their recognition
sites.
In the construct where the tandem lacO sites were placed 80 bp downstream of the
VirB binding site, a modest decrease (less than 1.2-fold effect) in VirB-dependent
promoter activity was observed in the presence of IPTG (i.e., absence of bound LacI)
when compared to the wild-type PicsP-lacZ reporter. In contrast, a dramatic decrease in
VirB-dependent regulation was detected in the absence of IPTG (i.e., presence of
bound LacI; 17-fold effect), reducing promoter activity to levels similar to those observed
in the virB mutant (Fig. 2.12B). These data demonstrate that a LacI molecular roadblock
located downstream of the VirB binding site significantly interferes with VirB-dependent
regulation of the icsP promoter. In combination with our results from DNase I protection
assays (Fig. 2.11B, panel iii), these data support our current hypothesis that VirB
oligomerization along DNA toward, but not away from, the region required for H-NSmediated silencing is required for VirB-dependent transcriptional anti-silencing of the
icsP promoter. As such, these data provide important insight into transcriptional antisilencing by VirB.
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Figure 2.13 Schematic of findings presented in this study. The icsP intergenic region is depicted. The
flexibility of regulatory elements is highlighted by experiments described in grey text. Precise
requirements or major effects on regulation of the icsP promoter by VirB are highlighted by experiments
described in black text. Black dotted line depicts the high affinity H-NS binding region. Hatched boxes
depict the lower affinity H-NS binding regions. Dark grey shaded area depicts the region required for HNS-mediated silencing of PicsP in vivo. Light grey shaded box depicts the sequences required for VirBdependent regulation in vivo. Black inverted arrows depict the single, remote, cis-acting VirB binding site
required for VirB-dependent transcriptional anti-silencing of the icsP promoter. White arrows depict
sequences strongly matching the proposed VirB binding site (Taniya et al., 2003) that do not contribute to
VirB-dependent regulation of the icsP promoter.

Discussion
The xenogeneic silencing and anti-silencing of virulence genes has had a profound
effect on the evolution of many bacterial pathogens and continues to play a key role in
controlling the pathogenicity of these organisms (Stoebel et al., 2008; Ali et al., 2012;
Marteyn et al., 2012; Picker and Wing, 2016) . Many virulence genes on the Shigella
virulence plasmid are transcriptionally silenced by H-NS and anti-silenced by VirB
(Porter and Dorman, 1997; Beloin et al., 2003; Le Gall et al., 2005; Turner and Dorman,
2007; Picker and Wing, 2016; Weatherspoon-Griffin and Wing, 2016). Despite VirB
being a key regulator of Shigella virulence, very little is known about how VirB functions
to offset transcriptional silencing mediated by H-NS (Turner and Dorman, 2007). To
help address this gap in knowledge, in this study, we thoroughly mapped the genetic
elements necessary for transcriptional silencing and anti-silencing of the icsP locus
located on the large Shigella virulence plasmid. Our work demonstrates the necessity of
remotely located DNA binding sites while highlighting the flexibility of key regulatory
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elements required for transcriptional silencing and anti-silencing at this genetic locus.
Moreover, our work demonstrates that a molecular roadblock placed between the key
regulatory elements (i.e., the VirB binding site and the H-NS-bound region) completely
blocks transcriptional anti-silencing by VirB. Finally, our findings support the need to reevaluate the currently proposed VirB binding site (Taniya et al., 2003; Turner and
Dorman, 2007). Based on our findings, a model of transcriptional silencing and antisilencing and a summary diagram of regulatory elements identified by this work are
presented in the graphical abstract and Figure 2.13, respectively.
Our study reveals that a stretch of DNA located between 900 and 436 bp upstream
of the primary icsP TSS (AT content 68%) is required for H-NS-mediated transcriptional
silencing of icsP. This is corroborated by our EMSAs because three of the six DNA
targets (targets 3, 4 and 5), each containing at least part of this region, bind H-NS in
vitro with relatively high affinity. Strikingly, a 100 bp, 79% AT-rich region located in
targets 4 and 5 (–844 to -744) contains a 20 bp, 95% AT-rich stretch starting at -782.
Taken together, the DNA sequences identified by our in vivo 5’ truncation analysis and
EMSAs are consistent with established binding characteristics of H-NS (Navarre et al.,
2006; Bouffartigues et al., 2007; Lang et al., 2007). Another AT-rich region (79%; -133
to 124; found in target 1) was found to display relatively high affinity for H-NS in our
EMSAs. The binding of H-NS to this region, which contains icsP promoter elements, is
consistent with other findings that demonstrate H-NS commonly binds to bacterial
promoter regions in vivo (Landick et al., 2015). Nonetheless, our 5’ truncation analysis
of the icsP promoter region reveals that the promoter-proximal sequences alone are not
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sufficient for H-NS mediated silencing, bringing into question their role in this regulatory
process.
Based on previous work (Basta et al., 2013) and data presented here, a repression
loop involving the H-NS bound promoter-distal and promoter-proximal sites does not
seem likely for three reasons. First, removal of the upstream H-NS binding region
causes a complete loss of H-NS-mediated silencing (Figure 2.8A). So, unless the
upstream region functions to stabilize the H-NS interaction with the promoter region, a
mechanism of promoter occlusion that directly involves the promoter region seems
unlikely. Secondly, analysis of the ospZ promoter, which lies divergent to the icsP
promoter, revealed that there was no requirement for icsP promoter-proximal
sequences for H-NS-mediated silencing (Basta et al., 2013). Instead, DNA sequences
overlapping the region necessary for H-NS-mediated silencing of icsP were required
(Basta et al., 2013). Finally, both small and large deletions that place the two regions
that bind H-NS in vitro on the same or opposite faces of the DNA helix do not impact HNS-mediated silencing (Figure 2.9B), suggesting that if a H-NS bridge complex does
form, it must tolerate these spatial changes. As such, we favor a model of transcriptional
silencing where H-NS forms a nucleoprotein filament along the icsP intergenic region
from the upstream H-NS binding region identified by this study. Future studies aimed at
fully characterizing the nature of the H-NS-DNA complex that forms at the icsP
promoter, as well as identifying which step in transcription is inhibited by H-NS, are
underway.
Regarding VirB-dependent regulation of the icsP promoter, our previous work had
shown that remote sites located over 1 kb upstream of the icsP promoter were required
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for VirB-dependent regulation (Castellanos et al., 2009). This same study identified
seven additional sites further downstream, each displaying at least a 6/7 match to the
proposed VirB binding site (Taniya et al., 2003). However, despite being closer to the
icsP gene than the required VirB binding site (Figure 2.10A), none of these sites
contribute to VirB-dependent regulation (Figure 2.10B). This finding not only validates
our previous result that VirB regulates transcription from a remote site, but also
challenges our understanding of the proposed VirB binding site sequence; clearly not all
sites resembling the currently proposed site are involved in VirB-dependent regulation
of icsP (Taniya et al., 2003; Turner and Dorman, 2007). When we expanded our search
on the large virulence plasmid for the previously proposed 7–8 bp VirB binding site
(Taniya et al., 2003), 250 perfect matches were identified, and this number increases to
4000 if a single base pair mismatch is tolerated. As such, it seems highly unlikely that all
of these sites are involved in VirB binding and VirB-dependent regulation of Shigella
virulence genes. Due to the functional differences in the VirB binding sites found at the
icsB (Turner and Dorman, 2007) and icsP promoters highlighted by this study, it is clear
that there is a pressing need to improve our understanding of VirB-DNA interactions on
the virulence plasmid in vivo. Further, it will be important to determine which of these
DNA-protein interactions are needed for the anti-silencing of virulence genes in this
important human pathogen.
It is unusual for bacterial transcription factors to influence promoter activity from
more than 250 bp upstream of a bacterial promoter (Collado-Vides et al., 1991), and
yet, the essential cis-acting VirB binding site at the icsP locus is centered at -1137
relative to the primary icsP TSS. This location places the VirB binding site only 237 bp
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upstream of the region required for H-NS-mediated silencing (Figue 2.8B). Our data
show that small or large deletions that maintain or alter the helical phasing of these
regulatory elements do not impact VirB-dependent transcriptional anti-silencing of the
icsP promoter (Supporting Information Figure 2.16). These findings demonstrate a level
of flexibility inherent to transcriptional anti- silencing complexes, a finding consistent
with previous work (Kane and Dorman, 2011). Given our work reveals that VirB
oligomerizes along DNA in vitro (Figure 2.11C), it is possible that these extended VirBDNA interactions facilitate this flexibility. Going forward, it would be interesting to probe
the limits of this apparent spatial flexibility.
New insights into the VirB anti-silencing mechanism come from our study where a
molecular roadblock was introduced on either side of the essential VirB binding site.
Strikingly, we found that the LacI roadblock only interferes with transcriptional antisilencing when placed in between the VirB binding site and the region required for HNS-mediated silencing (Figure 2.12B). While our finding is consistent with VirB
oligomerizing along the DNA towards the region required for H-NS-mediated silencing,
which is also supported by the extended footprints (Figure 2.11C, panel iii), it remains
unclear if VirB oligomerization along DNA occurs in vivo or if this activity is needed for
VirB-dependent transcriptional anti-silencing. Future experiments that more thoroughly
investigate the mechanism of transcriptional anti-silencing by VirB in vivo are in
progress.
In summary, we have: (i) identified that a remote region is required for H-NSmediated silencing of icsP, (ii) demonstrated that VirB binds directly to a remote, single
cis-acting site arranged as a near-perfect inverted repeat, (iii) revealed the significant
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plasticity in the spacing requirements between the two H-NS binding regions as well as
the VirB binding site and region required for H-NS-mediated silencing and (iv)
determined that a protein docked immediately downstream of the VirB binding site, but
upstream of the region required for H-NS-mediated silencing, completely blocks VirBdependent regulation. More generally, our findings stress the importance of considering
the involvement of DNA sequences outside of the canonical promoter region when
studying transcription regulation (Collado-Vides et al., 1991; Gralla & Collado-Vides,
1996), especially when the regulation is being imparted by NSPs and their countersilencing proteins. While our work highlights that there can be considerable flexibility in
the architecture of nucleoprotein complexes controlling transcriptional silencing and
anti-silencing, our work also shows the apparent ease with which transcriptional antisilencing can be disrupted. This insight may prove useful in the design of new
antibacterials that could be broadly applicable because gene regulation mediated by
transcriptional silencing and anti-silencing is common in bacteria and central to
numerous aspects of bacterial physiology, including virulence.

Table 2.2. Bacterial strains used in this work.
Strain
Descriptiona
E.coli
MC4100
E. coli strain K-12 with araD and lacZ deletion
MC4100 hns

r

MC4100 hns::Kn . The first 37 amino acids of HNS are expressed, resulting in a dominantnegative effect on other H-NS-like proteins in the
cell.

S. flexneri
2457T
S. flexneri serotype 2a
AWY3
2457T virB::Tn5; Knr
a
r
Kn , kanamycin resistance.

Source or Reference
(Pogliano and Beckwith, 1994)
(Yamada et al., 1991)

(Formal et al., 1958)
(Wing et al., 2004)

Experimental procedures
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Bacterial strains, plasmids and media
The bacterial strains and plasmids used in the present study are listed in Table 2.2
and Supporting Information Table A.1 respectively. E. coli strains were grown routinely
at 37°C in Luria-Bertani (LB) broth (Miller, 1972) with aeration or on LB agar (LB broth
containing 1.5% w v-1 agar). Shigella flexneri strains were routinely grown at 37 °C in
Tryptic Soy broth (TSB) with aeration or on trypticase soy agar (TSA; TSB containing
1.5% w v-1 agar). Where appropriate, antibiotics were added to achieve the following
final concentrations: ampicillin, 100 μg ml-1; chloramphenicol, 25 μg ml-1 and kanamycin,
50 μg ml-1. To ensure that Shigella strains had maintained the large virulence plasmid
during manipulation, Congo Red binding was tested on TSA plates containing 0.01% (w
v-1) Congo Red (Sigma Chemical Co., St. Louis, Mo.).

Plasmid construction
Plasmids and plasmid constructs used in this study are fully described in the
supporting information (Supporting Information Table A.1 and Plasmid construction). All
constructs had their DNA sequences verified by Sanger sequencing. DNA sequences of
oligonucleotide primers and duplexes used in this work are available upon request.

Quantification of icsP promoter activity using the PicsP-lacZ reporter and derivatives
To measure promoter activities, the PicsP-lacZ fusion plasmids described in this
work were introduced into S. flexneri and E. coli strains by electroporation. Activities of
the icsP promoter constructs were determined by measuring β-galactosidase activity as
described previously (Wing et al., 2004), using the Miller protocol (Miller, 1972).
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Overnight cultures were diluted 1:100 and grown for 5–7 h in either TSB medium (S.
flexneri) or LB (E. coli) at 37 °C with shaking at 325 rpm (LabLine/Barnstead 4000
MaxQ), prior to cell lysis. Routinely, β-galactosidase levels were measured in early
stationary phase cultures grown from three independent transformants because
experiments had shown that icsP expression significantly increases under these
conditions (Hensley et al., 2011). Assays routinely contained three independent
biological replicates and were repeated three times. For statistical analyses, a Student’s
t-test assuming equal variance was routinely used.
To assess the effect of LacI binding to lacO recognition sites engineered upstream
or downstream of the essential VirB binding sites in pAFW04, wild-type S. flexneri
(2457T) and the isogenic virB mutant (AWY3) were simultaneously transformed with
pAFW04 or a derivative (pHS27, pDRG01 or MAP07) and the lacIq-expressing plasmid,
pQE2. Overnight cultures bearing pQE2 and a pAFW04 derivative were back-diluted
1:100 and grown for 2 h at 37 °C. Cell cultures were either induced with a final
concentration of 250 mM IPTG or not induced and then all cultures were grown for an
additional 3 h. Cells were then harvested by centrifugation and resuspended in an equal
volume of PBS before lysis. β-galactosidase activities were determined using the Miller
protocol (Miller, 1972).

Purification of his-tagged H-NS and VirB proteins
For the purification of C-terminally tagged H-NS-His6 protein, the pQE60 derivative
pCTH01 was used. H-NS-His6 was purified as described previously with a few
exceptions (Deighan et al., 2003). Briefly, the protein was produced in the E. coli strain
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M15 carrying the plasmid pREP4. The expression of the C-terminally His-tagged
proteins were induced in 500 ml cultures growing exponentially with 1 mM IPTG
(isopropyl-β-thiogalactopyranoside). After a 2 h induction, the cells were harvested and
frozen at -80 °C overnight. The cell pellet was then thawed on ice and resuspended in
lysis buffer (60 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 8.0). Cells were lysed
by sonication, and cellular debris was pelleted by centrifugation at 10,000 x g at 4 °C.
Cell lysates were applied to Ni-NTA columns (Qiagen) pre-equilibrated with lysis buffer.
The columns were then washed with 10 bed volumes of wash buffer (100 mM
imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 8.0). Proteins were eluted by the addition
of 2.5 bed volumes of elution buffer (equilibration buffer with 500 mM imidazole). The HNS-His6 fractions were collected and analyzed on SDS-PAGE followed by Coomassie
staining. The H-NS fractions were combined and dialyzed against a storage buffer (350
mM NaCl, 50 mM Tris-HCl [pH 8.0], 1 mM EDTA, 0.5 mM DTT, 0.1 mM PMSF, 30%
glycerol). Protein concentration was determined using a Bradford assay. Previous
studies using an identical His-tag H-NS fusion protein, produced in a manner similar to
that described above, was shown to retain normal function of H-NS in assays (Williams
and Rimsky, 1997).
The C-terminally VirB-His6 protein was produced from pAJH03 and purified by
Monserate Biotech. The hexa-his tag was not found to interfere with VirB expression or
activity because His-tagged VirB was observed to restore icsP expression to wild-type
levels in a strain lacking virB in vivo (data not shown). SDS-PAGE and western blots of
purified proteins used in this work are shown in Supporting Information Figure 2.17.
Electrophoretic mobility shift assays
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To test H-NS binding to the six DNA fragments taken from the icsP intergenic region
in vitro, 0.25 pmol of 32P-labeled PicsP DNA (PCR amplified from pHJW20 with the
following primers: W63 and W64 target 1, W65 and W66 target 2, W67 and W68 target
3, W69 and W70 target 4, W71 and W148 target 5, W73 and W74 target 6 and gel
purified by electroelution) was incubated at 37 °C for 30 min with 0, 107, 134 or 161
pmol of purified His-tagged H-NS protein in a 10 μl reaction containing 50 mM Tris-HCl
(pH 8.0), 20 mM KCl, 10% glycerol, 100 mg ml-1 BSA and 25 mg ml-1 poly (dI-dC). DNA
loading dye solution was added to the reaction and directly subjected to 5%
polyacrylamide gel electrophoresis (PAGE) in 0.5X TBE running buffer. Radioactive
signals were detected using a Typhoon 9410 (Amersham) variable mode imager.
To test VirB binding in vitro, two 54 bp icsP promoter fragments containing either
wild-type or mutated VirB sites were used. To create each target, primer pairs
W391/W392 and W393/W394, respectively, were denatured at 95 °C for 5 min and
subsequently annealed using a cycle that decreased by 1 °C every minute until a final
temperature of 25°C. Each sample was then gel purified and electroeluted into the
surrounding buffer, and the resulting DNA was phenol-chloroform extracted and ethanol
precipitated. For radiolabeling of the non-coding strand, 4.8 pmol of each target was
single-end labeled using T4 polynucleotide kinase (Promega Cat. No. M4101) according
to manufacturer directions using [γ32P] ATP (specific activity, 3000 Ci mmol-1; Perkin
Elmer). Unincorporated radionucleotides were removed using Illustra ProbeQuant G-50
Micro Columns according to manufacturer directions (GE Healthcare).
Increasing concentrations of purified VirB-His6 (Monserate Biotech) were incubated
with 0.02 pmol of each icsP promoter target at 37 °C for 20 min in 1x binding buffer (10
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mM potassium phosphate, pH 7.5, 25 mM NaCl, 0.5 mM β-mercaptoethanol, 0.5 mM
EDTA, 50% glycerol, 25 ng μl-1 herring sperm DNA) in a total reaction volume of 20 μl.
The reactions were then resolved on a 6% native polyacrylamide gel in 1x TBE at 120 v
for 40 min. The gel was transferred to Whatman paper, covered with plastic wrap,
exposed to a phosphor-imaging screen and then scanned with the Typhoon 9410
(Amersham) Variable Mode Imager. For densitometric lane trace analysis, ImageJ
software (http://imagej.nih.gov) was used.

DNase I protection assays
DNase I protection assays to identify VirB bound regions of the icsP promoter were
carried out using PCR amplified DNA fragments. Primers W515 and W516 were used to
amplify a 250 bp fragment containing wild-type VirB boxes (amplified using pHJW20 as
a template) or mutated VirB boxes (amplified using pMIC18 as a template). Prior to the
PCR, one of the primers W515 or W516 was labeled with T4 polynucleotide kinase and
[γ-32P]-ATP (32P-labeled W515 allowed detection of the coding strand; 32P-labeled
W516 allowed detection of the non-coding strand). To detect the initial binding site of
VirB, approximately 0.25 pmol of labeled DNA and 0, 6.2, 12.3 or 24.6 pmol of the
purified His-tagged VirB were incubated at 37°C for 20 minutes in a 20 μl reaction
containing 50 mM Tris-HCl (pH 8.0), 20 mM KCl, 10% glycerol, 100 mg ml-1 BSA and 25
mg ml-1 poly (dI-dC). To investigate the potential for VirB oligomerization along DNA, the
same conditions were used, but the following amounts of VirB were added; 0, 15.4,
30.8, 61.6 or 92.4 pmol. Samples were treated with 0.06 U of DNase I (New England
Biolabs) for 30 seconds followed by phenol-chloroform DNA extraction and ethanol
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precipitation. DNA was resuspended in a gel loading buffer (40% deionized formamide,
5 M urea, 5 mM NaOH, 1 mM EDTA, 0.025% bromophenol blue and 0.025% xylene
cyanol) and analyzed by 6% denaturing PAGE by comparing to an appropriate DNA
sequence ladder generated by the Maxam and Gilbert A + G reaction (Maxam, Allan M.,
and Gilbert, 1980). Radiolabeled DNA fragments were detected using a Typhoon 9410
(Amersham) variable mode imager.
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Plasmid construction
The 5’ truncation series: The starting point for this work was the PicsP-lacZ reporter
plasmid pAFW04 ((Basta et al., 2013); Table A.1). pAFW04 carries a PstI-XbaI DNA
fragment that contains 1232 bp upstream of the primary TSS (Egile et al., 1997;
Hensley et al., 2011) of the icsP promoter and the first 48 bp of the icsP coding region.
This fragment is cloned upstream of a translation stop site and a promoterless lacZ
gene so that expression of lacZ is directly regulated by the icsP promoter. To prevent
any transcriptional read-through from genes on the pACYC184 backbone, the strong
lambda oop transcriptional terminator is cloned immediately upstream of the icsP
intergenic region fragment. To create a nested set of 5’ promoter truncations in
pAFW04, icsP promoter fragments were PCR amplified from pAFW04 using
oligonucleotide W89 in combination with each of the following oligonucleotides: W44,
W321, W45, W320, W319, W317, W46, W307, W308, W309, W310, W47, W528 or
W530. PCR products were digested with PstI and XbaI, and then ligated into pAFW04
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also digested with PstI and XbaI. This created a series of PicsP-lacZ_5’t fusion
plasmids containing promoter fragments with an upstream boundary of -1056, -900, 893, -874, -838, -693, -665, -637, -601,-550, -436, -351, -254 and -92, respectively
(Table A.1), all relative to the primary icsP TSS (Egile et al., 1997; Hensley et al., 2011).
Constructs carrying deletions between regions bound by H-NS: To construct PicsP-lacZ
reporters bearing deletions between the two H-NS binding regions, icsP promoter
sequences were PCR amplified from pAFW04 using the oligonucleotide primer W602
along with either W603, W604, W605, or W606. Each amplicon was restricted with AflII
and XbaI, and ligated into pAFW04 that was also digested with AflII and XbaI. This
created four pAFW04 derivatives (pMAP30 - 33) that contained either a 5, 10, 100, or
105 bp deletion beginning at position -431 relative to the primary icsP TSS, respectively.
Constructs carrying mutations in sites that resemble the proposed VirB binding site:
Mutations in each of the seven putative VirB binding sites (Sites 1 - 7; Fig. 3A) were
created by mutating promoter fragments either in a high copy cloning plasmid
(pBlueScript) using the QuikChange Lightning site-directed mutagenesis Kit (Agilent
Technologies, Inc.) or using a two-step PCR site-directed mutagenesis procedure,
described previously (Lie and Leigh, 2007). Regardless of the method, transversions
were routinely used to disrupt each site with two exceptions: the overlapping TSS was
not mutated in Site 2 and the third base of site 1 was a transition mutation (Table A.1).
Promoter fragments were introduced into the PicsP-lacZ reporter (pHJW20) using
standard cloning techniques.
Mutated sites 2 - 4 were generated using the following oligonucleotide pairs in
combination with the QuikChange Lightning Kit, respectively; W278 & W279; W276 &
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W277; and W274 & W275. To create mutated sites 5 - 7, PCR mutagenesis was
accomplished using the following divergent oligonucleotide pairs, the first in each case
is mutagenic; W239 & W240, W237 & W238, W235 & W236 along with the following
flanking oligonucleotides W89 & W93, respectively. To create mutated site 1, PCR
mutagenesis was used using the following divergent oligonucleotide pair, the first primer
being mutagenic; W155 & W156 along with flanking oligonucleotides W93 and W162,
but the resulting product was carried an unwanted mutation at +2, which was
subsequently corrected using the QuikChange Lightning Kit with oligonucleotides W229
and W230.
Construct carrying all seven mutated sites. Each of the seven mutated sites were
systematically combined into a single PicsP-lacZ reporter, pPU17, using the following
strategy. Sites 7, 6, 4, 3 and 1 were combined into one reporter plasmid pPU15 by
exploiting naturally occurring restriction sites. Mutated site 5 was subsequently added to
pPU15 using PCR mutagenesis using oligonucleotides W377 and W160, generating
pPU16. In a separate construct carrying a mutated site 2, site 1 was mutated using
QuikChange Lightning SDM Kit and oligonucleotides W382 and W383. Mutated sites 1
& 2 were next introduced into pPU16 by replacing the PacI-XbaI restriction fragment,
thereby creating the PicsP-lacZ reporter pPU17.
pBR322 derivatives carrying remote VirB binding sites in trans: pKLP09 and pADK05
were created by PCR amplifying DNA sequences upstream of -665 or -255 relative to
the primary TSS of icsP with the forward oligonucleotide W93 in combination with either
of the reverse oligonucleotides W234 or W567, respectively. Amplicons were then
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digested with BamHI and SalI and ligated into pBR322 that had been digested with the
same enzymes.
Constructs bearing insertions between half sites of the VirB binding site: Insertions
between the two halves of the VirB binding site were generated by mutating promoter
fragments in a high copy cloning plasmid (pBlueScript) using the QuikChange Lightning
site-directed mutagenesis Kit (Agilent Technologies, Inc.). Two, three and four base pair
insertions were engineered using the following oligonucleotide pairs respectively; W265
& W266; W263 & W264; and W261 & W262. Promoter fragments carrying these
insertions were subsequently used to replace the existing PstI-XbaI fragment in the
PicsP-lacZ reporter pHJW20, thereby generating pKLP11-13.
Constructs carrying deletions between the VirB binding site and proximal H-NS binding
region: 5, 10 and 50 bp deletions between the VirB binding site and the upstream H-NS
binding region were made by amplifying DNA sequences upstream of the naturally
occurring BglII site with primers that anneal either 5, 10 or 50 bp upstream of the BglII
site. PCR amplicons were generated by using W98 with either W226, W227 or W228
(each of these primers contained a BglII site). Amplicons were subsequently digested
with NruI and BglII and each of these inserts were used to replace the NruI-BglII
restriction fragment in pHJW20.
Constructs used to test the effect of a molecular roadblock on icsP promoter activity: As
a starting point for the construction of the downstream roadblock construct, the DNA
sequence 5’-TTTACA-3’ was mutagenized to a BsrGI site 5’-TGTACA-3’ in pAFW04
using the megaprimer PCR method (Perrin and Gilliand, 1990). Mutagenic
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oligonucleotide W352 and flanking primer W73 were used to create the megaprimer,
which was subsequently extended using PCR with W93. The resulting amplicon
containing the newly engineered BsrGI site was digested with BglII and PstI and ligated
into pAFW04, which had been restricted with the same enzymes. The resulting plasmid
pHS16 was subsequently digested with BsrGI and BglII and ligated with duplexes 3 and
8. This produced pHS27 which contains two lacO sites 80 bp downstream of VirB
binding site (Box 1). The upstream roadblock site was constructed by ligating duplex 10
to pAFW04a digested with PstI and SalI. This produced pDRG01 which contains two
lacO sites 87 bp upstream of the VirB binding site (Box 2).
Constructs producing inducible His-tagged VirB and H-NS proteins: The primers W38
and W39 were used to amplify the virB gene from the plasmid pATM324. The resulting
DNA was then digested using HindIII and NcoI restriction enzymes and the restricted
fragment was ligated into pQE-60 (Qiagen). This created a C-terminal His-tagged VirB
in an inducible plasmid, pAJH03. A similar strategy was used to create a C-terminal Histagged H-NS in an inducible plasmid, pCTH01. Briefly, the primers W134 and W137
were used to amplify the hns gene from Shigella flexneri serotype 2a with NcoI and BglII
sites for cloning into pQE-60.

95

Figure 2.14 DNase I protection analysis of VirB complexes formed on 250 bp DNA targets carrying either
wild-type boxes or mutated boxes (non-coding strand radiolabeled). Panels i and ii show sequencing gels
run to analyze products after DNase I cleavage of complexes formed with increasing final concentrations
of VirB-His6 (0, 0.68 and 1.36 μM) on DNA bearing wild-type boxes and mutated boxes, respectively.
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Figure 2.15 Effect of placing VirB binding sites in trans. Data are expressed as fold change in bgalactosidase activities between S. flexneri wild-type and isogenic virB mutant. Data indicated by * are
statistically different from the fold change observed in strains carrying PicsP-lacZ with mutated Box 1 and
2 and the empty plasmid control pBR322 (p < 0.05). Note, when the entire icsP promoter region is placed
in trans a similar result is observed (data not shown).
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Figure 2.16 Helical phasing and spacing requirements of the essential VirB binding site. A: Schematic
showing the size and location of deletions made in the icsP intergenic region relative to identified key
regulatory elements and regions (not drawn to scale). B: Effect of deletions that alter the spacing and/or
helical phasing between the VirB binding site and downstream sequences, including the region required
for H-NS-mediated silencing and promoter elements. Average b-galactosidase activities are expressed as
percent activity relative to the full-length PicsP-lacZ in wild-type S. flexneri (2457T). All data, except those
labeled ns, are statistically different from the average relative activity observed in wild-type S. flexneri
carrying full-length PicsP-lacZ, (p < 0.05).
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Figure 2.17 Purity of protein preparations used in this study. A: The C-terminally tagged H-NS-His6
protein and B: The C-terminally VirB-His6 protein were viewed by i/ SDS-PAGE and ii/ western blot
analysis. Western blot analyses were performed using a commercially available rabbit polyclonal anti-His
antibody (Santa Cruz Biotechnology) and antibodies were detected by chemi-luminescence using the
UVP BioSpectrum imaging system and accompanying software. To avoid image saturation during
capture, ten-fold less H-NS-His was loaded for western analysis than SDS-PAGE.
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2.5 MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Growth Conditions
The bacterial strains and plasmids used are provided in Table 2.2. Escherichia coli
strains were grown routinely at 37 °C in Luria-Bertani (LB) broth with aeration (325 rpm),
or on LB containing 1.5% agar (w v-1), respectively. Antibiotics were added at the
following final concentrations, as needed: ampicillin, 100 µg ml-1; chloramphenicol, 25
µg ml-1; kanamycin, 50 µg ml-1; and tetracycline, 12.5 µg ml-1.

Construction of the lacZ reporter and protein expression plasmids
For the construction of the IPTG-inducible H-NS and Sfh expression plasmids, the
hns and sfh genes were PCR amplified from 2457T (S. flexneri 2a) using primer pairs
W433 and W434 and W431 and W432, respectively. The hns and sfh amplicons were
then restricted with StuI and HindIII. The pCA24N-stpA was requested from the National
BioResource Project E. coli Strain (https://shigen.nig.ac.jp/ecoli/strain/; Kitagawa et al.,
2005). The hns and sfh amplicons were ligated into pCA24N (Kitagawa et al., 2005)
previously digested with StuI and HindIII. The resulting constructs were verified by DNA
sequencing. Expression of each H-NS family member in an MC4100 hns::Knr
background led to significantly lower icsP promoter activity compared to no expression
(Figure 2.5), confirming that the cloned genes of each H-NS family member produces a
functional protein. For this study, the PicsP-lacZ reporter pAFW02 was used, which is
the pHJW20 reporter with the Cmr cassette replaced with an Ampr cassette and was
constructed previously in the Wing lab (unpublished).
All primers used are listed in Table D.2.
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Quantification of icsP promoter activity using the PicsP-lacZ reporter and its
derivatives
Activity of the icsP promoter was determined by measuring b-galactosidase activity,
as described previously (Wing et al., 2004). Each reporter was transformed into either
wild-type MC4100, or one of its isogenic hns::Knr (dominant-negative), hns null
(MC4100 Δhns), and stpA null (MC4100 ΔstpA) derivatives. Freshly transformed
colonies were grown overnight at 37 °C, subcultured 1:100 into fresh LB broth, and
grown at 37 °C for 5 h to early stationary phase prior to cell lysis. All assays were
performed in triplicate on three separate occasions, unless otherwise stated, and
representative data are shown. Standard deviations are reported, and a two-tailed
Student’s t-test assuming equal variance was used to determine statistical significance
between averages of the activities.
To test if VirB can alleviate silencing of the icsP promoter mediated by H-NS family
members in constructs generated in this study, b-galactosidase activity of the pAFW02
PicsP-lacZ reporter was measured in an E. coli MC4100 or an isogenic hns::Knr
(dominant-negative) strain (Figure 2.6) carrying two additional inducible plasmids,
pCA24N or its derivatives bearing hns, stpA, or sfh, and pBAD or its derivative bearing
virB. Each hns family member was induced with 0.2 mM isopropyl β-D-1thiogalactopyranoside (IPTG) from the pCA24N series throughout growth in LB broth at
37 °C for a total of 5 h. In the last hour of growth, virB was induced with 0.2% (w v-1) Larabinose. Cultures were then harvested for a β-galactosidase assay.
For identifying sequences required for H-NS- or StpA-mediated silencing of the icsP
promoter, the PicsP-lacZ reporter and its 5’ truncation derivatives were transformed into
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MC4100 or its isogenic hns::Knr (dominant-negative), hns null (MC4100 Δhns), or stpA
null (MC4100 ΔstpA) derivatives, and activities of each reporter was measured using a
β-galactosidase assay.

DNase I Protection Assays with Recombinant H-NS
Targets 1, 4, and 5 (Figure 2.1) of the icsP promoter were prepared from pBluescript
KS II+ carrying each target (Harrison, 2010). First, pBluescript KS II+ carrying each
target was purified using a MAXIprep kit (Qiagen). Then, for radiolabeling of the coding
strand, each target was restricted with SalI, treated with CIP (Promega) to remove the 5’
- PO3-, and then restricted with EcoRI to expose a single 5’ - PO3-. The procedure was
reversed for radiolabeling of the non-coding strand. Each target (6.4 pmol) was then
single-end labeled with T4 polynucleotide kinase (Promega) according to manufacturer
directions [γ-32P] ATP (specific activity, 3000 Ci mmol-1; Perkin Elmer). Unincorporated
radionucleotides were removed from single-end labeled products using Illustra
ProbeQuant G-50 Micro Columns according to manufacturer directions (GE
Healthcare).
Increasing concentrations of purified H-NS-His6 was incubated with ~0.32 pmol of
each icsP promoter target at 37 °C for 20 minutes in 2x binding buffer (100 mM TrisHCl, pH 8.0, 40 mM KCl, 20 % glycerol, 200 ug/ml BSA, 50 ug/ml poly dI-dC) in a total
volume of 20 μl. After incubation, DNase I was added at 1:100 dilution (pre-determined
empirically where ~50% of the target was digested) in dilution buffer (10 mM Tris-HCl,
10 mM CaCl2, 10 mM MgCl2, 10 % glycerol) and allowed to proceed for 30 seconds.
The reactions were stopped by the addition of 200 μl of stop buffer (0.3 M Sodium
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Acetate, 10 mM EDTA). The samples were then extracted once with 200 μl
phenol:chloroform (1:1), once with 200 μl of chloroform:isoamylalcohol (24:1), followed
by ethanol precipitation with 600 μl of 100% ethanol in the presence of 20 μg glycogen
at -20 °C overnight. The following day, samples were spun down at 4 °C, and washed
once with 500 μl of 70% ethanol. After drying, the DNA samples were resuspended in
10 μl of loading dye (40% deionized formamide, 5 M Urea, 5 mM NaOH, 1 mM EDTA,
0.025 % bromophenol blue, 0.025 % xylene cyanol). Next, samples were
electrophoresed in a pre-run (30 min) 6% sequencing gel (UreaGel Concentrate, EC830; UreaGel Buffer, EC-835; UreaGel Diluent, EC-840) at 60 W for 2 h and 15 min,
unless otherwise stated. Following electrophoresis, the gel was transferred to Whatman
Paper (3MM), dried in a gel drier for 1-2 h at 80 °C., and exposed to a Phosphorimaging
cassette. The images were captured with a Typhoon 9410 variable mode imager.
Protection was analyzed by comparison of samples to the G+A ladder generated using
the Maxam-Gilbert method (Maxam and Gilbert, 1980).
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CHAPTER 3

VIRB, A TRANSCRIPTIONAL REGULATOR ESSENTIAL FOR SHIGELLA
VIRULENCE, MODULATES DNA SUPERCOILING THROUGH DNA BINDING IN
VIVO

3.1 FOREWORD
This chapter is mainly composed of empirical data compiled into a manuscript,
focusing on the initial identification of the effect of VirB on the electrophoretic mobility of
our VirB-dependent PicsP-lacZ isolated from E. coli or S. flexneri on an agarose gel.
These initial observations were made by Juan C. Duhart, an undergraduate researcher
at the time. Stemming from his work, I discovered that the change in the electrophoretic
mobility of the reporter observed in E. coli was due to a change in DNA supercoiling
using chloroquine-based agarose gel electrophoresis.
For all of this work, the pHJW20 PicsP-lacZ reporter (in pACYC184 vector) was
originally chosen as the starting point. Hence, all of the constructs I have used are
derivatives of pHJW20, some of which were previously published. During the course of
my investigations, a strong transcriptional terminator was cloned upstream of icsP
promoter sequences in pHJW20 to prevent possible transcriptional read-through from
an upstream chloramphenicol resistance cassette, creating pAFW04 (Basta et al.,
2013). Although I have used pHJW20-based plasmids for my analyses, I have also
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tested the ability of VirB to alter the electrophoretic mobility and supercoiling of the
pAFW04 reporter. These data are reported in the Appendix B. Other data in this
appendix include analyses of the supercoiling of PicsP derivatives in a different vector
context as well as an attempt to block VirB-dependent changes in supercoiling using a
molecular roadblock upstream with previously constructed reporters. Here, I expand
upon these initial observations and investigate the effect of VirB on DNA topology of a
plasmid containing VirB-dependent icsP promoter sequences. My findings are likely
important to the mechanism of anti-silencing.

105

3.2 ABSTRACT
Transcriptional silencing and anti-silencing lie at the heart of bacterial pathogenesis.
In Shigella spp., transcriptional silencing mediated by H-NS is alleviated by the
transcriptional anti-silencing protein VirB through an under-characterized mechanism.
To shed light on this mechanism, I investigate the effect of VirB on DNA topology. I
describe for the first time the ability of VirB to modulate DNA supercoiling of a reporter
plasmid bearing the VirB-dependent PicsP-lacZ sequences, an activity shared with its
closest homologs, the ParB family of plasmid partitioning proteins. VirB-mediated
changes in DNA supercoiling are likely involved in the mechanism of anti-silencing. This
work opens up the possibility that transcriptional anti-silencing proteins found in other
bacterial pathogens also alter DNA topology to control virulence gene expression,
mechanistically uniting this important group of proteins.
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3.3 INTRODUCTION
The VirB protein is a transcriptional regulator of many virulence genes in S. flexneri,
that functions through anti-silencing of virulence gene promoters that are
transcriptionally silenced by H-NS (Wing et al., 2004; Turner and Dorman, 2007; Basta
et al., 2013). Despite this knowledge, the mechanism of VirB-mediated anti-silencing
has not been fully elucidated. To better understand this mechanism, the DNA binding
properties of VirB have been compared to its closest homolog, the plasmid partitioning
protein ParB of P1 phage (42.8% identity). Through these comparisons, it was
discovered that VirB binds a ParB-like binding site (Taniya et al., 2003; Turner and
Dorman, 2007; Weatherspoon-Griffin et al., 2018) and, like ParB (Rodionov, O.,
Lobocka M., and Yarmolinsky, 1999), potentially oligomerizes along DNA (Beloin et al.,
2002; McKenna et al., 2003; Weatherspoon-Griffin et al., 2018). The DNA binding and
subsequent oligomerization along DNA are thought to lead to the remodeling of the HNS silencing complex (Gao et al., 2013), but how this occurs is unknown. More insight
into this mechanism may be gained by additional comparisons to ParB. The
oligomerization of ParB along DNA triggers changes in DNA supercoiling of a plasmid
bearing its binding site (Edgar et al., 2001). However, this phenomenon has not been
studied for VirB. Thus, as a first step to better defining the mechanism of anti-silencing,
the goal of this chapter is to investigate the effect of VirB on DNA topology of a plasmid
containing VirB-dependent icsP promoter sequences.
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3.4 TRANSCRIPTIONAL ANTI-SILENCING PROTIEIN VIRB, A KEY REGULATOR IN
SHIGELLA VIRULENCE, MODULATES DNA SUPERCOILING THROUGH DNA
BINDING
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SUMMARY
At ≤ 30 °C, many genes on the large Shigella virulence plasmid are transcriptionally
silenced by the histone-like nucleoid structuring protein H-NS. Upon a switch to 37 °C,
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VirB, a positive transcriptional regulator essential for Shigella virulence, is produced.
VirB functions to counter remaining H-NS-mediated silencing at this temperature, in a
process called transcriptional anti-silencing. To date, the mechanistic details
underpinning this molecular antagonism remain unclear. Here, we show that VirB
mediates a change in the DNA supercoiling of our plasmid-borne, VirB-regulated PicsPlacZ reporter in vivo. The changes are not caused by a VirB-dependent increase in
transcription and nor do they require the presence of H-NS. Instead, the supercoiling
changes, which appear as a loss of negative supercoils, are dependent on direct
binding of VirB to the site required for VirB-dependent regulation. Additional factors or
conditions are likely required in vivo as VirB is unable to change the supercoiling of the
PicsP-lacZ reporter in vitro. Together, our findings demonstrate a new VirB-dependent
activity that relies on VirB:DNA interactions that may play a role in the transcriptional
anti-silencing of virulence genes in Shigella spp.

INTRODUCTION
VirB is a transcriptional regulator essential for the virulence of the gram-negative
bacterial pathogens in the Shigella genus (Schuch and Maurelli, 1997), the causative
agents of bacillary dysentery in humans. Rather than functioning as a transcriptional
activator, VirB upregulates many virulence genes encoded by the large virulence
plasmid (~222 kb) by countering transcriptional silencing mediated by the nucleoid
structuring protein H-NS (Wing et al., 2004; Turner and Dorman, 2007; Basta et al.,
2013), a process known as transcriptional anti-silencing. Consequently, VirB is an
essential regulator of Shigella pathogenesis. Transcriptional anti-silencing proteins
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controlling virulence gene regulation are also present in a number of other bacterial
pathogens (reviewed in (Stoebel et al., 2008), including SsrB of Salmonella enterica
(Walthers et al., 2011), RovA of Yersinia pseudotuberculosis (Heroven et al., 2004),
ToxT from Vibrio cholera (Yu and DiRita, 2002), and Ler from enteropathogenic
Escherichia coli ((Mellies et al., 2006). Despite the low homology in primary amino acid
sequence between these anti-silencing proteins, it appears that bacterial pathogens
have independently evolved these specialized proteins specifically to overcome
transcriptional silencing effect of H-NS. Thus, much interest has been generated in
studying the mechanisms of transcriptional anti-silencing employed by this cohort of
transcriptional regulators. By studying these proteins, perhaps a common mechanistic
theme will emerge.
VirB bears little homology to known transcriptional activators, but instead, belongs to
a protein superfamily containing both plasmid and chromosomal partitioning proteins,
most closely resembling ParB, the plasmid partitioning protein of P1 phage (35.8%
identity and 75.1% similarity). Although VirB does not appear to function in plasmid
partitioning (Radnedge et al., 1997; Buchrieser et al., 2000; Taniya et al., 2003),
comparisons of VirB to ParB have led to a better understanding of the VirB protein and
its interactions with DNA (Beloin et al., 2002; Turner and Dorman, 2007; Gao et al.,
2013). For instance, both VirB (Beloin et al., 2002) and ParB (Radnedge et al., 1996;
Surtees and Funnell, 1999) share a conserved, centrally located helix-turn-helix DNA
binding domain (>70% identity), and consequently, the proposed DNA sequence
recognized by VirB is highly similar to that of ParB (Taniya et al., 2003; Turner and
Dorman, 2007; Castellanos et al., 2009; Gao et al., 2013). Additionally, both proteins
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have the ability to form homooligomers (Surtees and Funnell, 1999; Beloin et al., 2002;
Gao et al., 2013) and, like ParB (Rodionov et al., 1999), gel shift assays and DNase I
protection assays support that VirB may oligomerize along DNA (Beloin, McKenna, &
Dorman, 2002; Gao et al., 2013; McKenna, Beloin, & Dorman, 2003; Surtees & Funnell,
1999, Weatherspoon-Griffin et al., 2017, manuscript under edit for resubmission). These
studies, in combination with the recent co-crystallization of a heavily truncated VirB
protein with its recognition site, have led to the current model of VirB-dependent
regulation (Gao et al., 2013). In this model, VirB docks to its DNA binding site, inducing
wrapping of the DNA around VirB. Subsequently, VirB oligomerizes along the DNA,
leading to the destabilization of the downstream H-NS silencing complex (Gao et al.,
2013). However, precise details of the VirB-mediated remodeling of the H-NS silencing
complex are lacking.
Much of our understanding of this mechanism comes from studies of the regulatory
interplay between VirB and H-NS at only two virulence gene promoters, icsB (Turner
and Dorman, 2007) and icsP (Wing et al., 2004; Castellanos et al., 2009). At the icsB
promoter, the sequence required for VirB-dependent regulation is located within 150 bp
upstream of the transcription start site (TSS), lying immediately upstream of the region
bound by H-NS (Turner and Dorman, 2007). In contrast, at the icsP promoter, the cisacting VirB binding site is organized as an inverted repeat, located over 1 kb upstream
of primary TSS, and lies ~250 bp upstream of the remotely located region required for
H-NS-mediated silencing (Castellanos et al., 2009; Hensley et al., 2011, WeatherspoonGriffin et al., 2017, manuscript under edit for resubmission). The regulation imparted by
this remote binding site is unusual because most transcription factors bind to sites
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located up to 250 bp upstream of the TSS (Collado-Vides et al., 1991). Thus, the icsP
promoter represents a unique example for which to study long range regulation by VirB
and its interplay with H-NS.
An additional activity of ParB that has not been described for VirB is the ability of
ParB to cause changes in DNA supercoiling in vivo once it binds to its DNA recognition
site (Edgar et al., 2001), an activity that has also been described for another ParB family
member, SopB (Biek and Shi, 1994). Based on the shared evolutionary history of VirB
with ParB, we hypothesize that the interaction of VirB with its binding site also leads to
changes in DNA supercoiling, which may be important for countering H-NS-mediated
transcriptional silencing of virulence genes in Shigella. In this study, we test this
hypothesis by analyzing changes in DNA supercoiling of our VirB-dependent PicsP-lacZ
reporter (Wing et al., 2004; Castellanos et al., 2009) and its derivatives using
chloroquine-based agarose gel electrophoresis. While most of our assays exploit an E.
coli surrogate system to avoid complications arising from the accessory plasmids
present in Shigella, we go on to demonstrate that the transcriptional regulator VirB
docks to its binding site, triggering a loss of negative supercoiling of the reporter
plasmid in Shigella with native VirB levels using 2D-DNA gel electrophoresis. The ability
of transcriptional anti-silencing proteins like VirB to modulate DNA supercoiling may be
a common feature important in countering transcriptional silencing mediated by H-NS or
other nucleoid associated proteins in other bacteria.

MATERIALS AND METHODS
Bacterial strains, plasmids, and media
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The bacterial strains and plasmids used in this study are listed in Table 2.2.
Overnight bacterial cultures were grown routinely at 37 °C (E. coli) or 30 °C (S. flexneri)
in Luria-Bertani (LB) with aeration or on LB agar [E. coli; LB broth containing with 1.5%
agar (wt. vol-1)]. To ensure that Shigella strains maintained the virulence plasmid,
Congo red binding was tested on TSA plates containing 0.01% (wt. vol-1) Congo Red.
Shigella strains were grown at 30 °C in order to stably maintain the virulence plasmid
(Schuch and Maurelli, 1997). For all experiments, overnight cultures were subcultured
1:100 in fresh LB broth and allowed to grow for 5 h at 37 °C. Where appropriate,
antibiotics were added at the following final concentrations, as needed: ampicillin, 100
µg ml-1 and chloramphenicol, 25 µg ml-1.

Strain construction
The DH10B hns mutant derivative was constructed using a modified one-step
method (Datsenko and Wanner, 2000). Briefly, the hns::Knr locus was PCR amplified
from MC4100 hns mutant (Yamada et al., 1991) using primers W428 and W429 and the
amplicon was electroporated into wild-type DH10B strain expressing the λ RED
recombinase system (pKD46) [grown at 30 °C in Super Optimal Broth with Catabolite
Repression (SOC) medium; (Datsenko and Wanner, 2000)]. Recipients of the hns::Knr
locus were selected for on LB agar containing kanamycin (25 μg ml-1), and the new
strain was verified by sequencing using primers W428 and W429.
To test the regulatory phenotype of the new DH10B hns::Knr strain, icsP promoter
activity was measured in DH10B and the isogenic hns mutant using a β-galactosidase
assay as previously described (Wing et al., 2004). Activity of the icsP promoter was
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significantly higher in the DH10B hns::Knr background compared to wild type DH10B
(data not shown), consistent with previous studies using the same hns mutant locus in
E. coli MC4100 (Wing et al., 2004).

Plasmid construction
The plasmids used in this study are listed in Table 2.2. For all experiments, the VirBdependent PicsP-lacZ reporter pHJW20, (pACYC184 derivative; Wing, Yan, Goldman,
& Goldberg, 2004), or its derivatives were used. For the construction of the PicsP-lacZ
lacking just the promoter-proximal H-NS binding region, pHJW20 was digested with
AflII-BamHI (3809 bp) restriction enzymes. The remaining plasmid DNA was treated
with T4 DNA polymerase according to manufacturer’s directions (Promega Cat. No.
M4211) to fill in the 5’ overhangs and the product was then self-ligated. The resulting
construct, pMAP27, is a pHJW20 derivative containing icsP promoter sequences -1232
to -426 relative to the primary TSS (Hensley et al., 2011), but lacking sequences
downstream of -426 through the lacZ gene (+27 from stop codon).
For the construction of the PicsP-lacZ derivative lacking both the promoter-proximal
and promoter-distal H-NS binding regions, these regions were removed by restriction
digest of pMAP27 with SwaI and AflII (533 bp) restriction enzymes. The remaining
plasmid was treated with T4 DNA polymerase to fill in the 5’ overhang of AflII, and the
product was then self-ligated. The resulting construct pMAP29 is a pHJW20 derivative
containing icsP promoter sequences -1232 to -964 relative to the primary TSS (Hensley
et al., 2011), but lacking sequences downstream of -964 through the lacZ gene (+27
from stop codon).
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For the construction of the mutated pBAD-virB producing VirB protein with K152E
amino acid substitution (pADK15), a two-step, mutagenic megaprimer PCR method was
used. First, the mutagenic megaprimer (214 bp) was generated by PCR amplifying a
small fragment of the virB open reading frame from pATM324 (pBAD-virB) using
mutagenic oligo W651 with W652. The mutagenic megaprimer generated from the first
PCR reaction was then used with W653 to PCR amplify a 704 bp amplicon from
pATM324. The resulting fragment was then digested with BglII and HindIII restriction
enzymes and ligated into pATM324 digested with the same restriction enzymes. The
new construct (pADK15) was verified by sequencing using primers W43 and W653.

In vivo plasmid supercoiling assays
DNA Isolation Procedures
For in vivo supercoiling assays in E. coli, the PicsP-lacZ reporter or its derivatives
and the pBAD-virB expression plasmid or its derivative were introduced either alone or
in combination into DH10B or its isogenic derivative hns::Knr mutant. DH10B containing
PicsP-lacZ (or derivatives) and inducible pBAD-virB, or DH10B with single plasmid
controls for the lacZ reporters or pBAD-virB, were grown overnight in the presence 0.2%
(wt. vol-1) D-glucose if the strains contained pBAD-virB (Guzman et al., 1995). The
following day, each overnight culture was subcultured 1:100 into two separate cultures
containing LB broth and then grown for 3 h at 37 °C. The expression of virB was then
induced in half of the cultures with the addition of 0.2% (wt. vol-1) L-arabinose, and all of
the cultures were grown for 2 h more at 37 °C. Cells were then harvested, and the
optical density (600 nm) of each culture was measured, and the same number of cells
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from each culture were processed using the PureYield Plasmid Miniprep System
according to the manufacturer’s directions (Promega).
For in vivo supercoiling assays in Shigella, the PicsP-lacZ reporter was introduced
into the wild-type S. flexneri strain 2457T or the isogenic virB mutant AWY3 strain. Cells
were grown as above, and then the DNA was isolated using the Plasmid Maxi Kit
(Qiagen) according to manufacturer’s directions except all steps and reagents, except
Buffer P2, were carried out at 4 °C and the DNA was eluted in TE buffer (10 mM TrisHCl, pH 7.5 and 1 mM, EDTA, pH 8.0). This process helped prevent excessive nicking
and smearing of the DNA, as reported previously (Carbone et al., 2012).

1D Chloroquine Gel Electrophoresis
To analyze the topoisomer distribution of the isolated DNA samples, 500 ng total
DNA was electrophoresed in one dimension through a 2x TBE [178 mM Tris base, 178
mM Borate, 4 mM EDTA (pH 8.0)], 0.7% (wt. vol-1) agarose gel, for 16 - 24 h in the dark
at 2.0 - 2.5 v cm-1 in the presence of chloroquine (final 2.5 μg ml-1, in gel and buffer). To
analyze whether supercoiling changes caused by VirB were positive or negative,
chloroquine was used at 10 μg ml-1 final concentration.

2D Chloroquine Gel Electrophoresis
For 2D gel electrophoresis of DNA samples from E. coli, the same 1D
electrophoresis conditions were used. Next, the bottom 2 cm of the gel was cropped so
that the gel could be rotated 90°, and then the gel was soaked in fresh 2x TBE
containing 12.5 ug ml-1 chloroquine for 4 h in the dark to allow for equilibration of the gel
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to the new chloroquine concentration. The DNA was electrophoresed for 12 h at 2 v
cm-1 in the dark. After electrophoresis, the chloroquine was removed from the gel by
soaking in fresh 2x TBE for 3 - 4 h, changing the water every 30 - 60 min. The gel was
then stained with ethidium bromide (100 μg) for 1 h followed by imaging of the gel. A
minimum of two independent experiments were performed, using at least duplicate
samples for each experiment. The gel was imaged with UVP Imaging Software
(BioImaging Systems).
For 2D gel electrophoresis of DNA samples isolated from S. flexneri, the same
electrophoresis conditions of the E. coli samples were used, except in the 1D, 500 ng of
total DNA was electrophoresed in the presence of 10 μg ml-1 chloroquine for 30 h at
2 v cm-1. In the 2D, the samples were electrophoresed in the presence of 15 μg ml-1 for
16 h at 2 v cm-1.
The ∆Lk was calculated by densitometric analysis of each discrete topoisomer
divided by the total pixel density of each discrete topoisomer. Densitometry was
analyzed using ImageJ software (Schneider et al., 2012). The ∆Lk was calculated by
subtracting the topoisomer number with the highest density in the wild-type S. flexneri
background to that in the virB mutant AWY3 background. The mean and standard
deviations of these calculations were used.

Electrophoretic mobility shift assays
To test VirB binding in vitro, two 54 bp icsP promoter fragments containing either
wild-type or mutated VirB sites were used. To create each target, primer pairs W391
and W392 and W393 and W394, respectively, were annealed together under the
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following conditions; denaturation at 95 °C for 5 min, followed by annealing at 95 °C for
1 min at -1 °C cycle-1. To isolate each annealed reaction, each sample was then gel
purified and electroeluted, and the resulting DNA was phenol:chloroform extracted and
ethanol precipitated. For radiolabeling of the non-coding strand, 4.8 pmol of each target
was single-end labeled using T4 polynucleotide kinase (Promega) according to
manufacturer directions using [γ32P] ATP (specific activity, 3000 Ci mmol-1; Perkin
Elmer). Unincorporated radionucleotides were removed using Illustra ProbeQuant G-50
Micro Columns according to manufacturer directions (GE Healthcare).
Increasing concentrations of purified VirB-His6 (Monserate Biotech) was incubated
with ~0.02 pmol of each icsP promoter target at 37 °C for 20 minutes in 1x binding
buffer (10 mM potassium phosphate, pH 7.5, 25 mM NaCl, 0.5 mM β-mercaptoethanol,
0.5 mM EDTA, 50 % glycerol, 25 ng µl-1 herring sperm DNA) in a total volume of 20 μl.
After incubation, the reactions were resolved on a 6% native polyacrylamide gel in
1x TBE at 120 v for 40 min. The gel was transferred to Whatman paper, covered with
plastic wrap, and exposed to a phosphor-imaging screen, and the screen was scanned
with the Typhoon 9410 Variable Mode Imager. For lane trace analysis and
densitometry, ImageJ software (http://imagej.nih.gov) was used.

In vitro plasmid supercoiling assays
To analyze the effect of purified VirB protein on plasmid supercoiling in vitro, the
following experiment was done. Purified PicsP-lacZ plasmid containing mostly
supercoiled DNA was incubated with increasing amounts of purified VirB-His6 (courtesy
of Monserate Biotech) at 37 °C for 30 min in a total reaction volume of 20 μl containing
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1x VirB binding buffer (10 mM KPO4 pH 7.5, 25 mM NaCl, 0.5 mM β-mercaptoethanol,
0.5 mM EDTA, and 50% glycerol). After incubation, each sample was divided in two in
order to analyze, first, VirB binding to plasmid DNA, and, second, the effect on DNA
topology. The first subsamples used to analyze VirB binding to plasmid DNA were
electrophoresed in a 1% agarose gel made in 1x TAE (40 mM Tris-HCl, 20 mM Glacial
Acetate, 2 mM EDTA, pH 8.1) at 4.7 v cm-1 for 1.5 h in the absence of ethidium
bromide. Then, to visualize the DNA, the gels were stained with ethidium bromide and
imaged using UVP Imaging Software. The second set of subsamples were
deproteinized by processing each with the PureYield Plasmid Miniprep System
(Promega). according manufacturer’s directions. The samples were electrophoresed in
the presence of chloroquine, as described above.

RESULTS
VirB causes changes in DNA supercoiling of a PicsP-lacZ reporter
Although the mechanism of VirB-mediated anti-silencing has been studied before
(Beloin et al., 2002; Gao et al., 2013), the exact mechanism by which transcriptional
silencing by H-NS is countered by VirB has not been elucidated. Indeed, comparisons
to the closest homolog of VirB, the plasmid partitioning protein ParB of P1 phage, has
revealed similar DNA binding properties. (Taniya et al., 2003; Turner and Dorman,
2007; Gao et al., 2013). The plasmid partitioning protein ParB, as well as the related
SopB protein, both cause changes in DNA supercoiling of plasmids bearing their
respective binding sites (Biek and Strings, 1995; Edgar et al., 2001). To gain insight into
whether VirB can also cause changes in DNA supercoiling, we made use of our
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previously characterized, VirB-dependent PicsP–lacZ reporter plasmid (Castellanos et
al., 2009; Wing, Yan, Goldman, & Goldberg, 2004; Figure 3.1). This plasmid was
isolated from cells either with or without VirB. The E. coli recA- strain DH10B was
initially chosen for this work because i) it is known to stably maintain multicopy plasmids
without risk of recombination (Grant et al., 1990), and ii) this strain background avoids
complications arising from the accessory plasmids present in wild-type S. flexneri cells.
Because DH10B does not encode virB, the virB gene was provided in trans on an Larabinose inducible plasmid, pATM324 (pBAD-virB).

PicsP-lacZ
(pHJW20)
VirB
binding site

Region required for H-NSmediated silencing

-1232
-1137

-900

-436

P2

P1

+28
lacZ
-84 +1

Figure 3.1 Schematic of parent PicsP-lacZ reporter construct used in this study. Not drawn to scale.
The primary (+1) and secondary (-84) icsP TSS’s are indicated (Hensley et al., 2011). The region
required for H-NS-mediated silencing and binding site required for VirB-dependent anti-silencing of
the icsP promoter are indicated (Weatherspoon-Griffin et al., 2018, Castellanos et al., 2009).

DNA was isolated from cells carrying either the PicsP-lacZ reporter, the pBAD-virB
expression plasmid, or both, under inducing or non-inducing conditions to control virB
expression, as previously described (Wing et al., 2004). Isolated DNA was then
subjected to electrophoresis through agarose gels, and the mobilities of the DNA
samples were analyzed. While DNA samples containing single plasmids were not
altered by the presence or absence of the L-arabinose inducer (Figure 3.2A; compare
lane 1 with lane 6 & lane 2 with lane 5), each of the samples containing both plasmids
were altered when virB was induced by the addition of L-arabinose (Figure 3.2A;
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compare lanes 3 & 4). Comparison of these samples to those containing single
plasmids allowed us to deduce that only one of the plasmids, the VirB-dependent PicsPlacZ reporter, displayed an altered mobility (Figure 3.2A; lane 4, denoted with *). These
observations suggest that VirB, either directly or indirectly, was responsible for the
altered mobility of the PicsP-lacZ reporter.
Subsequent experiments demonstrated that the altered mobility of the PicsP-lacZ
reporter was neither caused by residual VirB protein remaining associated with the
reporter (Figure 3.9A; compare lanes 3 – 5 with lane 1) nor triggered by a VirBdependent change in size of the PicsP-lacZ reporter (Figure 3.9B). Consequently, we
next tested the possibility that VirB triggers a change in DNA supercoiling of the PicsPlacZ reporter. To test this prediction, DNA samples isolated from cells either with or
without virB induction were electrophoresed in the presence of chloroquine, an
intercalating agent that resolves plasmid topoisomers (Clark and Leblanc, 2009) by
inducing positive supercoiling. While the single plasmid controls showed little to no
change in their topoisomer distributions regardless of induction (Figure 3.2B; compare
lane 1 with lane 6 & lane 2 with lane 5), the topoisomer distribution of the DNA samples
containing two plasmids was altered by virB induction, displaying a shift towards the top
of the gel compared its counterpart isolated from cells without virB induction (Figure
3.2B; compare lanes 3 and 4). A schematic for this phenomenon is shown (Figure 3.2C;
left panel). Comparison of these samples to the single plasmid lanes allows us to
deduce that the PicsP-lacZ reporter topoisomer specifically displayed this change in
topoisomer distribution. Collectively, these data strongly suggest that the altered
electrophoretic mobility of the PicsP-lacZ reporter observed in the presence of VirB
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(Figure 3.2A) was caused by a VirB-dependent change in DNA supercoiling of this
plasmid.

VirB causes a loss of negative supercoiling of the PicsP-lacZ reporter in vivo
To better understand the directional change in DNA supercoiling of the PicsP-lacZ
reporter mediated by VirB, we electrophoresed the DNA samples isolated under the
same conditions in the presence of a high concentration of chloroquine (10 μg ml-1). The
chloroquine-induced positive supercoiling relaxes DNA with a high degree of negative
supercoiling, which results in a slow migration of this DNA. On the other hand, DNA with
a low degree of negative supercoiling is made more positively supercoiled, resulting in a
fast migration. A schematic for these migration patterns is shown (Figure 3.2C; right
panel).
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Figure 3.2 VirB-mediated change in the electrophoretic mobility and supercoiling of PicsP-lacZ. A)
Electrophoretic mobility of wild-type PicsP-lacZ reporter isolated from DH10B in the presence or
absence of virB induction during growth. The * denotes the band of interest where the change in
electrophoretic mobility takes place. B) Topoisomer distribution of samples from (A) analyzed on an
agarose gel containing chloroquine (2.5 μg ml-1). C) Schematic of the effect of low and high
[chloroquine] on negatively supercoiled DNA D) Topoisomer distribution of identically isolated
samples from (A) analyzed on an agarose gel containing chloroquine (10.0 μg ml-1). For (A), (B), and
(D), the single plasmid controls are indicated. R = relaxed, SC = supercoiled.

Under the high chloroquine concentration (10 μg ml-1), the topoisomer distributions
of the PicsP-lacZ or pBAD-virB single plasmids are relaxed regardless of inducing
conditions (Figure 3.2D; lanes 1, 2, 5, and 6) compared to their counterparts
electrophoresed under the lower chloroquine concentration (Figure 3.2B, lanes, 1, 2, 5,
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& 6). Because chloroquine introduces positive supercoils, the chloroquine-mediated
relaxation of plasmid DNA indicates that each plasmid initially is negatively supercoiled,
consistent with the known negative superhelical density of DNA in E. coli (Bauer, 1978).
In samples containing both plasmids, only the PicsP-lacZ reporter displayed a faster
migration of plasmid topoisomers under virB induction conditions compared to no
induction (Figure 3.2D; compare lane 3 with 4), opposite of its counterparts
electrophoresed under a low chloroquine concentration (Figure 3.2B; lanes 3 and 4).
Thus, the VirB-dependent relaxation of the PicsP-lacZ topoisomers under a low
chloroquine concentration and subsequent increase in positive supercoiling under a
high chloroquine concentration demonstrate that the PicsP-lacZ reporter has undergone
a VirB-mediated loss of negative supercoiling.

VirB-mediated changes in supercoiling are independent of transcription
Transcription elongation is known to generate positive supercoils downstream of a
translocating RNA polymerase and negative supercoils upstream (Liu and Wang, 1987),
a process later coined the twin-domain model of transcription (Leng and McMacken,
2002). Although our observations demonstrate VirB mediates a change in supercoiling
of the PicsP-lacZ reporter, it remained unclear if VirB-dependent increase in
transcription elongation or preceding events were responsible for the observed changes
in DNA supercoiling of our PicsP-lacZ reporter.
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Figure 3.3 Transcription does not contribute to VirB-dependent changes in DNA supercoiling. A)
Electrophoretic mobility of PicsP-lacZ reporter with truncated P1 and P2 (Hensley et al., 2011)
isolated from DH10B in the presence or absence of virB induction during growth. The asterisk
denotes the band of interest where the change in electrophoretic mobility takes place. B) Topoisomer
distribution of samples from (A) analyzed on an agarose gel containing chloroquine (2.5 μg ml-1). For
both (A) and (B), the single plasmid controls are indicated.

To test the role of transcription (all steps) in the VirB-mediated changes in
supercoiling, a previously constructed PicsP-lacZ reporter that lacks both VirBdependent promoters, P1 and P2 (Hensley et al., 2011; Figure 3.1), but retains the VirB
binding site (Weatherspoon-Griffin et al., manuscript submitted for publication), was
analyzed for its electrophoretic mobility and topoisomer distribution using the previously
125

described assays. Analysis of the lanes containing two plasmids showed a change in
electrophoretic mobility (Figure 3.3A, compare lanes 3 & 4, denoted with *) and
topoisomer distribution (Figure 3.3B, compare lanes 4 & 5) of only the PicsP-lacZ
derivative under virB inducing conditions, similar to observations made with the fulllength PicsP-lacZ reporter under identical conditions (Figure 3.2A, lanes 3 & 4; Figure
3.2B, lanes 4 & 5). Because the PicsP-lacZ derivative lacks both VirB-dependent
promoters, we conclude that all steps of transcription, including transcription elongation,
are not responsible for the observed changes in supercoiling, implicating the steps prior
to transcription initiation.

VirB-dependent changes in supercoiling require direct binding of VirB to its binding site
We previously demonstrated that the inverted repeat centrally located at position 1137 relative to the primary TSS is a bona fide VirB binding site (Weatherspoon-Griffin,
et al., manuscript under edit for resubmission). We next wanted to address whether VirB
binding to this site was responsible for the observed change in supercoiling. We tested
this in two ways. First, to test the role of the VirB binding site, the PicsP-lacZ reporter
with a mutated VirB binding site (Castellanos et al., 2009) and pBAD-virB were
introduced into wild-type DH10B and the samples were assayed as before. Analysis of
the samples containing both plasmids revealed that the mobility of the PicsP-lacZ
reporter bearing a mutated VirB binding site (Figure 3.4A, compare lanes 6 & 7) and its
topoisomer distribution (Figure 3.4B, compare lanes 6 & 7) was not altered under virB
inducing conditions compared to non-inducing conditions. In contrast, samples
containing the wild-type PicsP-lacZ reporter and pBAD-virB displayed a change in
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mobility (Figure 3.4A, compare lanes 4 and 5) and topoisomer distribution (Figure 3.4B,
compare lanes 4 & 5). These findings demonstrate the VirB binding site is required for
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VirB-mediated changes in supercoiling.
Second, to test the role of DNA binding, we made use of a previously characterized
VirB protein derivative, VirB K152E, in our in vivo electrophoretic mobility and
supercoiling assays. The K152E amino acid substitution is in the helix-turn-helix DNA
binding domain, and renders VirB severely compromised in its ability to bind DNA both
in vivo and in vitro (Beloin et al., 2002; McKenna et al., 2003), and consequently, fails to
regulate virulence gene expression (Beloin et al., 2002; Gao et al., 2013). Nearly
equivalent expression levels of the wild-type VirB and VirB K152E from the pBAD
expression system was confirmed by Western blot (Figure 3.4D). In samples containing
both the wild-type PicsP-lacZ reporter and the wild-type pBAD-virB, the mobility (Figure
3.4D; compare lanes 4 & 5) and topoisomer distribution (Figure 3.4E; compare lanes 4
& 5) of only the PicsP-lacZ reporter was altered under virB induction conditions. In
contrast, the mobility (Figure 3.4D; compare lanes 6 & 7) and topoisomer distribution
(Figure 3.4E; compare lanes 6 & 7) of the wild-type PicsP-lacZ reporter isolated in the
presence of pBAD-virB (K152E) expression plasmid was not altered regardless of
induction conditions. These data indicate that the VirB K152E protein incapable of DNA
binding is unable to cause a change in DNA supercoiling. Together, these data
demonstrate that direct binding of VirB to its binding site is required for VirB-mediated
changes in DNA supercoiling in vivo.

H-NS is not involved in VirB-dependent changes in supercoiling
Because VirB functions to counter transcriptional silencing mediated by the nucleoid
structuring protein H-NS (Wing et al., 2004; Turner and Dorman, 2007; Basta et al.,
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2013), it was unclear whether VirB itself or a remodeling of the H-NS:DNA complex
(Mojica and Higgins, 1997) was responsible for VirB-mediated changes in DNA
supercoiling. To determine the role of H-NS in the observed changes in supercoiling,
the full-length PicsP-lacZ reporter was isolated from an isogenic derivative of DH10B
lacking hns, and the mobility and topoisomer distribution of the reporter was analyzed
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Figure 3.5 The role of H-NS in VirB-dependent changes in supercoiling of the PicsP-lacZ reporter. A)
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using our previously described assays.
In samples containing both the PicsP-lacZ reporter and pBAD-virB isolated from the
DH10B hns mutant, only the reporter showed an altered mobility under virB inducing
conditions (Figure 3.5A; lanes 4 & 5). Subsequent analysis of the PicsP-lacZ
topoisomers isolated in the presence of pBAD-virB from the hns mutant background
revealed that the reporter has undergone a change in its topoisomer distribution (Figure
3.5B compare lanes 4 & 5). A similar observation was made for the PicsP-lacZ isolated
from the wild-type background under identical conditions (Figure 3.2B; compare lanes 3
& 4). Together, these data indicate that VirB mediates changes in DNA supercoiling
independently of H-NS.

VirB-dependent changes in supercoiling occur in S. flexneri
The preceding supercoiling experiments have been conducted thus far using DNA
samples from E. coli DH10B and with overexpression of VirB. However, it is unclear if
natural levels of VirB modulate DNA supercoiling of the PicsP-lacZ reporter in Shigella.
Early attempts using the same experimental conditions for the samples isolated from E.
coli did not allow changes in supercoiling to be assessed in Shigella due to poor
resolution of plasmid topoisomers (data not shown). To circumvent this issue, we used
two-dimensional DNA gel electrophoresis to allow for a clear separation of all negatively
and positively supercoiled topoisomers within a DNA sample (Figure 3.6A). Briefly,
plasmid topoisomers are separated in the first dimension by the addition of chloroquine,
the gel is rotated 90°, and electrophoresed in the presence of a higher chloroquine
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Figure 3.6 VirB mediates changes in DNA supercoiling in S. flexneri. A) Schematic of two-dimensional
agarose gel electrophoresis to analyze topoisomer distributions. In the first dimension, the faster
migrating topoisomers are more negatively supercoiled while the slower migrating topoisomers are less
negatively supercoiled. In the second dimension, the faster migrating topoisomers are increasingly
positively supercoiled. B) Two-dimensional gel electrophoresis of PicsP-lacZ reporter isolated from
DH10B with or without virB induction. C) Representative lane trace analysis of topoisomer distributions
from samples in (B). D) Two-dimensional gel electrophoresis of PicsP-lacZ isolated from wild-type 2457T
and isogenic virB mutant AWY3 backgrounds. E) Representative lane trace analysis of topoisomer
distributions of samples in (D). N = nicked, L = linear DNA.

concentration. In the first dimension, the faster migrating topoisomers are more
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negatively supercoiled while the slower migrating topoisomers are less negatively
supercoiled. In the second dimension, the slower migrating topoisomers are more
relaxed/negatively supercoiled while the faster migrating topoisomers are relatively
more positively supercoiled.
As a proof of principle that this new methodology is effective in separating plasmid
topoisomers, we began by testing the previously isolated PicsP-lacZ reporter from
DH10B in the absence or presence of virB induction under the two-dimensional gel
electrophoresis conditions. In the sample containing the PicsP-lacZ reporter and the
pBAD-virB isolated without virB induction, the PicsP-lacZ reporter topoisomers are
largely negatively supercoiled (Figure 3.6B) and in a tight distribution (Figure 3.6C). In
contrast, in the sample containing the PicsP-lacZ reporter and pBAD-virB isolated with
virB induction, the PicsP-lacZ topoisomers are more evenly spread over a larger
distribution of negatively supercoiled DNA (Figures 3.6B and C). Calculation of the ∆Lk
= +9.5 ± 3.5, indicating that expression of VirB leads to a loss of negative supercoiling,
consistent with previous results (Figures 3.2B and D).
Having established that these two-dimensional gel electrophoresis conditions allow
for the identification and quantification of the change in supercoiling of the PicsP-lacZ
reporter caused by virB overexpression, we next wanted to use these conditions to
analyze the change in supercoiling of the PicsP-lacZ reporter with natural VirB levels in
S. flexneri. Our reporter was introduced into wild-type S. flexneri strain 2457T and an
isogenic virB mutant AWY3 background and the two-dimensional gel experiment was
repeated. Under the same electrophoresis conditions, a change in supercoiling of the
PicsP-lacZ reporter was not immediately obvious, as most of the DNA was negatively
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supercoiled to a similar degree in both conditions (data not shown). Upon addition of
more chloroquine in the first dimension (10 μg ml-1), the PicsP-lacZ topoisomers were
better separated, allowing for quantification of the ∆Lk. The topoisomer distribution of
the PicsP-lacZ reporter isolated from the virB mutant compared to its distribution when
isolated from wild-type S. flexneri shows an apparent ∆Lk of +3.5 ± 0.71 (Figures 3.6D
and E). These data demonstrate that physiological VirB levels in S. flexneri are
sufficient to cause a loss of negative supercoiling of the PicsP-lacZ reporter.

VirB is not sufficient to cause changes in DNA supercoiling in vitro
Having demonstrated that VirB mediates a change in supercoiling of our PicsP-lacZ
reporter in vivo, we next tested if VirB could also mediate changes in DNA supercoiling
in vitro. To test this, we incubated increasing concentrations of recombinant VirB with
purified PicsP-lacZ reporter, allowed the nucleoprotein complexes to form, removed
VirB protein, and electrophoresed the DNA through agarose gels. Prior to removal of
the VirB protein from the reactions, electrophoresis of a subsample from each reaction
revealed a dose-dependent shift of the reporter with increasing amounts of VirB-His6
(Figure 3.7A; lanes 2 – 5), indicating that VirB engages the PicsP-lacZ reporter in vitro.
After deproteinization, the PicsP-lacZ topoisomer distribution from each sample was
analyzed in a chloroquine gel. The distribution of PicsP-lacZ topoisomers was
unchanged regardless of the presence of VirB (Figure 3.7B; lanes 1 – 5), indicating that
VirB alone is not sufficient to cause changes in DNA supercoiling in vitro under the
conditions tested. These data suggest that additional factors and/or conditions may be
required.
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DISCUSSION
Despite research spanning nearly 15 years on VirB, a transcriptional anti-silencing
protein that counters silencing mediated by the nucleoid structuring protein H-NS in
Shigella spp., the mechanism of action of VirB has not been fully elucidated. To better
understand this mechanism, we took advantage of the evolutionary relationship of VirB
with the plasmid partitioning proteins ParB of P1 phage and SopB of the F plasmid; both
of these proteins cause a loss of negative supercoiling dependent on their respective
recognition sites (Biek and Shi, 1994; Edgar et al., 2001). Here, we report that,
independent of transcription (Figure 3.3B) and through DNA binding (Figures 3.4C and
F), VirB overexpression causes a loss of negative supercoiling (dextrorotation of the
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double helix) of our VirB-dependent transcriptional reporter in E. coli (Figure 3.6B) and
with natural VirB levels in S. flexneri (Figure 3.6D).
ParB-dependent changes in supercoiling are triggered by oligomerization along DNA
(Rodionov et al., 1999; Edgar et al., 2001). Although ParB does not translocate along
DNA like RNAP, the twin-domain model of supercoiling is likely still applicable for
proteins that oligomerize along DNA; positive supercoils accrue ahead of proteins
oligomerizing along DNA while negative supercoils accrue behind. Indeed, VirB also
forms oligomers in vivo (Beloin et al., 2002). In support of oligomerization along DNA in
vivo, in vitro evidence reveals that with high amounts, VirB oligomerizes along the icsP
promoter bidirectionally (McKenna, Beloin, & Dorman, 2003, Weatherspoon-Griffin et
al., 2017, manuscript under edit for resubmission). Given the presence of 6 known VirBdependent virulence gene promoters (Sasakawa et al., 1993; Turner and Dorman,
2007; Castellanos et al., 2009; Basta et al., 2013), this equates to ~855 VirB molecules
per promoter. These numbers coincide with a scenario in which VirB oligomerization
along virulence gene promoters in vivo occurs, perhaps triggering changes in DNA
supercoiling to alleviate H-NS mediated silencing. This idea will need to be tested more
thoroughly.
Consistent with ParB (Spo0J) of Bacillus subtilis (Taylor et al., 2015a) and SopB of
the F plasmid (Bouet and Lane, 2009), VirB alone is not sufficient to change
supercoiling of our reporter in vitro (Figure 3.9B), suggesting the involvement of
additional in vivo factor(s). One proposed explanation in the SopB literature is that SopB
displaces DNA binding proteins that impose negative superhelicity leading to a loss of
negative supercoils (Bouet and Lane, 2009). Surprisingly, although H-NS can constrain
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DNA supercoiling in vitro (Zhang et al., 1996) and alter DNA topology in vivo (Mojica
and Higgins, 1997), our experiments revealed that H-NS does not affect the intrinsic
supercoiled state nor VirB-mediated changes in supercoiling of the reporter (Figure
3.5B). One explanation is that the hns::Knr used leads to only partial derepression of the
icsP promoter due to the presence of a second H-NS homolog, StpA (Picker and Wing,
2016). Thus, it is possible that VirB still counters the partial silencing effects of StpA
(Wing et al., 2004; Picker and Wing, 2016).
Another reason proposed in the ParB and SopB literature for the observed loss of
negative supercoiling is the involvement of topoisomerases (Edgar et al., 2001; Bouet
and Lane, 2009). In the ParB system, topoisomerases are thought to alleviate
superhelical stress in one part of the plasmid caused by the ParB:DNA interactions in
another part of the plasmid (Edgar et al., 2001), while in the SopB system, SopB is
thought to prevent the action of topoisomerases like DNA gyrase, leading to a deficit of
negative supercoils (Bouet and Lane, 2009). Nonetheless, the inability of VirB to alter
DNA supercoiling in vitro is consistent with observations of a similar study with ParB
(Spo0J) of Bacillus subtilis (Taylor et al., 2015). At this stage, the mechanism by which
VirB triggers a change in supercoiling cannot be determined.
Because H-NS can be sensitive to changes in DNA topology at some promoters
(Prosseda et al., 2004; Bouffartigues et al., 2007), the possibility remains that VirBmediated changes in DNA supercoiling are involved in countering transcriptional
silencing of virulence gene promoters by H-NS. Based on the data described here, we
propose a model of how a VirB-triggered loss of negative supercoiling results in
transcriptional anti-silencing of the icsP promoter (Figure 3.8). In this model, H-NS
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transcriptionally silences the icsP promoter without altering DNA supercoiling, likely
through the formation of a nucleoprotein filament (Weatherspoon-Griffin et al., 2018);
Figure 8). VirB binds its recognition sequence as a dimer (Weatherspoon-Griffin et al.,
2018), oligomerizes along DNA bidirectionally, triggering a loss of negative supercoiling
of the PicsP-lacZ reporter. The loss of negative supercoiling remodels the H-NS
silencing complex in such a way that is permissible for icsP promoter expression. This
model is currently being investigated more rigorously in our laboratory.
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Figure 3.8 Proposed model of VirB-dependent anti-silencing of the icsP promoter. A) H-NS
transcriptionally silences the icsP promoter from sites located between -900 to -436 relative to the TSS
(Weatherspoon-Griffin et al., 2018). VirB docks to its binding site (Castellanos et al., 2009,
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transcription.
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In summary, we have shown that VirB, a transcriptional regulator essential for
virulence gene expression in Shigella spp., causes a loss of negative supercoiling in
vivo of our VirB-dependent reporter plasmid through recognition of its binding site,
recognition site. Thus, the ability of VirB to cause changes in supercoiling is an
evolutionarily conserved trait with plasmid partitioning proteins ParB and SopB,
reaffirming that comparisons of VirB to this protein family generates new insights of
VirB. Our findings have broader implications for other transcriptional anti-silencing
proteins in bacteria (Stoebel et al., 2008) because transcriptional regulators like VirB
that counter transcriptional silencing by H-NS and its homologs (Picker and Wing,
2016), may do so by altering DNA supercoiling. Indeed, the role of DNA supercoiling is
an underappreciated form of gene regulation in bacteria (reviewed in Dorman, Colgan,
& Dorman, 2016)), and therefore, requires more consideration. The links between
nucleoid structuring proteins like H-NS, their antagonists, and DNA supercoiling in
bacteria will continue to grow stronger as interest into this fascinating avenue of
research continues to grow.
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TABLES
Table 3.1 Bacterial strains and plasmids used in this study
Label
Description
Strains
S. flexneri
2457T
Wild-type S. flexneri serotype 2a
AWY3
2457T virB::Tn5; Knr
E. coli
F- endA1 deoR+ recA1 galE15 galK16
nupG rpsL Δ(lac)X74 φ80lacZΔM15
DH10B
araD139 Δ(ara, leu)7697 mcrA Δ(mrrhsdRMS-mcrBC) StrR λ–
MC4100 hns::Knr
r

DH10B hns::Kn

hns dominant negative mutant
expressing 1 - 37 amino acids
DH10B with hns::Knr allele transduced
from MC4100 hns::Knr

Reference

(Formal et. al., 1958)
(Wing et. al., 2004)

(Grant et al., 1990)

(Yamada et. al., 1991)
This Work

Plasmids
pHJW20

PicsP-lacZ reporter plasmid derived
from pACYC184

(Wing et al., 2004)

pMIC21

pHJW20 lacking all promoter sequences

(Castellanos et al., 2009)

pCTH03

pHJW20 truncated from the 3’ end to 32 relative to the TSS; remove P1 and
P2

(Hensley et al., 2011)

pMIC18

pHJW20 with VirB boxes 1 and 2
mutated by transition mutations

(Castellanos et al., 2009)

pMAP27

pMAP29

pATM324
pADK15

pHJW20 with icsP sequences
downstream of -426 relative to TSS and
entire lacZ gene removed; promoterproximal H-NS binding region and lacZ
gene excised.
pMAP27 with icsP sequences
downstream of -964 relative to TSS
through +27 of entire lacZ gene
removed; promoter-distal and proximal
H-NS binding regions and lacZ gene
excised.
virB expression plasmid in a pBAD18
vector
pATM324 derivative that produces VirB
K152E
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This Work

This Work

(Schuch, Sandlin and Maurelli,
1999)
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SUPPLEMENTARY MATERIALS AND METHODS
The role of H-NS in VirB-mediated changes in DNA supercoiling in vivo
The PicsP-lacZ reporter and its derivatives lacking one or both H-NS binding regions
was isolated in the presence or absence of virB induction during growth from DH10B or
DH10B hns::Knr. The isolated DNA was first electrophoresed in a 1% (w v-1) agarose
gel in the absence of ethidium bromide (4.7 v cm-1) for 1.5 h. After staining with 30 μg of
ethidium bromide, the gel was imaged (Figures 6A and C). Next, the same gel
containing ethidium bromide was electrophoresed for 1 h more at the same voltage
speed.
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In vitro VirB supercoiling assays with Vaccinia topoisomerase I
For analyzing the effect of purified VirB protein on plasmid supercoiling in vitro, the
experiment was done as previously described (Zhang and Rimsky, 1996), with some
minor modifications. Briefly, purified pPicsP-lacZ plasmid containing mostly supercoiled
DNA or a previously relaxed pPicsP-lacZ substrate, was incubated with increasing
amounts of purified VirB-His6 (courtesy of Monserate Biotech) at 37 °C for 10 min in a
total reaction volume of 10 μl containing 1x Vaccinia topoisomerase I reaction buffer
(200 mM Tris pH 7.5, 100 mM NaCl, 20 mM dithiothreitol, and 50 mM MgCl2) and 1x
VirB binding buffer (10 mM KPO4 pH 7.5, 25 mM NaCl, 0.5 mM β-mercaptoethanol, 0.5
mM EDTA, and 50% glycerol). After the incubation, a small volume was removed to
analyze VirB binding to plasmid DNA using agarose gel electrophoresis. After the 10
min incubation, topoisomerase I from the Vaccinia virus (supplied in 50 mM NaPO4 pH
7.5, 0.1 mM EDTA, 1 mM dithiothreitol, 50 mM NaCl, 0.04% Tween 20, 0.04% Igepal
Ca-630, 50% glycerol; Monserate Biotech Cat. No. 10005), which is capable of relaxing
both positive and negative supercoils, was added (0.2 units) to the appropriate reactions
followed by incubation at 37 °C for 30 min longer. After 30 min, reactions were stopped
by the addition of SDS (1% w v-1 final) and proteinase K (2 μg). Samples were then
electrophoresed in a 1x TAE (40 mM Tris-HCl, 20 mM Glacial Acetate, 2 mM EDTA, pH
8.1) 1% agarose gel in the absence of ethidium bromide for 4.7 v cm-1 for 1.5 h. After
electrophoresis, gels were stained with ethidium bromide and imaged. For experiments
where agarose gels were post-stained with ethidium bromide, the gels were
electrophoresed for 1 h more (Supplemental Figures 1A, B and C).
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For assessing whether topoisomerase I was still active in the presence of VirB-His6,
the following methods were done. The reaction conditions are the same as that
described in the materials and methods of in the main text. Briefly, the purified pPicsPlacZ reporter (0.5 nM) was incubated with increasing concentrations of purified VirB-His6
(100 and 200 nM) at 37 °C for 10 min. After 10 min, A small sample was taken from
each reaction to analyze VirB binding. Next, Vaccinia topoisomerase I (0.2 units) was
added to the appropriate reactions and allowed to incubate at 37 °C for 30 min more.
After incubation, pBluescript was added to each reaction, and the reactions were
allowed to incubate for 10 in more at 37 °C. All reactions were then stopped with the
addition of proteinase K and SDS followed by a 15 min incubation at 37 °C. The
samples were then electrophoresed on a 1% agarose gel at 4.7 v cm-1 for 1.5 h. The
DNA was stained with ethidium bromide and the gel was imaged.
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Figure 3.9 Phenol:chloroform extraction and restriction digestion of PicsP-lacZ isolated from E. coli in the
presence or absence of virB induction. A) To remove possible protein contaminants, triplicate DNA
samples containing the PicsP-lacZ and pBAD-virB were phenol:chloroform extracted and ethanol
precipitated. The resulting samples were electrophoresed next to samples that were not extracted. B)
DNA samples containing either PicsP-lacZ, pBAD-virB, or both isolated in the presence or absence of Larabinose inducer were linearized with AflII and electrophoresed.
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Table 3.2 Primers used in this study.
Primer

Sequence 5’ to 3’

Description and Use

W43

CTCTACTGTTTCTCCATACCC

Used for sequencing pATM324 derivative;
binds 60 bp upstream of ATG

W391

/5Phos/GATTGAATACTTCCGGGGATTTCA
GTATGAAATGAAGTATATTTAATATACTTT

Top strand to be annealed with W392; Target
6 wild-type VirB boxes; 54 bp

W392

AAAGTATATTAAATATACTTCATTTCATACT
GAAATCCCCGGAAGTATTCAATC

Bottom strand to be annealed with W392;
Target 6 wild-type VirB boxes; 54 bp

W393

GATTGAATACTTCCGGGGcgggtcgTgctgg
gcGAAGTATATTTAATATACTTT

Bottom strand to be annealed with W392;
Target 6 mutated VirB boxes (lowercase); 54
bp

W394

/5Phos/GATTGAATACTTCCGGGGgcccag
cTcgacccgGAAGTATATTTAATATACTTT

Top strand to be annealed with W392; Target
6 mutated VirB boxes (lowercase); 54 bp

W428

ATTGCACAACTGAATTTAAGGC

Used with W429 to amplify hns locus; binds
50 bp upstream of ATG

W429

TTAAATTGTCTTAAACCG

Used with W428 to amplify hns locus; binds
56 bp downstream of TAA

W651

CGAGACAGATTCTCTTTTTTGGCgATaTCcT
cATAGGACATCCC

Mutagenic primer codon 152 of virB ORF TTT
à cTc, K152E; EcoRV created by silent
mutations (lowercase); Used with W652 to
generate mutagenic megaprimer

W652

GCACTCGTAGAAGAGCATCTGCA

Used with W651 to generate mutagenic
megaprimer; binds 272 bp downstream of virB
ATG

W653

GGCTGAAAATCTTCTCTCATCCGCC

Used mutagenic megaprimer to generate
insert for pADK15; binds 46 bp downstream of
virB TAA
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CHAPTER 4

THE INTERACTION OF VIRB WITH THE INVERTED REPEAT OF THE ICSP-OSPZ
INTERGENIC REGION AND ITS RELATION TO THE P1 PARB BINDING SITE

4.1 FOREWORD
Some of the reporter constructs used in this chapter were constructed by other
members of the Wing laboratory. For the assays measuring the activities of the PicsPlacZ reporters containing mutations of the putative VirB half sites 1 – 7, the pPU series
was used (constructed by undergraduate researcher Pashtana Usufzy and laboratory
technician Monika Karney). Monika assayed the individual half site mutations in the
context of the icsP promoter along with a combination of all 7 half sites. I assayed the
various combinations of mutated VirB half sites in the context of icsP promoter as well
as the ospZ promoter. Table 4.1 was collected by me and is published (Basta et al.,
2013).
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4.2 ABSTRACT
The DNA site required for the transcriptional anti-silencing by VirB, a protein
essential for Shigella pathogenesis, has only been characterized at two VirB-dependent
promoters, icsB and icsP. Despite being organized as an inverted repeat, only the
promoter-proximal half of the VirB binding site, located within 120 bp of the icsB TSS, is
required for VirB-dependent regulation, while the entire inverted repeat is required at
icsP. Strikingly, at icsP, this site is located over 1100 bp upstream of the primary TSS,
and the same site is required for regulation of the divergently transcriibed ospZ
promoter (located 397 bp upstream of the TSS). My study reveals that the inverted
repeat contributes to VirB binding in vitro, but VirB appears to have a high specificity for
its site in vivo. I also show that 7 sites resembling half of the inverted repeat are not
important for VirB-dependent regulation of the icsP and ospZ promoters. Interestingly,
the VirB binding site resembles the binding site of ParB of P1 phage, the closest
homolog of VirB. Despite these similarities, I show that the newly identified box A4
element is not required for VirB-dependent regulation of the icsP promoter. Future work
should study VirB:DNA interactions in vivo and investigate the other ParB binding sitelike elements of the icsP/ospZ intergenic region.
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4.3 INTRODUCTION
The discovery that VirB modulates a loss of negative supercoiling through binding its
DNA recognition sequence brings us closer to understanding the mechanism of VirBdependent anti-silencing of virulence genes in Shigella. The initial interaction of VirB
with this recognition sequence is required for VirB-dependent anti-silencing, as
mutations of this DNA sequence or amino acid substitutions in the DNA binding domain
completely block VirB-dependent anti-silencing (Beloin et al., 2002; McKenna et al.,
2003; Turner and Dorman, 2007; Castellanos et al., 2009; Basta et al., 2013; Gao et al.,
2013). However, there is contention in the field about what truly constitutes a VirB
binding site as well as the nature of the VirB:DNA interaction itself.
Based on studies at the icsB promoter in S. sonnei, the VirB recognition site was
proposed to be a 7-8 nucleotide sequence, 5’- (A/G)(A/T)G(G)AAAT -3’, resembling Box
A elements of the binding site parS of ParB P1 phage, the closest homolog of VirB
(Taniya et al., 2003); the parS site is comprised of asymmetrically spaced heptameric
(Box A) and hexameric (Box B) repeats (Figure 4.1A). The VirB recognition sequence at
icsB (centrally located -116 relative to the TSS) was later found to be organized as an
inverted repeat, each half is called Box 1 and Box 2. These boxes have high identity to
boxes A2 and A3 of parS, which is also organized as an inverted repeat (Turner &
Dorman, 2007; Figure 4.1B). Consistent with the work of Taniya et al. (2003), only the
promoter-distal box, Box 2, was found to be required for VirB-dependent regulation of
the icsB promoter (Taniya et al., 2003; Turner and Dorman, 2007). These results
appear to be corroborated by electrophoretic mobility shift assays (EMSAs) showing
that mutation of VirB box 2 reduces, but not abolishes, the ability of VirB to bind the icsB
148

A) parS site from P1 phage

IHF consensus
binding site

TTCGCCATTCAAATTTCACTATTAACTGACTGTTTTTAAAGTAAATTACTCTAAAATTTCAAGGTGAAATCGCCACGATTTCACCTTGGATTTTA
B1

A1

A2

icsB

B2

Box
B

A4

minimum parS site

B) parS and icsB
P1 parS

A3

Box A

A1
A2
A3
A4
B1
B2
AACTTTCGCCATTCAAATTTCACTATTAACTGACTGTTTTTAAAGTAAATTACTCTAAAATTTCAAGGTGAAATCGCCACGATTTCAC
*
**
**
** * **
* *
*
*
** * **
*****
******* *
* *
CATAATCAAATTTTCTTTTGCTGTACATAATATGTACCTCGTGAGCATATGTAGTGCTCGTTTCATCATGAAATCCCACAAGATAAAG
Direction of TSS

Box 1

Box 2

C)

parS ATCCAAGGTGAAATCGTGGCGATTTCACCTTGAAATTTTAGAGTAATTTAC
icsB -CAGGCACTTTATCTTGTGGGATTTCATGATGAAACGAGCACTACATATGC
icsP --TGATTGAATACTTCCGGGGATTTCAGTATGAAATGAAGTATATTTAATA
*
* *******
*****
*
Box 2

Box 1

D) parS and icsP
P1 parS
icsP

A1
A2
A3
A4
B1
B2
TTCGCCATTCAAATTTCACTATTAACTGACTGTTTTTAAAGTAAATTACTCTAAAATTTCAAGGTGAAATCGCCACGATTTCACC
* **
**
* *
* * ** **
** *
******
******
**** *
GGGCTCCCTCTTCCTTTTATGGTGTAATTGTTTGATTGAATAC--TTCCGGGG--ATTTCAGTATGAAATGAAGTATATTTAATA
Box 2

Box 1

Direction of TSS

Figure 4.1 Alignment of the P1 ParB binding site, parS, with VirB-dependent sequences of the icsB
and icsP/ospZ intergenic regions. A) schematic of parS site from P1 phage. Box A and Box B
elements are indicated, as well as a the IHF consensus binding site (Adapted from Vecchiarelli,
Schumacher, & Funnell, 2007). B) Alignment of parS with the icsB non-coding strand containing VirB
boxes 1 and 2 (Adapted from Turner & Dorman, 2007). C) Alignment of minimum parS site and
flanking sequences with VirB boxes 1 and 2 of the icsB (coding strand) and icsP (coding strand)
promoters D) Alignment of parS with the region of the icsP promoter (coding strand) containing VirB
boxes 1 and 2 (Adapted from Harrison, 2010). The direction of the TSS is indicated. Asterisks denote
100% identity between sequences. For (B) and (D), sequences were aligned using Clustal Omega
(Sievers et al., 2014). Alignment of (C) was done by hand.

promoter (Taniya et al., 2003, Turner and Dorman, 2007). Unfortunately, however, the
effect of a box 1 mutation on VirB binding to the icsB promoter was not assessed.
On the other hand, at the icsP and divergently transcribed ospZ promoters, the
same, remotely located VirB boxes 1 and 2 (centrally located -1137 relative to the
primary icsP TSS and -397 relative to ospZ TSS) are absolutely required for VirBdependent anti-silencing (Castellanos et al., 2009; Basta et al., 2013). Indeed, these
boxes also resemble boxes A2 and A3 of parS and boxes 1 and 2 of icsB (Figure 4.1C).
Before starting this work, early attempts in our laboratory tested the role of these sites in
149

VirB binding in vitro. These results showed diminished binding of VirB to a DNA
fragment containing a mutation in VirB boxes 1 and 2 (Harrison, 2010). However, the
reliability of these results was called into question because the DNA binding activity of
the recombinant VirB protein was not consistent across multiple independent trials.
Therefore, a reevaluation of these preliminary data was needed.
Prior analysis of the long, icsP/ospZ intergenic region revealed 7 additional
instances of Box A-like sequences that have at least a 6/7 match to the proposed VirB
binding site (Taniya et al., 2003); all of these sites are located between -600 and +40
relative to the primary icsP TSS (Castellanos et al., 2009). Interestingly, my analysis of
the icsP promoter region containing boxes 1 and 2 revealed the existence of a Box A4like element (Figure 4.1D; 5/7 match to parS Box A4 and 6/7 match to proposed
consensus). A systematic, 5’ truncation analysis through many of these matches to the
proposed consensus did not support a role for these sites in VirB-dependent regulation
alone (Castellanos et al., 2009). Prior to me starting this work, site-directed
mutagenesis of each site alone or in combination in the presence of VirB boxes 1 and 2
was in the works to test the contribution of these sites to VirB-dependent regulation of
the icsP promoter. Because the same remote VirB boxes 1 and 2 are also required for
VirB-dependent regulation of the divergently transcribed ospZ promoter (Basta et al.,
2013), the role of these additional sites also needed to be assessed.
The overall goal of this chapter is to further define a VirB binding site so that a
clearer understanding of how VirB controls Shigella pathogenesis at the transcriptional
level can be achieved. To this aim, I sought to characterize the interaction of VirB with
the remotely located sites required for VirB-dependent regulation of the icsP and ospZ
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promoters. Using a combination of in vitro and in vivo techniques, I test the role of each
box to VirB binding in vitro with stable, recombinant VirB (Monserate Biotech) and
assess the specificity of VirB to its sites in vivo. Then, I test the contribution of 7
previously found sites with matches to the proposed VirB binding site consensus in
combination with one another at the icsP and ospZ promoters, as well as the newly
discovered Box A4-like site. Overall, my data strongly support that VirB regulates the
icsP and ospZ promoters directly from a remotely located inverted repeat, resembling
boxes A2 and A3 of parS, and that the proposed VirB binding site (Taniya et al., 2003)
needs to be reevaluated. These findings are corroborated in our recent publication,
Weatherspoon-Griffin et al., (2018).
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4.4 RESULTS
4.4.1 VIRB DOES NOT REGULATE THE ICSP PROMOTER SEQUENCES LOCATED
-1056 TO -351 RELATIVE TO THE PRIMARY TSS
The transcriptional regulatory cascade of virulence genes in S. flexneri is complex
(Figure 1.7). To uncouple these hierarchical regulatory events from each other, E. coli,
which has a high chromosome identity with Shigella (>85%; Jin et al., 2002), has been
successfully used as a surrogate system to study virulence gene regulation, especially
by the NAP H-NS and the VirB protein (Beloin and Dorman, 2003; Wing et al., 2004;
Basta et al., 2013). With this surrogate system, we identified that VirB functions to
transcriptionally anti-silence the icsP promoter by countering the negative transcriptional
effect of H-NS (Wing et al., 2004). Subsequently, in S. flexneri, our lab showed that
VirB-dependent regulation requires VirB boxes 1 and 2, located over 1 kb upstream of
the primary TSS (Castellanos et al., 2009). Using the E. coli surrogate system, we then
tested if VirB could regulate the icsP promoter in the absence of the previously
characterized inverted repeat, but in the presence of the Box A-like elements (Harrison,
2010). To do this, 5’ truncation analysis (full-length PicsP-lacZ, -1056, -893, -665, and 351 reporters) was repeated in the presence or absence of H-NS (E. coli MC4100 and
hns::Knr backgrounds) and the presence of pBAD-virB with or without L-arabinose
induction. The activities of each construct under each condition was measured using a
b-galactosidase assay.
In the wild-type MC4100 background and in the absence of virB induction, a gradual
loss of H-NS-mediated silencing was observed (Figure 4.2A), similar to before (Figure
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Figure 4.2 VirB does not regulate the activity of truncated PicsP-lacZ reporter derivatives lacking the
VirB recognition site. A) Activities of full-length PicsP-lacZ reporter (pHJW20) and its derivatives and
pBAD-virB in the presence or absence of L-arabinose induction in MC4100 and hns::Knr
backgrounds. Data adapted from Harrison (2010). B) Activities of the full-length PicsP-lacZ reporter
(pAFW04) and its derivatives and pBAD-empty or pBAD-virB in the presence of L-arabinose in the
same cell backgrounds as (A). For statistical significance, a Student’s t-test was conducted, *p <
0.001.

2.8A). In contrast, the activities of all of the reporter constructs were high in hns::Knr
background (Figure 4.2A). In the wild-type background, induction of virB led to a slight
upregulation of only the full-length PicsP-lacZ construct, which contains wild-type VirB
boxes 1 and 2 (Figure 4.2A). However, anomalous results were also obtained in the
wild-type MC4100 background where virB induction led to a decrease in the activities of
the -665 and -351 reporters (Figure 4.2A). I investigated the reason for this result and
discovered that this was likely caused by the toxic effect of L-arabinose in MC4100 and
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its derivatives, which occurs because of the araD139 mutation, leading to a buildup of
the toxic metabolite L-ribulose-5-phosphate (Englesberg et. al., 1962). Thus, the
conditions initially used invalidates comparisons of the virB induced (L-arabinose
added) and non-induced conditions (no L-arabinose added). Consequently, I resolved
the issue by repeating the experiment so that L-arabinose was added to all cultures in
order to treat the cultures equally. Instead of the non-induced control, the pBAD-empty
(parent vector to pBAD-virB) was used. For this experiment, the pAFW04 PicsP-lacZ
reporter and its 5’ derivatives were also used, as this vector background avoids possible
transcriptional read-through from the upstream chloramphenicol resistance cassette due
to the presence of the λ oop transcriptional terminator downstream of this cassette.
Importantly, the activities of the pHJW20 and pAFW04 reporters are similar to one
another (Wing et al., 2004; Basta et al., 2013).
As the icsP promoter is truncated from the 5’ end, a gradual loss of H-NS-mediated
silencing is observed (Figure 4.2B), similar to previously collected data (Figure 4.2A). In
the same background, expression of virB leads to a significant increase in the activity of
only the full-length reporter, although not to the same high level obtained with the -351
construct in the presence or absence of virB (Figure 4.2B). In the hns::Knr background,
although the activity of each reporter is higher than their counterparts in the wild-type
background, a gradual increase in promoter activity is still observed as the promoter is
truncated from the 5’ end (Figure 4.2B), consistent with the removal of sequences
required for partial silencing of the icsP promoter by StpA or another repressor protein
(Figure A.2). Also consistent with this partial silencing, expression of virB significantly
increases the activity of the full-length construct (1.92-fold ± 0.22) in the hns::Knr
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background (Figure 4.2B) due to the nature of the hns::Knr allele (Section 2.4.1). The
expression of virB also increased the activity of the -665 construct (1.28-fold ± 0.06) in
the hns mutant background (Figure 4.2B). Although statistically significant in this trial,
this observation does not appear to be biologically significant, as this statistic was not
consistent across all three trials. Overall, these data indicate that VirB is unable to
regulate the icsP promoter from sequences downstream of -1056, strongly supporting
remote regulation from the inverted repeat identified previously (Castellanos et al.,
2009). These data also provide additional evidence that E. coli serves as a suitable
surrogate for studying the regulatory interplay between H-NS and VirB.

4.4.2 THE ROLE OF SEVEN ADDITIONAL SITES WITH A CLOSE MATCH TO THE
PROPOSED CONSENSUS IN REGULATION OF THE ICSP AND OSPZ
PROMOTERS BY VIRB
Previous research in our laboratory revealed that there are 7 matches to proposed
consensus sequence (Castellanos et al., 2009), which resemble Box A elements of the
parS site (Figure 4.3A), but prior to this dissertation, their contribution to VirB-dependent
regulation in the presence of VirB boxes 1 and 2 had not been tested. To test their
contribution, each putative site was mutated by site-directed mutagenesis alone or in
combination (Sites 1 - 7, Sites 1, 3 - 7, Sites 1, 3, and 4, Sites 1, 3, 4, 6, and 7, Sites 3,
4, 6, and 7, Sites 4, 6, and 7, and Sites 6 and 7) using transition mutations in the
context of the PicsP-lacZ reporter pHJW20 in the presence of wild-type VirB boxes 1
and 2 (these reporters constructed Pashtana Usufzy and Monika Karney). The reporters
with single site mutations and the construct with mutations in all 7 sites were assayed
155

by Monika Karney (Weatherspoon-Griffin et al., 2018) while I assayed the reporters with
various site combinations. Each PicsP-lacZ reporter derivative was introduced into wild-
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Figure 4.3 Effect of mutated VirB sites 1 – 7 on VirB-dependent regulation of the icsP and ospZ
promoters. A) Schematic of icsP promoter showing VirB half sites 1 – 7. The coordinates are from the
3’ boundary of each site relative to the primary icsP TSS. B) β-galactosidase activity of the wild-type
PicsP-lacZ or its derivatives in wild-type 2457T and AWY3 backgrounds. Data are represented as
average fold changes (activity in 2457T/activity in AWY3) of three independent trials C) Activities of
the PospZ-lacZ reporter and its derivatives. Means and standard deviations are shown (B) and (C).
Statistical significance was calculated using a Student’s two-tailed t-test assuming equal variance, *p
< 0.001.

type S. flexneri strain 2457T and its isogenic virB mutant AWY3 and the activity of each
reporter was measured using a β-galactosidase assay. Regardless of the binding site
mutation alone (Weatherspoon-Griffin et al., 2018) or in any combination (Figure 4.3B),
strong VirB-dependent regulation increase in promoter activity occurred, similar to the
wild-type PicsP-lacZ reporter. These data indicate that each putative VirB box does not
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contribute to VirB-dependent regulation of the icsP promoter alone or cooperatively with
VirB boxes 1 and 2.
Because of the different sequence requirements for H-NS-mediated silencing of the
icsP and ospZ promoters (Basta et al., 2013; Weatherspoon-Griffin et al., 2018; Figure
4.3B and C), questions still remained as to whether these sites contribute to VirBdependent regulation of the divergently transcribed ospZ promoter. To test this
possibility, I constructed a PospZ-lacZ reporter containing a combination of mutated
VirB sites 1 – 7. This construct, a wild-type PospZ-lacZ reporter, a negative control
containing mutated VirB boxes 1 and 2, and a promoterless lacZ control were
introduced into S. flexneri 2457T and AWY3 virB mutant backgrounds and the activity of
each reporter was measured using a β-galactosidase assay. The activity of the wildtype PospZ-lacZ reporter in the 2457T background is 1.7-fold higher than in the virB
mutant background (Figure 4.3C). Similarly, the activity of the PospZ-lacZ derivative
containing the combination of mutated sites 1 – 7 is 2.3-fold higher in 2457T compared
to its activity in the virB mutant (Figure 4.3C). However, mutations in VirB boxes 1 and 2
led to a complete loss of VirB-dependent regulation (Figure 4.3C), consistent with
previously collected data (Basta et al., 2013). Overall, these data indicate that VirB sites
1 - 7 do not contribute to VirB-dependent regulation of the ospZ or icsP promoters in the
presence of VirB boxes 1 and 2.

4.4.3 THE ROLE OF AN ADDITIONAL VIRB SITE THAT RESEMBLES A PARS BOX
A4-LIKE ELEMENT IN VIRB-DEPENDENT REGULATION
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Each VirB box closely matches the proposed consensus, which resembles Box A
elements of parS (Taniya et al., 2003). The VirB boxes 1 and 2 of the icsP promoter
closely resemble boxes A2 and A3 of the ParB binding site parS of P1 phage parS site,
and putative Box A4 was also identified (Figure 4.1D). However, it is not known if this or
other parS-like DNA sequences contribute to VirB-dependent regulation of the icsP
promoter. The role of putative box A4 in VirB-dependent regulation of the icsP promoter
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Figure 4.4 The putative box A4 does not contribute to VirB-dependent regulation of the icsP promoter
or VirB binding in vitro. β-Galactosidase activity of the wild-type PicsP-lacZ or its derivative containing
a mutated putative Box A4 in wild-type 2457T and AWY3 backgrounds. Data shown are a
representative of three independent trials. Means and standard deviations are shown. Statistical
significance was calculated using a Student’s two-tailed t-test assuming equal variance, *p < 0.001.

was tested by site-directed mutagenesis of this site in the PicsP-lacZ pAFW04 reporter.
The wild-type reporter and its derivative were introduced into wild-type 2457T and
AWY3 virB mutant backgrounds, and their activities were measured using a βgalactosidase assay. Both the wild-type reporter and its derivative containing a mutated
putative box A4 show similar levels of VirB-dependent regulation (Figure 4.4),
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demonstrating that the putative box A4 does not contribute to VirB-dependent regulation
of the icsP promoter. These data are consistent with the observation that Box A4 of
parS appears to be dispensable for ParB functionality (Vecchiarelli et al., 2007).

4.4.4 VIRB DIRECTLY BINDS THE VIRB SITES REQUIRED FOR ANTI-SILENCING
OF THE DIVERGENTLY TRANSCRIBED ICSP AND OSPZ PROMOTERS
Both VirB boxes 1 and 2 contribute to VirB binding in vitro
We previously established that VirB boxes 1 and 2 centrally located at position -1137
relative to the primary icsP TSS, and -397 relative to the ospZ TSS, are required for
VirB-dependent regulation of each promoter (Castellanos et al., 2009; Basta et al.,
2013). When I began this work, electrophoretic mobility shift assays (EMSAs) had been
employed to test if VirB binds directly to boxes 1 and 2 present in a 246 bp fragment
(Target 6; Figure 2.1) of the icsP-ospZ intergenic region (Harrison, 2010). However, due
to the lack of reproducibility caused by the instability of the purified VirB protein used in
these assays, the results of these EMSAs are not reliable, and therefore, require
corroboration with a more stable recombinant VirB protein. A stable preparation of
C-terminally tagged VirB-His6 was kindly provided by Dr. David Fujimoto (Monserate
Biotech).
To begin, I used the new recombinant VirB-His in an EMSA to test the contribution of
the VirB boxes 1 and 2 to VirB. Increasing concentrations of VirB-His were incubated
with wild-type target 6 (Figure 2.1) of the icsP-ospZ intergenic region (246 bp) or the
same DNA fragment containing mutated VirB boxes 1 and 2. The icsB promoter region
containing its VirB binding site (Turner and Dorman, 2007), was used as a positive
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Figure 4.5 VirB boxes 1 and 2 contribute to VirB-His6 binding in vitro. A) EMSA of increasing VirBHis6 concentrations (0.5, 1.0, 1.25, and 1.5 µM). Reactions were incubated at 37 °C for 30 minutes.
B) Pixel density plotted as ratio of non-specific DNA competitor (NSC) density divided by DNA target
density. Data are generated from one gel. Pixel densities were captured using ImageJ software.

control, while an internal fragment of the pstS gene from E. coli not known to be bound
by VirB was used as a negative control. A 146 bp fragment of pBluescript was used as
a non-specific competitor DNA and was added to each reaction. To analyzed the ratio of
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target pixel density to the density of the non-specific competitor. The negative control
pstS target DNA showed little to no change mobility with increasing VirB-His, consistent
with a fairly even pixel density ratio (Figure 4.5A & B). Although a similar pattern is
observed for the positive control icsB target (Figure 4.5B), the formation of VirB:DNA
complexes is evident starting at the 1 μM concentration of VirB (Figure 4.5A). With the
wild-type DNA target of the icsP/ospZ intergenic region, a dose-dependent loss of free
target DNA is observed starting at 0.5 µM of VirB-His, and at the highest VirB-His
concentration (1.5 µM), almost a complete loss of target free DNA was observed (Figure
4.5A). A similar dose-dependent increase in pixel density ratio is also observed (Figure
4.5B). Although with the DNA target containing, mutated VirB boxes a loss of free target
DNA was observed, the loss was relatively more gradual compared to the wild-type
target under the same VirB concentrations (Figure 4.5A & B). Thus, high concentrations
of VirB seem to promote non-specific DNA binding in vitro. Together, these data
demonstrate that the VirB binding site of the icsP-ospZ intergenic contributes to VirB
binding in vitro, corroborating previous findings (Harrison, 2010).

Assessing the contribution of each VirB box to VirB binding in vitro
Having demonstrated that both VirB boxes 1 and 2 contribute to VirB binding, I next
wanted to assess the role of each VirB box to VirB binding in vitro. To test this, an
EMSA using target 6 of the icsP/ospZ intergenic region or its derivatives containing a
mutation in either box 1, box 2, or both was incubated with increasing concentrations of
VirB-His. As before, VirB:DNA complexes were resolved using agarose gel
electrophoresis. For all reactions, non-specific competitor DNA shows little to no loss of
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signal in the presence of increasing VirB (Figure 4.6A - E). The wild-type target 6 shows
a dose-dependent shift that is mostly non-discrete starting at the lowest VirB
concentration (0.5 µM) (Figures 4.6A and B), consistent with previous results (Figure
4.5A). The other targets with mutated VirB boxes 1, 2, or both show a similar dosedependent shift, but is more pronounced at the second lowest VirB concentration (1.0
µM) (Figures 4.6A-E). Considering the loading issues in the 4th and 9th lanes from the
left, and that only one trial was done, these results are still preliminary, and thus, require
replication. When repeated, radiolabeled DNA targets should be used, as this approach
was successful (Weatherspoon-Griffin et al., 2018).
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Figure 4.6 Assessing the individual contribution of VirB boxes 1 and 2 to VirB binding in vitro. EMSA
of increasing VirB-His6 concentrations (0.5, 1.0, 1.25, and 1.5 μM) with wild-type target 6 and
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4.4.5 SPECIFICITY OF VIRB FOR BOXES 1 AND 2 OF THE ICSP-OSPZ
INTERGENIC REGION IN VIVO
DNA binding is required for VirB-dependent regulation of its target genes (Beloin et
al., 2002; McKenna et al., 2003; Gao et al., 2013). In vitro, VirB can bind DNA nonspecifically when high concentrations of VirB are used (McKenna et al., 2003; Turner
and Dorman, 2007; Gao et al., 2013; Weatherspoon-Griffin et al., 2018; Figures 4.5A &
4.6A), which is consistent with observations made for other ParB homologs (Vecchiarelli
et al., 2007; Graham et al., 2014; Taylor et al., 2015). The non-specific binding of VirB in
vitro suggests that high levels of VirB in vivo may allow non-specific binding of VirB in
vivo. Perhaps, given high intracellular levels, VirB could bind to a mutated VirB binding
site and regulate VirB-dependent genes. Because DNA binding is a prerequisite for
VirB-dependent regulation, I decided to test if virB overexpression could lead to the
regulation of the icsP or ospZ promoters in the presence of either the wild-type or
mutated VirB sites in AWY3 virB mutant or DH10B backgrounds. The activities of each
reporter were measured using a β-galactosidase assay.

Table 4.1 Superphysiological levels of VirB do not upregulate the ospZ promoter in the presence of
mutated VirB boxes 1 and 2.
Fold Increase in ospZ promoter activity (mean ± S.D.) at:
Strain

37 °C
pBAD-virB

pBAD18

AWY3 PospZ-lacZ

1.93 ± 0.11

0.84 ± 0.01

AWY3 PospZ-lacZ (mutated boxes)
Adapted from (Basta et al., 2013)

0.75 ± 0.04

1.00 ± 0.01

At the ospZ promoter, my previously collected data show that overexpression of virB
led to high promoter activity in the presence of wild-type VirB boxes, but not mutated
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boxes (Table 4.1; Basta et al., 2013). Similarly, overexpression of virB in the presence
of wild-type VirB boxes lead to a significant increase in promoter activity in the DH10B
and AWY3 backgrounds, but not in the presence of mutated VirB boxes (Figures 4.7A
and B). These data demonstrate that superphysiological levels of VirB cannot
upregulate the icsP and ospZ promoters in the presence of mutated VirB boxes,
strongly supporting that VirB has high specificity for its recognition site in vivo.

Figure 4.7 Superphysiological levels of VirB do not upregulate the icsP promoter in the presence of
mutated VirB boxes 1 and 2. A) β-Galactosidase activity of the icsP promoter in a DH10B background
in the presence of superphysiological levels of VirB and mutated VirB boxes 1 and 2. Two
independent trials have been completed for (A). B) Activity of the icsP promoter in an AWY3
background in the presence of superphysiological levels of VirB and mutated VirB boxes 1 and 2.
Only one trial has been conducted for (B). Means and standard deviations are shown. Statistical
significance was calculated using a Student’s two-tailed t-test [paired t-test for (A) and equal variance
assumed for (B)], *p < 0.05 and **p < 0.01.
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4.5 DISCUSSION
Although DNA binding is required for the regulation of virulence genes by VirB
(Beloin et al., 2002; Gao et al., 2013), the nature of a VirB binding site and its interaction
with VirB is not fully understood. Therefore, the aim of this chapter was to further
investigate these processes in order to better understand the molecular mechanism of
virulence gene regulation by VirB in Shigella. Previously, 7 instances of the proposed 7
- 8 nucleotide consensus VirB binding site (Taniya et al., 2003) were found in the icsPospZ intergenic region (Castellanos et al., 2009; Figure 4.3A), but site-directed
mutagenesis of the sites revealed no contribution of these sites to VirB-dependent
regulation of the icsP (Figure 4.3B) or ospZ promoters (Figure 4.3C) in the presence of
VirB boxes 1 and 2. These data strongly suggest that the proposed consensus binding
site is not correct. In fact, a search for the proposed consensus VirB binding site,
allowing a single nucleotide mismatch, on the Shigella virulence plasmid yields over
4,000 hits (Weatherspoon-Griffin et al., 2018), well over the number of predicted ORFs
of the virulence plasmid (262 ORFs on NCBI). Thus, the number of proposed binding
sites does not appear to be an accurate representation of the actual number of VirBregulated virulence genes (~30 genes controlled by at least 3 promoters). Instead of a
single VirB half site, an inverted repeat comprised of boxes 1 and 2 is likely the basic
recognition site for VirB.
Using a previous alignment of the ParB (P1) binding site (parS) by alignment parS
with the coding strand of the icsP promoter, I discovered an 8th putative VirB binding site
resembling Box A4 (located -1116 from the 3’ end relative to the primary icsP TSS)
(Harrison, 2010; Figure 4.1D). Mutation of this putative Box A4 revealed that this site
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does not contribute to VirB-dependent regulation of the icsP promoter in the presence of
VirB boxes 1 and 2 (Figure 4.4). Because of this negative result, I realigned the icsP
promoter with parS using the non-coding strand match to parS. Based on this new
alignment, the new putative Box A4 (6/7 match to parS Box A4) is located upstream of
VirB box 2 (Figure 4.8). Interestingly, this new alignment also revealed a strong
alignment of putative ParB-like box A1 (6/7 match), B1 (3/6), B2 (3/6 match), and the
IHF consensus binding site (21/28 match). While IHF does not appear to play a role
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-1137
Box 1
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Alignment of parS with icsP promoter sequences
PicsP

TAAGCTATTGTCCTTATTCCACTAATA-CAAACTTTTTGTAAAGTATATTAAATATACTTCATTTCATACTGAAATCCCCGGAAGTATTCAATCAAACAATTACACCATAAAAGGAA
: :: :::
: ::: ::::: :: : ::: ::: ::::::: ::::
:
:::::::
::::::: ::
:: ::: :::: : :
:
P1 parS TTCGCCATT---CAAATTTCACTATTAACTGACTGTTTTTAAAGTAAATTACTCTAAA--CATTTCAAGGTGAAATCGCC----------------ACGATTTCACCTTGGATTTTA

B1
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A
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minimum parS site

Box
B

Figure 4.8 New alignment of parS of ParB from P1 plasmid with non-coding strand of the icsP
promoter containing VirB boxes 1 and 2. A) Alignment of the parS site (P1 ParB) with the icsP/ospZ
intergenic region containing VirB boxes 1 and 2. The direction of transcription is indicated.

in VirB-dependent regulation of the icsP promoter (Harrison, 2010), subsequent work
has implicated the Box B2-like site (unpublished data). These data suggest that the VirB
binding site differs from the ParB of P1 phage parS site but retains some similarities.
Future work should assess the roles of the remaining parS elements in VirB-dependent
regulation of the icsP and ospZ promoters by site-directed mutagenesis.
In vitro analysis of the interaction of VirB with boxes 1 and 2 revealed that mutation
of both boxes decreases the affinity of VirB for Target 6 (Figure 2.1) of the icsP/ospZ
intergenic region (Figure 4.5A), suggesting that VirB boxes 1 and 2 are important for
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VirB binding. An additional preliminary analysis revealed that box 2 may be important
for the initial VirB binding event at the icsP promoter (Figure 4.6A), consistent with
previous observations (Taniya et al., 2003; Turner and Dorman, 2007; Gao et al., 2013).
However, because both boxes 1 and 2 are required for the regulation of the icsP
promoter by VirB (Castellanos et al., 2009), box 1 likely also contributes to VirB binding
in vivo. Interestingly, VirB was still able to bind Target 6 containing the mutated boxes,
albeit at higher concentrations (Figure 4.5A). These results suggest that VirB can bind
DNA non-specifically in vitro and are consistent with the observations of others (Beloin
et al., 2002; McKenna et al., 2003; Turner and Dorman, 2007; Gao et al., 2013), as well
as the characterized non-specific binding of a ParB homolog (B. subtilis) (Taylor et al.,
2015a). The inclusion of divalent cations and exclusion of EDTA from the gel and buffer
allows for specific ParB:DNA complexes to be detected in an EMSA (Taylor et al.,
2015a; Fisher et al., 2017). Perhaps VirB EMSAs conducted under similar conditions
would also allow for specific VirB:DNA complexes to be detected in vitro. In the
presence of mutated boxes 1 and 2, high levels of VirB were unable to upregulate the
icsP and ospZ promoters in vivo (Figure 4.7 and Table 4.1), suggesting that VirB has a
high specificity for its targets in vivo. In support of this observation, VirB is unable to
affect the expression of some H-NS-silenced genes on the chromosome (Turner and
Dorman, 2007). The high specificity of VirB to its targets in vivo but not in vitro suggests
that there is a determinant for the specificity of VirB binding to its target binding sites in
vivo. Perhaps divalent cations contribute to the specificity of VirB for its targets in vivo.
The work in this chapter highlights preliminary work prior to publications in Chapter 2
showing that remotely located VirB boxes 1 and 2 of the icsP and ospZ promoters bind
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VirB in vitro and emphasizes that non-specific interactions of DNA can also occur,
consistent with other observations (Gao et al., 2013). My study also highlights that in
vivo studies of VirB:DNA interactions are likely better suited for understanding and
defining a VirB binding site. Additionally, for those wanting to study the interplay
between VirB and H-NS without conflation from the complex virulence gene cascade,
an E. coli surrogate can be used. Overall, this work provides a foundation on which to
better study VirB:DNA interactions.
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4.6 MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Growth Conditions
The bacterial strains and plasmids used in this chapter are listed in Table D.1.
Escherichia coli strains were grown routinely at 37 °C in Luria-Bertani (LB) broth with
aeration (325 rpm), or on LB containing 1.5% agar (w v-1). Shigella flexneri strains were
grown on trypticase soy agar plates containing 0.01% (w v-1) Congo red to verify the
virulence phenotype of S. flexneri. Single, isolated colonies of S. flexneri were routinely
grown in trypticase soy broth (TSB) at 30 °C overnight (~16 h) with aeration (325 rpm)
in order to stably maintain the virulence plasmid. Antibiotics were added at the following
final concentrations, as needed: ampicillin, 100 µg ml-1; chloramphenicol, 25 µg ml-1;
kanamycin, 50 µg ml-1; and tetracycline, 12.5 µg ml-1.

Construction of the lacZ reporter plasmids
The constructs used in this chapter are listed Table D.1. For the construction of
PospZ-lacZ reporters with mutations in VirB box 1 (pMAP21) or box 2 (pMAP22), the
previously constructed PicsP-lacZ reporters containing a mutation in box 1 or box 2,
pMIC17 or pMIC10, respectively, were digested with PstI and AflII restriction enzymes
and cloned into the full-length PospZ-lacZ pJAI01 digested with the same restriction
enzymes.
For the construction of the PospZ-lacZ derivative containing the combination of VirB
half sites mutations 1 - 7 (pMAP22), W177 and W405 were used to generate a PCR
amplicon containing the aforementioned mutations using pPU17 (PicsP-lacZ containing
VirB half site mutations 1 – 7) as a template. The amplicon was then digested using
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restriction enzymes BglII and SalI and cloned into pJAI01 (PospZ-lacZ with λ oop
transcriptional terminator upstream of ospZ promoter sequences and downstream of the
chloramphenicol resistance cassette) digested with the same restriction enzymes. The
resulting construct was verified by sequencing.
For the construction of the PospZ-lacZ derivative containing boundaries -412 to -51
(pMAP16), primers W336 and W201 were used to PCR amplify from the PospZ-lacZ
template (pDB05). The resulting amplicon was then digested with the SalI and XbaI
restriction enzymes and cloned into pDB05 digested with the same restriction enzymes.
The new construct was verified by sequencing.
For the construction of the PicsP-lacZ (pAFW04) derivative with the mutation of
putative Box A4 (pMAP19), a 173 bp G block (Table D.3) was generated from
Integrated DNA Technologies and contained transitions mutations in the entire box. The
G block DNA was digested with PstI and BsrGI restriction enzymes and cloned into
pHS16 (pAFW04 with BsrGI site) digested with the same restriction enzymes.

Quantification of icsP promoter activity using the PicsP-lacZ and PospZ-lacZ
reporters and their derivatives
Activities of the icsP and ospZ promoters were determined by measuring bgalactosidase activity, as described previously (Wing et al., 2004; Basta et al., 2013).
Briefly, each reporter was transformed into either wild-type 2457T or one of its isogenic
virB mutant AWY3, or DH10B. For S. flexneri, freshly transformed colonies were grown
overnight at 30 °C in TCS. The next day, overnight cultures were subcultured (1:100)
into fresh TCS medium and grown at 37 °C for 5 h to early stationary phase prior to cell
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lysis. The 5 h time point was chosen because icsP (Hensley et al., 2011) and ospZ
promoter expression (data not shown) is maximal under these conditions
For studies where virB was overexpressed in the presence of mutated VirB binding
sites at the icsP promoter, pATM324 (pBAD-virB) was transformed into either E. coli
DH10B or the S. flexneri virB mutant AWY3 backgrounds carrying the PicsP-lacZ
reporter or its derivative. The negative control pBAD-empty was also transformed into
AWY3. DH10B cells were grown overnight in LB at 37 °C. The next day, each culture
was subcultured (1:100) into two tubes of fresh LB and the cultures were incubated for 3
h at 37 °C. One set of samples was then induced with L-arabinose (0.2% w v-1) while
the other set was not induced, and all of the cultures were incubated for 2 h more at 37
°C. A similar strategy was done for AWY3 cells carrying the PicsP-lacZ and pBAD-virB
or empty plasmid control (pBAD-empty) except TCS medium was used. The cultures
were then harvested and b-galactosidase activity of each reporter was measured.
Unless otherwise stated, all assays were performed in triplicate on three separate
occasions, and representative data are shown. Standard deviations are reported, and a
two-tailed Student’s t-test assuming equal variance was used to determine statistical
significance between averages of the activities.

Electrophoretic mobility shift assays
Target 6 (246 bp; Section 2.1 Figure 1) of the icsP promoter or its derivative
containing mutated VirB box 1, box 2, or both was prepared with primers W73 and W74
from pHJW20, pMIC17, pMIC13, or pMIC18 DNA template, respectively. A shorter
version of Target 6 (54 bp native icsP-ospZ DNA) is duplex 5 lacking a 5’- PO3 on the
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template strand the created by Integrated DNA Technologies. Duplex 6 is duplex 5 with
mutation of putative box A4. Duplex 7 is duplex 5 with mutation of VirB boxes 1 and 2.
Duplex 1 is a non-specific competitor DNA used with duplex 6. The sequences of Gblocks and duplexes are listed in Table D.3.
For radiolabeling of non-coding strand of target 6 short or derivative containing
mutated VirB boxes (54 bp native or mutated VirB boxes icsP sequences, respectively),
primer pairs W391 and W392 and W393 and W394, respectively, were annealed
together under the following conditions; denaturation at 95 °C for 5 min, followed by
annealing at 95 °C for 1 min at -1 °C cycle-1. Each annealed reaction was then
electroeluted followed by a phenol:chloroform extraction and ethanol precipitation. Then
4.8 pmol of each target was single-end labeled using T4 polynucleotide kinase
(Promega) according to manufacturer directions [γ-32P] ATP (specific activity, 3000 Ci
mmol-1; Perkin Elmer). Unincorporated radionucleotides were removed from single-end
labeled products using Illustra ProbeQuant G-50 Micro Columns according to
manufacturer directions (GE Healthcare).
Increasing concentrations of purified VirB-His6 (Monserate Biotech) was incubated
with ~0.02 pmol of each icsP promoter target at 37 °C for 20 minutes in 1x binding
buffer (10 mM potassium phosphate, pH 7.5, 25 mM NaCl, 0.5 mM β-mercaptoethanol,
0.5 mM EDTA, 50 % glycerol, 25 ng µl-1 herring sperm DNA) in a total volume of 20 μl.
After incubation, the reactions were resolved on a 6% native PAGE gel in 1x TBE at
120 v for 40 min. The gel was transferred to Whatman paper, exposed to a
phosphorimaging screen, and the screen was scanned with the Typhoon 9410 Variable
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Mode Imager. For lane trace analysis and densitometry, ImageJ software
(http://imagej.nih.gov) was used.
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CHAPTER 5

DISCUSSION

Transcriptional silencing and anti-silencing mechanisms are central to bacterial
pathogenesis. The overall aim of my dissertation is to elucidate mechanisms of
transcriptional silencing and anti-silencing of virulence genes in Shigella species, the
causative agents of bacillary dysentery in humans. Many virulence genes found on the
large virulence plasmid in Shigella spp. are controlled by the transcriptionally silencing
NAP, H-NS, and anti-silenced by the VirB protein. Consequently, my work has focused
on investigating the regulatory interplay between these two proteins because their
mechanisms of action are not fully understood. To study these mechanisms, I focused
on the transcriptional regulation of icsP, which shares a long (1.5 kb) intergenic region
with the divergently transcribed ospZ.
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5.1 MODEL OF TRANSCRIPTIONAL SILENCING BY H-NS AND ANTI-SILENCING
BY VIRB OF THE ICSP PROMOTER IN SHIGELLA FLEXNERI
The Mechanism of Transcriptional Silencing by H-NS of the icsP Promoter
Despite the similar arrangement of H-NS binding regions at the virF (Falconi et al.,
1998; Prosseda et al., 2004) and icsP promoters (Figure 2.8A and B), the work
presented in Chapter 2 reveals that, unlike the virF promoter, changes to the spacing
and helical orientation between the two H-NS binding regions of the icsP promoter does
not affect H-NS-mediated silencing (Figure 2.9). These data suggest that H-NS
transcriptionally silences the virF and icsP promoters through distinct mechanisms. One
explanation for these results is that the promoter-distal H-NS binding region is solely
required for transcriptional silencing, while the promoter-proximal region, identified only
through an in vitro study, is not required. While the promoter-proximal H-NS binding
region was not tested in its role in H-NS-mediated regulation, in the context of the
divergent ospZ promoter, the same region of DNA was found not to be important for
H-NS-mediated silencing (Basta et al., 2013). In contrast, part of the promoter-distal HNS binding region was found to be involved in regulation of the ospZ promoter by H-NS
(Basta et al., 2013). I hypothesize that one of three mechanisms are likely to lead to
transcriptional silencing by H-NS at the icsP and ospZ promoters. The first mechanism
is that H-NS oligomerization from the promoter-distal region to the core icsP promoter
elements sterically hinders RNAP from engaging the promoter (Figure 5.1A). This
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Figure 5.1 Hypothesized mechanisms of transcriptional silencing of the icsP promoter by H-NS. A)
H-NS nucleoprotein filament forms whereby H-NS nucleates from the promoter-distal H-NS binding
region (-900 to -436 relative to the primary icsP TSS) to downstream core promoter elements. B)
H-NS nucleoprotein filament forms only at the promoter-distal H-NS binding region, which creates
enough torque on downstream DNA such that RNAP binding is no longer permissible. C) H-NS forms
a highly stable nucleoprotein bridge.

mechanism is more similar to that proposed at the icsB promoter, where a H-NS
nucleoprotein filament forms over core promoter elements to prevent transcription
initiation (Beloin et al., 2003, Turner and Dorman, 2007). The second mechanism is
that, based on single molecule studies of H-NS and DNA supercoiling (Lim et al., 2014),
the H-NS nucleoprotein filament formed from the promoter-distal region could introduce
sufficient torque on core promoter sequences such that it is not permissive for DNA
unwinding by RNAP (Figure 5.1B). The third mechanism is that H-NS forms a highly
stable nucleoprotein bridge at the icsP promoter (Figure 5.1C) that can tolerate spatial
and helical changes between the two H-NS-binding regions (Figure 2.9A).
To help distinguish between these possibilities, the extent of H-NS binding to icsP
promoter sequences in vivo needs to be determined, which can be accomplished using
a ChIP-PCR approach in combination with an in vivo dimethyl sulfide protection assay.
The ChIP-PCR experiment allows for defining the limits of the H-NS binding regions to
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the icsP/ospZ intergenic region, while the in vivo DMS protection assay will identify the
exact sequences protected by H-NS in vivo. Because each hypothesized mechanism
results in different H-NS binding patterns, this combinatorial approach narrows in on the
most likely mechanism of transcriptional silencing by H-NS.

The Mechanism of VirB-mediated Anti-silencing of the icsP Promoter
In E. coli and other bacteria, DNA is typically negatively supercoiled. Consistent with
this observation, the VirB-dependent PicsP-lacZ isolated from E. coli and S. flexneri is
negatively supercoiled (Figures 3.2B and D). My work in Chapter 3 demonstrates that a
loss of negative supercoiling is triggered upon VirB docking to its recognition site
(Figures 3.2B & D, and 3.4C & F), in a manner similar to its plasmid partitioning
homologs ParB of P1 phage and SopB of F plasmid (Biek and Shi, 1994; Edgar et al.,
2001). Importantly, transcription alone, a process known to alter the superhelicity of
plasmid DNA (Liu and Wang, 1987; Leng and McMacken, 2002), is not responsible for
these observations (Figure 3.3B), strengthening the involvement of the DNA binding
activity of VirB in the observed changes in DNA supercoiling. Because ParB of P1
phage oligomerization along DNA is required for a loss of DNA supercoiling (Edgar et
al., 2001), the VirB binding to and subsequent oligomerization along the icsP intergenic
region may trigger the changes in DNA in vivo. This possibility can be tested by blocking
the bi-directional spread of VirB along DNA using a molecular roadblock or by using a
VirB protein capable of DNA binding but deficient in oligomerization. Interestingly, the
VirB-mediated loss of negative DNA supercoiling of the PicsP-lacZ reporter could not be
recapitulated in vitro (Figure 3.9B), even in the presence of topoisomerase (Figures
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3.10A & B), suggesting the involvement of other in vivo factors. Genome-wide
transposon mutagenesis of wild-type S. flexneri and subsequent screening of colonies
unable to cause a change in supercoiling of the reporter may be useful in identifying
other factors involved. Additionally, a more directed approach could be used to
complement this screen because essential genes that might be involved in the process
would not be identified. In this complementary approach, the involvement of
topoisomerases, a total of 4 found in Shigella, should be analyzed for their role in VirBdependent changes in supercoiling.
At some promoters, H-NS-mediated transcriptional silencing is sensitive to changes
in DNA topology (Prosseda et al., 2004; Bouffartigues et al., 2007). Thus, the loss of
negative DNA supercoiling (Section 3) triggered by the anti-silencing protein VirB (Wing
et al., 2004; Turner and Dorman, 2007; Basta et al., 2013) are likely involved in
alleviating H-NS-mediated transcriptional silencing of the icsP promoter. Based on my
findings in Chapters 2 – 4, I propose a model for the transcriptional silencing and antisilencing of the icsP promoter by H-NS and VirB, respectively (Figure 5.2). Starting with
a negatively supercoiled template, H-NS binds a remotely located, promoter-distal
region (-900 to -436 relative to the primary icsP TSS), likely forming a nucleoprotein
filament (Chapter 2) that transcriptionally silences the icsP promoter remotely (Figure
5.2A). Then, a VirB dimer docks to a remotely located inverted repeat (centrally located
-1137 relative to the primary icsP TSS) (Chapters 2 and 4), bidirectionally oligomerizes
of VirB along the DNA (Chapter 2) (Figure 5.2B), which triggers a loss of negative
supercoiling (Figure 5.2C). This loss of negative supercoiling leads to the remodeling of
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the H-NS nucleoprotein filament (Figure 5.2D), allowing for the icsP promoter to
become active.
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Figure 5.2 Proposed mechanism of VirB-mediated anti-silencing of the icsP promoter. A) Starting
with a negatively supercoiled PicsP-lacZ reporter template, an H-NS nucleoprotein filament
transcriptionally silences the icsP promoter. B) Then, a VirB dimer docks to its binding site, C)
oligomerizes bi-directionally along DNA, D) which triggers a loss of negative supercoiling and the
subsequent remodeling of the H-NS silencing complex.

Future work will test if changes in supercoiling alone are sufficient to alleviate H-NSmediated silencing of the icsP promoter independently of VirB, and if VirB also mediates
a change in supercoiling of other VirB-dependent promoters such as icsB. It will also be
useful to identify how the H-NS silencing complex at the icsP promoter is remodeled by
VirB in vivo using ChIP-PCR.
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5.2 CONCLUSIONS
In summary, through the research presented in this dissertation, I have improved our
understanding of transcriptional silencing by H-NS family members and anti-silencing by
VirB of the icsP promoter in S. flexneri. My work highlights potential differences in the
mechanisms of transcriptional silencing by H-NS and the H-NS paralog StpA of the icsP
promoter; an H-NS nucleoprotein filament is likely the mechanism of transcriptional
silencing of the icsP promoter, while a nucleoprotein bridge is likely the mechanism of
silencing by StpA. It is of interest to further characterize and compare mechanisms of
transcriptional silencing by H-NS family members, not only in S. flexneri, but in related
pathogens as well.
VirB is most closely related to ParB of P1 phage, and as such, comparisons of the
DNA binding activities of the two proteins have been paramount in understanding the
mechanism of VirB-dependent anti-silencing of virulence genes in S. flexneri. Based on
these similarities, I demonstrated that, through direct interaction with its binding site,
VirB triggers a loss of negative supercoiling of a VirB-dependent reporter plasmid, an
activity likely involved in transcriptional anti-silencing of virulence genes silenced by
H-NS family members in Shigella. Despite the low sequence homology between VirB
and other anti-silencing proteins that bind DNA, mechanistically, changes to DNA
supercoiling may underlie how these important group of regulatory proteins function in
other bacteria to offset transcriptional silencing mediated by H-NS family members. As
more discoveries of H-NS homologs are made, investigators should also be aware that
partner anti-silencing proteins may be present.
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The role of DNA topology in bacterial gene regulation is an underappreciated
phenomenon (Dorman et al., 2016). Perhaps the role of DNA topology in gene
regulation is more intimately linked with transcriptional silencing and ant-silencing than
previously thought. Consequently, future work that characterizes the interplay
transcriptional silencing, anti-silencing, and DNA topology, all of which play a role in
many aspects of bacterial physiology, including virulence, is needed. As this area of
research moves forward, it is possible that novel antibacterials that prevent or treat
infections can be developed that target these vital processes that are central to bacterial
physiology.

182

APPENDICES
APPENDIX A
A1. COPYRIGHT APPROVALS FOR CHAPTER 2 PUBLICATIONS
Genes (2016)
The full copyright agreement can be found at: http://www.mdpi.com/about/openaccess
MDPI Open Access Information and Policy
“…everyone is free to re-use the published material if proper accreditation/citation of the
original publication is given.”

Molecular Microbiology (2018)
COPYRIGHT TRANSFER AGREEMENT
The full copyright agreement can be found at the following link:
https://authorservices.wiley.com/asset/photos/licensing-and-open-accessphotos/eCTA_sample2018.pdf
“…3. Final Published Version. The Owner hereby licenses back to the Contributor the
following rights with respect to the final published version of the Contribution (the "Final
Published Version"):
b. Re-use in other publications. The right to re-use the Final Published Version or
parts thereof for any publication authored or edited by the Contributor (excluding journal
articles) where such re-used material constitutes less than half of the total material in
such publication. In such case, any modifications must be accurately noted.”
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A2. TABLE FOR SECTION 2.4.2
Table A.1 Plasmids used in this work
Plasmids
Descriptiona

Source or reference

pBR322

Low-copy plasmid cloning vector; Ampr & Tetr

New England Biolabs

pHJW20b

icsP promoter region transcriptionally fused to
lacZ in pACYC184 Cmr. Carries 1232 bp of
wild-type sequence upstream of the icsP TSS.

(Castellanos et al., 2009)

pAFW04b

pHJW20 with lambda oop terminator inserted
upstream of the cloned icsP promoter region to
prevent transcriptional read-through into this
region from pACYC184 backbone.

(Basta et al., 2013, Castellanos et al., 2009)

pMIC13

pHJW20 with all 7 bp substituted in promoter
distal box (Box 2) of the VirB binding site

(Castellanos et al., 2009)

pMIC17

pHJW20 with all 7 bp substituted in promoter
proximal box (Box 1) of VirB binding site

(Castellanos et al., 2009)

pMIC18

pHJW20 with all 14 bp substituted in the
essential VirB binding sites (box 1 & 2)

(Castellanos et al., 2009)

pMIC21

pHJW20 lacking all icsP promoter sequences

(Castellanos et al., 2009)

pQE2

Qiagen cloning vector; Ampr; overproduces
LacI repressor.

Qiagen

pQE60

Cloning vector for production of C-terminally
His–tagged proteins

Qiagen

pCTH01

IPTG inducible vector derived from pQE60 that
carries hns-his

This work

pAJH03

IPTG inducible vector derived from pQE60 that
carries virB-his

This work

pHS27

pAFW04 carrying tandem lacO sites 80 bp
downstream of Box 1 of the VirB binding site

This work

pDRG01

pAFW04 carrying tandem lacO sites 87 bp
upstream of Box 2 of the VirB binding site.

This work

pMIC31

pHJW20 carrying transversion mutations in Site
7, changes 5’ ATTGAAT 3’ to 5’ CGACCG
3’.

This work

pMIC29

pHJW20 carrying transversion mutations in Site
6, changes 5’ ATTTCCAT 3’ to 5’
CGGGAACG 3’.

This work
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pMIC27

pHJW20 carrying transversion mutations in Site
5, changes 5’ ATTTCAC 3’ to 5’ CGGGACA
3’.

This work

pJCD06

pHJW20 carrying transversion mutations in Site
4, changes 5’ ATTTCAT 3’ to 5’ CGGGACG
3’.

This work

pJCD05

pHJW20 carrying transversion mutations in Site
3, changes 5’ GAGAAAT 3’ to 5’ TCTCCCG
3’.

This work

pJCD04

pHJW20 carrying transversion mutations in Site
2, changes 5’ ATTTCAA 3’ to 5’ AGGGACC
3’. Note, the TSS (+1) was not altered.

This work

pMIC25

pHJW20 carrying mostly transversion
mutations in Site 1, except position 3. Changes
5’ ATGAAAT 3’ to 5’ CGACCG 3’.

This work

pPU17

pHJW20 carrying all mutations in Site 1-7 that
are described above.

This work

pKLP09

pBR322 derivative carrying icsP promoter
sequences from -1232 to -665 relative to the
TSS +1 (Hensley et al., 2011, Egile et al.,
1997); Ampr.

This work

pADK05

pBR322 derivative carrying icsP promoter
sequences from -1232 to -255 relative to the
TSS +1 (Hensley et al., 2011, Egile et al.,
1997); Ampr.

This work

pKLP11

pHJW20 carrying a 2 bp insertion between Box
1 and 2 of the VirB binding site.

This work

pKLP12

pHJW20 carrying a 3 bp insertion between Box
1 and 2 of the VirB binding site.

This work

pKLP13

pHJW20 carrying a 4 bp insertion between Box
1 and 2 of the VirB binding site.

This work

pKLP03

pHJW20 with a 5 bp deletion between -1044 at
-1038, relative to the TSS +1 (Hensley et al.,
2011, Egile et al., 1997).
pHJW20 with a 10 bp deletion between -1049
and -1038 relative to the TSS +1 (Hensley et
al., 2011, Egile et al., 1997).
pHJW20 with a 50 bp deletion between -1089
and -1038 relative to the TSS +1 (Hensley et
al., 2011, Egile et al., 1997).

This work

pMAP30

pAFW04 with a 105 bp deletion between -425
and -320 relative to the TSS +1 (Hensley et al.,
2011, Egile et al., 1997).

This work

pMAP31

pAFW04 with a 100 bp deletion between -425
and -325 relative to the TSS +1 (Hensley et al.,
2011, Egile et al., 1997).

This work

pKLP04
pKLP05
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This work
This work

pMAP32

pAFW04 with a 5 bp deletion between -425 and
-420 relative to the TSS +1 (Hensley et al.,
2011, Egile et al., 1997).

This work

pMAP33

pAFW04 with a 10 bp deletion between -425
and -415 relative to the TSS +1 (Hensley et al.,
2011, Egile et al., 1997).

This work

pMAP07

pAFW04 lacking all promoter sequences.

(Basta et al., 2013)

picsP_5’t(-1056)

pAFW04 derivative carrying 1056 bp of wildtype sequence upstream of the primary icsP
TSS.

This work

picsP_5’t(-900)

pAFW04 derivative carrying 900 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-893)

pAFW04 derivative carrying 893 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-874)

pAFW04 derivative carrying 874 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-838)

pAFW04 derivative carrying 838 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-683)

pAFW04 derivative carrying 683 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-665)

pAFW04 derivative carrying 665 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-637)

pAFW04 derivative carrying 637 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-601)

pAFW04 derivative carrying 601 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-550)

pAFW04 derivative carrying 550 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-436)

pAFW04 derivative carrying 436 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-351)

pAFW04 derivative carrying 351 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-254)

pAFW04 derivative carrying 254 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

picsP_5’t(-92)

pAFW04 derivative carrying 92 bp of wild-type
sequence upstream of the primary icsP TSS.

This work

a

Ampr, ampicillin resistance; Tetr, tetracycline resistance; Cmr, chloramphenicol resistance; Knr,
kanamycin resistance.
b
pHJW20 and pAFW04 derivatives routinely yield similar patterns of b-galactosidase production in our
assays. Nevertheless, the promoterless derivative of pHJW20 (pMIC21) displays modestly higher bgalactosidase production than the pAFW04 derivative, pMAP07 (data not shown).
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A3. DNASE I PROTECTION ANALYSIS OF H-NS DNA COMPLEXES WITH
TARGETS 1 AND 4 OF THE ICSP PROMOTER
To more precisely identify the sequences of the icsP promoter bound by H-NS, DNase I
protection assays were carried out using targets 1, 4, and 5 (Figure 2.1). H-NS
protected two regions of target 4 (coding strand labeled), called regions I and II, at the
lowest (20 µM) concentration used, corresponding to -618 to -786 (71% AT-rich)
and -796 to -830 (85.7% AT-rich) relative to the TSS, respectively (Figure A.1A). H-NS
protected four regions of target 1 (non-coding strand labeled), called regions I to IV, at
the second lowest concentration (9.6 µM), corresponding to -149 to -120 (76.7% ATrich), -104 to -86 (94.7% AT-rich), -69 to -48 (95.5% AT-rich), and -40 to -18 (69.6% ATrich) relative to the TSS, respectively (Figure A.1B). DNase I protection analysis data for
target 5 could not be analyzed because either protection was not observed, or when
protection was observed, the GA ladder was not readable. The results of the DNase I
protection analysis for targets 4 and 1 are summarized in Figure A.2. The pitfalls of this
experiment are discussed next.
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Figure A.1 DNase I protection of targets 4 and 1 of the icsP promoter with recombinant H-NS. A)
From left to right: GA ladder, 0, 20, 40, and 80 μM of H-NS-His6. Electrophoresis was carried out at
60W for 2 h and 15 min in a 6% sequencing gel. B) From left to right: GA ladder, 0, 4.8, 9.6, 14.4, and
19.2 μM of H-NS-His6 was used (different H-NS stock than target 4). Electrophoresis was carried out
at 20W for 5 h in a 6% sequencing gel.
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Figure A.2 Updated schematic showing regions of the icsP promoter required for transcriptional
silencing by H-NS. Regions were identified using in vivo mapping by 5’ truncation analysis and in vitro
mapping with EMSAs (Weatherspoon-Griffin et al., 2018; Figure 2.8) and DNase I protection assays
(Figure A.1).

PITFALLS AND TECHNICAL ISSUES
A significant limitation of my DNase I protection analysis is that different H-NS
protein preparations were used in experiments that characterized H-NS interactions with
targets 1 and 4. Extensive troubleshooting resulted in the depletion of the original H-NS
stock before clear regions of protection were observed for target 4. Depletion of the
stock necessitated the preparation and use of a new, purified H-NS-His6 stock.
Additionally, very high concentrations (high μM range) of H-NS were used for target 4
because protection by H-NS was not observed at lower concentrations. In hindsight, the
extremely high concentrations of H-NS may have hindered the ability of H-NS to bind
DNA properly.
Aside from these issues, I also experienced a technical issue with the
electrophoresis of DNase I protection samples, which was not overcome: frequently, the
DNA samples did not electrophorese straight, making the interpretation of DNA
sequences near the bottom of the gel difficult. Various running conditions were
attempted, including varying the wattage, voltage, and gel running temperature (i.e.
room temperature and 4 °C). Additionally, three gel constituents were changed one by
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one to assess which component may have been faulty. Other attempts included
removing possible excess salts from the DNA samples and changing the gel apparatus.
Unfortunately, none of these attempts were successful in resolving the issue, and, I was
unable to obtain a publication quality images of H-NS interactions with these DNA
targets.
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A4. STPA-MEDIATED SILENCING OF THE ICSP PROMOTER
In vivo mapping of sequences required for transcriptional silencing of the icsP promoter
mediated by StpA
All Shigella spp. contain at least one additional H-NS homolog, StpA, which is
capable of silencing virulence gene promoters (Dorman and Porter, 1998; Beloin et al.,
2003; Picker and Wing, 2016). However, there is little knowledge about its mechanism
of silencing and the DNA sequences that are required for this silencing are poorly
understood. Based on the similar DNA binding preferences for H-NS and StpA (Zhang
et al., 1996; Sonnenfield et al., 2001), I hypothesized that StpA and H-NS would have
similar sequence requirements for transcriptional silencing of the icsP promoter. As a
starting point, the sequence requirements for silencing of the icsP promoter by StpA
were mapped using a subset of the 5’ truncation PicsP-lacZ reporter series (-1056, 893, -665, -550, and -351 relative to the primary TSS) described previously
(Weatherspoon-Griffin et al., 2018) was introduced into wild-type MC4100, hns::Knr
(dominant-negative; reviewed in Picker and Wing, 2016), hns null (MC4100 Δhns), or
stpA null (MC4100 ΔstpA) strains. The hns null (MC4100 Δhns) and stpA null (MC4100
ΔstpA) strains allow for the identification of sequences required for silencing by either
StpA or H-NS alone, respectively. The activities of the 5’ truncation series in each strain
background were measured using a β-galactosidase assay.
In the wild-type, stpA null, and hns null backgrounds, activities of the three longest
constructs are silenced to similar levels (Figure A.3). Further truncation to -665, and
then to -550, results in a gradual loss of transcriptional silencing, each to a similar
degree in the same three strain backgrounds (Figure A.3). However, the activity of the 191

351 construct in the wild-type and stpA null backgrounds (where H-NS is the only H-NS
family member present) is significantly higher than the activity of the same construct in
the two hns mutant backgrounds (StpA is the only H-NS family member present) (Figure
A.2). These results suggest that H-NS silences the icsP promoter in the wild-type and
stpA null backgrounds, while StpA silences the icsP promoter in both hns mutant
backgrounds and are consistent with previous results (Figure 2.5). Thus, in the absence
of H-NS, StpA can fulfill the role of H-NS in silencing the icsP promoter under the
conditions tested. Future studies should investigate the possibility that other conditions
allow StpA to play more of a major role, either alone, or in conjunction with H-NS to
regulate the icsP promoter.
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Figure A.3 Mapping of sequences required for StpA-mediated silencing of the icsP promoter in vivo.
Promoter activity of full-length icsP promoter and its 5’ truncation derivatives were measured using a
β-galactosidase assay. Three independent trials were conducted for wild-type, hns null, and hns::Knr
strains while only two independent trials were conducted for the stpA null. Representative data are
shown, * p < 0.01.
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These results also demonstrate that either H-NS or StpA require sequences located
between -893 and -351 relative to the primary TSS for transcriptional silencing of the
icsP promoter. Interestingly, the activity of the -351 reporter is lower in the two hns
mutant backgrounds compared to the wild-type and stpA null backgrounds. At first
glance, these data suggest that additional sequence downstream of -351 are involved in
StpA-mediates silencing. However, there are three other explanations for this
observation. First, StpA levels are higher in an hns mutant compared to wild-type
(Sonnenfield et al., 2001), and second, StpA is a global gene regulator, at least in
uropathogenic E. coli (Müller et al., 2006); both of these characteristics could lead to
pleiotropic effects that influence icsP promoter activity either directly or indirectly. Thus,
Western blotting for StpA would be useful in determining how StpA levels compare in
wild-type MC4100 and hns mutant (dominant-negative) backgrounds under the
conditions tested. Based on the similar specificities for AT-rich DNA by H-NS and StpA
in vitro (Sonnenfield et al., 2001) and in vivo (Uyar et al., 2009), it is likely that StpA
silences the icsP promoter directly. However, EMSAs, DNase I protection assays, and
ChIP-based experiments of the interaction of StpA with the icsP promoter is needed to
test this hypothesis. A third consideration is that StpA has 4 – 6-fold higher DNA binding
affinity than H-NS, at least in vitro (Sonnenfield et al., 2001). Although the in vivo DNA
binding affinity of StpA is not known, this property may allow StpA to, if direct,
transcriptionally silence the icsP promoter more strongly than H-NS. Thus, the more
precise identification of sequences required for silencing by StpA and the ability of StpA
to interact with these sequences directly, the determination of StpA binding affinities
with these sequences, and the identification of StpA levels in the cell under the assay
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conditions will be helpful in characterizing the properties of StpA-mediated silencing of
the icsP promoter.

Possible Helical-face Dependency for StpA-mediated Silencing of the icsP promoter
Interestingly, reanalysis of data collected by Krystle Pew provide preliminary
evidence into the possible mechanism of StpA-mediated silencing of the icsP promoter.
Deletion of ½ a helical DNA turn downstream of the region required for StpA-mediate
silencing led to a significant increase in the average fold-change (activity in hns::Knr ÷
activity in wild-type; 10.4-fold), while deletion of a full helical turn restored the average
fold-change to wild-type levels (6.7-fold) (Figure A.4). These preliminary observations
mirror those of the virF promoter (Prosseda et al., 2004), suggesting a bridging
mechanism of silencing by StpA. Because of the potential complications with the
hns::Knr background (Picker & Wing, 2016; Section 2.4.1), these preliminary data
should be repeated using the hns and stpA null mutants.
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Figure A.4 Spacing and helical phasing requirements for StpA-mediated silencing of the icsP
promoter. A) Schematic of icsP intergenic region summarizing sequence requirements for H-NS
(Figure 2.1A) and StpA-mediated silencing (Figure A.3). B) Activity of the full-length PicsP-lacZ and
its derivatives containing a D5 or D10 bp located 312 bp upstream of the primary TSS were measured
using a β-galactosidase assay. Two independent trials were conducted. Fold-change was calculated
by dividing the activity of each reporter in the hns::Knr background by its activity in the wild-type
background. A Student’s t-test was performed and for statistical significance, *p < 0.05. Data adapted
from (Pew, 2011).
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APPENDIX B
B1. VIRB-MEDIATED CHANGES IN SUPERCOILING OF THE PICSP-LACZ
REPORTER CONTAINING THE λ OOP TRANSCRIPTIONAL TERMINATOR AND IN
OTHER VECTOR CONTEXTS
VirB-mediated changes in supercoiling of PicsP-lacZ with the λ oop
transcriptional terminator
At the start of this project, the PicsP-lacZ reporter pHJW20 was used to test for VirBdependent changes in DNA supercoiling. Thus, the constructs used to further
characterize this phenomenon are derivatives of pHJW20. During the course of my
studies, pAFW04 was constructed, which is the same PicsP-lacZ reporter except it
contains the λ oop transcriptional terminator upstream of icsP promoter sequences to
prevent possible transcriptional read-through from an upstream chloramphenicol
resistance cassette. VirB-dependent regulation of pAFW04 (Basta et al., 2013) is similar
to that of pHJW20 (Castellanos et al., 2009). Nonetheless, it was still unknown if VirB
could trigger a change in supercoiling of pAFW04.
To begin, the effect of the presence or absence of virB induction during growth in
DH10B cells on the electrophoretic mobility of pAFW04 was analyzed. In the samples
containing both pAFW04 and pBAD-virB, in the absence of virB induction, the mobility
of the DNA is similar to the single plasmid lanes (Figure B.1A, compare lanes 1 & 2 with
3). On the other hand, in the presence of virB induction, pAFW04, in the sample
containing both plasmids, shows a change in its electrophoretic mobility (Figure 3.8A,
lane 4 marked with asterisk). Similarly, when electrophoresed in the presence of
chloroquine, a VirB-dependent change in the topoisomer distribution of pAFW04 is
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observed (Figure B.1B, compare lanes 3 & 4). These results are consistent with
experiments done with pHJW20 (Figure 3.2), indicating that the presence of the λ oop
transcriptional terminator does not affect the ability of VirB to mediate changes in
supercoiling. Thus, use of the pHJW20 reporter and its derivatives in supercoiling
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Figure B.1 VirB-mediated changes in supercoiling of pAFW04. A) The electrophoretic mobility of the
pAFW04 isolated from DH10B in the presence or absence of virB induction. Electrophoresis
conditions: 1% Agarose 1x TAE 4.6 v cm-1 for 1.5 h without ethidium bromide. Gel was cropped to
remove duplicate samples. B) Analysis of the topoisomer distribution of the pAFW04 samples in (A).
Electrophoresis conditions: 0.7% Agarose containing 2.5 μg ml-1 chloroquine, 2x TBE, 2.5 v cm-1 for
15 h. SC = Supercoiled, R = Relaxed.
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VirB-mediated Changes in Supercoiling of the icsP Promoter in Different Vector
Contexts
My previous experiments on the VirB-dependent change in the electrophoretic
mobility and supercoiling of the PicsP-lacZ reporter tested the role of icsP promoter
sequences, but it is not known if the vector context is also important for this
phenomenon to occur. To test the vector context, I began by performing the
electrophoretic mobility assay with the full-length icsP promoter DNA (-1232 to +24
relative to the primary TSS without lacZ) cloned in the context of the high copy vector
pBluescript (pNE01, 4243 bp), or pBluescript vector only (2961 bp) as a control, in the
presence of pBAD-virB (Cmr, pHJW16). In the presence of virB expression during
growth, triplicate samples of PicsP in pBluescript showed no observable change in its
electrophoretic mobility compared to the absence of virB expression during growth and
single plasmid controls, similar to the triplicate samples of pBluescript empty vector
(Figure B.2). These data indicate that VirB is unable to alter the electrophoretic mobility
of the icsP promoter in the context of pBluescript. One possible reason for this
observation is that VirB levels are insufficient to act on the high amount of plasmid
copies in the cell (300 – 500 copies cell-1). Other issues encountered are the mobility of
the single plasmid lanes of pBluescript, which did not migrate to the correct size, and
the presence of extra DNA bands in many of the samples, some of which appear to be
supercoiled. Because of these issues, the samples were not analyzed further on
chloroquine.
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Figure B.2 The effect of intracellular VirB on the electrophoretic mobility of the full-length icsP
promoter (-1232 to +24 relative to the primary TSS) in pBluescript (pNE01). This experiment was
performed only 1 time.

Next, I decided to change the vector context of the icsP promoter to the well-known
low-copy vector (15 – 20 copies cell-1), pBR322. For this experiment, I cloned the PicsPlacZ from pHJW20 into pBR322 (pMAP25) and began by testing the ability of VirB to
alter the electrophoretic mobility of this construct. Because of the antibiotic resistance
cassette incompatibilities between pBR322 (Ampr) and the previously used pBAD-virB
(Ampr), pBAD33-virB (Cmr) was used as the virB source for this experiment. In the
samples containing both plasmids, without virB induction, the mobility of each plasmid is
similar to the motilities of the single plasmid controls (Figure B.3A). Similarly, the
expression of virB does not appear to alter the mobility of pMAP25 (Figure B.3A). These
data suggest that VirB does not alter the electrophoretic of pMAP25. One reason for this
could be that VirB does not regulate the icsP promoter in this vector context. To test this
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possibility, I measured the promoter activity of pMAP25 in the presence or absence of
virB expression (pBAD33-virB) in E. coli DH10B using a β-galactosidase assay. In this
experiment, virB expression increased the activity of pMAP25 (1.6 – 2.1-fold, data not
shown). Because the pBAD33 vector containing virB used is different
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than that used for pBAD-virB (Ampr), pBAD18, I decided to use another pBAD18-virB
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Figure B.3 Analysis of the effect of VirB on the electrophoretic mobility and promoter activity of the PicsPlacZ in pBR322. A) Electrophoresis of pMAP25 isolated from DH10B E. coli in the presence or absence of
virB induction during growth. B) Promoter activities of pMAP25 and pBR322 in wild-type S. flexneri 2457T
and virB mutant (AWY3). C) Promoter activities of pHJW20 (PicsP-lacZ in pACYC184), pMAP25 (PicsPlacZ in pBR322), pMIC18 (pHJW20 with mutated VirB boxes 1 and 2, (Castellanos et al., 2009), and
pMAP28 (pMAP25 with mutated VirB boxes 1 and 2). The activity of each reporter was measured using a
β-galactosidase assay as previously described (Castellanos et al., 2009). One trial was conducted for (B).
Representative data of two trials run in triplicate are shown and were collected from the same
transformation (C).
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(pHJW19, Tetr) to more closely mimic the conditions of the original experiment (PicsPlacZ and pBAD18- virB). The expression of virB from pBAD18-virB (Tetr) increased the
activity of pMAP25 3.6-fold, whereas the activity of pHJW20 (PicsP-lacZ in pACYC184)
was increased 32.3-fold (data not shown). These results suggest that VirB-dependent
regulation the icsP promoter in pBR322 weaker than regulation of the icsP promoter in
pACYC184.
These results prompted me to test the ability of VirB to regulate pMAP25 in S.
flexneri. To test this, I introduced pMAP25, or pBR322 control, into wild-type S. flexneri
2457T and AWY3 virB mutant backgrounds and measured the activity of this construct
in each background using a β-galactosidase assay. A 5.6-fold higher promoter activity
was observed in the wild-type background compared to the virB mutant background
(Figure B.3B), indicating VirB upregulates pMAP25 in S. flexneri. However, proper
controls were not utilized. I repeated the experiment, adding the following controls:
pHJW20 (PicsP-lacZ in pACYC184), pMIC18 (pHJW20 with mutated VirB boxes 1 and
2, Castellanos et al., 2009), and pMAP28 (pMAP25 with mutated VirB boxes 1 and 2).
The activity of pHJW20 showed strong VirB-dependent regulation (21.4-fold), and
mutation of VirB boxes 1 and 2 (pMIC18) completely abolished this regulation (Figure
B.1C), consistent with previous results (Castellanos et al., 2009). Unlike the previous
assay (Figure B.3B), the activity of pMAP25 was abnormally high in the virB mutant
background, similar to its activity in the wild-type background (Figure B.3C), suggesting
VirB no longer regulates this reporter construct. Additionally, the activity of pMAP28,
containing mutations in VirB boxes 1 and 2, is low in both backgrounds (Figure B.3C). I
suspect that AWY3 virB mutant colonies containing pMAP25 may have accumulated (a)
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mutation(s) during the transformation process, either in the chromosome of the strain
(i.e. in the hns allele), the pMAP25 construct (i.e. promoter mutation), or a combination
thereof. Overall, these data should be repeated to verify which situation (Figure B.1A or
B) is truly the case. At the time this experiment was performed, I had not yet optimized
the 2D-DNA gel electrophoresis assay. Because the VirB-dependent fold change
appears to be higher in S. flexneri compared to E. coli, these experiments should then
be followed up with 2D-DNA gel analysis of the topoisomer distribution of pMAP25 in
wild-type 2457T and virB mutant AWY3 backgrounds.

LacI Molecular Roadblock and VirB-mediated Changes in Supercoiling of the PicsPlacZ Reporter
Both VirB and ParB share the ability to oligomerize along DNA (Rodionov et al.,
1999; Beloin et al., 2002; McKenna et al., 2003). When this activity of ParB was
prevented using a molecular roadblock, ParB-mediated changes in DNA supercoiling
were also prevented (Edgar et al., 2001), demonstrating that ParB oligomerization along
DNA was necessary for changes in supercoiling to occur. This observation raises the
possibility that VirB oligomerization along DNA also drives changes in DNA supercoiling
in vivo. To test this hypothesis, I placed a LacI molecular roadblock 70 bp either
upstream or downstream of the VirB binding site and subjected the PicsP-lacZ reporter
to the supercoiling assay (these constructs were created and tested by lab technician
and post-baccalaureate student Hiro Park and post-baccalaureate Daren Ginete,
Weatherspoon-Griffin et al., 2018). The PicsP-lacZ reporter along with pQE2, a plasmid
that constitutively expresses LacI, and pBAD-virB, where virB expression can be
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induced with L-arabinose, were grown in DH10B cells for a total of 5 h at 37 °C. LacI
binding was controlled with 0.25 µM IPTG and was added to half the cultures after 2 h
of growth. After 3 h of growth, the expression of virB was either induced or non-induced.
Total plasmid DNA was isolated and subjected to gel electrophoresis to observe the
electrophoretic mobility and topoisomer distribution of each sample.
The data are not presented here. Upon reflection, this experiment was too contrived
because in total, E. coli harbored three multicopy plasmids. The pBAD-virB expression
plasmid and PicsP-lacZ reporter were mid-copy (10 -15 copies cell-1) while pQE2 was
present at very high copy (300 – 500 copies cell-1) and constitutively expressed LacI.
Additionally, the multicopy lacZ gene was expressed in response into induced amounts
of virB. Taken together, the physiology of the cell was likely drastically altered due to the
high expression of lacZ, virB, and lacI as well as maintenance of these three plasmids,
especially pQE2. In support of this hypothesis, the growth of these cells at the same
harvest time (5 h growth at 37 °C in LB broth with aeration), had approximately 40% of
the cell density of a culture harboring just the PicsP-lacZ reporter or derivative with
pBAD-virB. Although the growth conditions were not exactly the same, the optical
density readings give an indication that the growth of the cells harboring three plasmids
was severely compromised. Therefore, these data should be taken with a grain of salt.
While I will not show the data, I will describe it briefly. VirB-dependent regulation of the
icsP promoter, and its blockage with the downstream LacI roadblock was observed, no
change in supercoiling was observed even in the absence of LacI binding. As I stated
above, the poor physiology of the cells could have led to these seemingly inexplicable
results. A redesign of this experimental is required. For example, this experiment can be
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repeated in JM110 E. coli strain, which has the lacI gene integrated into its
chromosome. Given the evidence that changes in DNA supercoiling alleviate H-NSmediated silencing (Prosseda et al., 2004; Bouffartigues et al., 2007), H-NS itself
modulates DNA supercoiling in vitro (Zhang et al., 1996) and in vivo (Hulton et al., 1990)
and the role of DNA supercoiling in regulating gene expression in bacteria (reviewed in
(Dorman et al., 2016), it seems likely that VirB-mediated changes in DNA supercoiling
impacts H-NS-mediated silencing of virulence genes.
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APPENDIX C
ONE PROMOTER CONTROLS THE EXPRESSION OF THE POSPZ-LACZ
REPORTER
We identified that the ospZ promoter is controlled by one promoter, where
transcription starts 28 nucleotides upstream of the ospZ ATG (Basta et al., 2013).
However, the possibility that a second promoter controlling the expression of ospZ was
raised during the review of the manuscript from the following data: Using a series of 5’
truncations of the ospZ promoter, we had identified that sequences located
between -731 to -412 relative to the ATG are required for H-NS-mediated silencing
(Basta et al., 2013). Although we did not detect a second promoter in our transcription
start site mapping, the high activity of the -412 PospZ-lacZ derivative in the wild-type
background prompted the reviewer to speculate that there may be an additional, cryptic
promoter. To address this concern, I truncated the -412 PospZ-lacZ reporter construct
from the 3’ end to the -51 position (relative to the ATG), which was shown to abolish
ospZ promoter activity of the full-length PospZ-lacZ reporter (Basta et al., 2013). βGalactosidase activity of the new construct was measured in 2457T at 37 °C, along with
the following controls: full-length PospZ-lacZ reporter with a downstream boundary at
position +32 (relative to ATG), a PospZ-lacZ derivative truncated at the 3’ end to
position -51 (relative to ATG), and a 5’ truncation to -412 (relative to ATG) with a
Downstream boundary at position +32 (relative to ATG). Activity of the full-length
PospZ-lacZ reporter (-1613 to +32 relative to ATG) is low (Figure C.1). When the
promoter is truncated from the 5’ end to the -412 position (relative to ATG), activity of
the ospZ promoter increases ~3.2-fold (Figure C.1), consistent with a loss of H-NS205
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Figure C.1 No cryptic promoters exist in the ospZ intergenic region. Β-galactosidase activity of the
full-length PospZ-lacZ or its truncation derivatives with varying 5’ and 3’ boundaries in a wild-type
2457T background. Data shown are a representative of three independent trials. Means and standard
deviations are shown.

mediated silencing (Basta et al., 2013). When the ospZ promoter is truncated from the
3’ end to position -51 (relative to ATG) of both the full-length and -412 PospZ-lacZ
reporters, activity of each reporter is low, similar to the promoterless lacZ control (Figure
C.1). These data, along with the identification of one TSS (Basta et al., 2013),
collectively demonstrate that only one promoter controls the expression of ospZ.

HOMOLOGY OF VIRB WITH PARBC NUCLEASE SUBFAMILY MEMBER PARB OF
RK4 PLASMID
ParB family members fall into two categories based on their ability to segregate
chromosomes or partition plasmids. Of the plasmid partitioning ParB family members,
the ParB (KorB) encoded by the RK2/RP4 plasmid of gram-negative bacteria has
calcium-dependent nuclease activity in vitro (Grohmann et al., 1997; Johnson et al.,
1999). An alignment of VirB with KorB revealed low sequence identity (28% amino acid
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identity). Because the nuclease domain of KorB has not been fully characterized and
considering the function of the N-terminus of VirB is not known, it is unclear if VirB also
possesses nuclease activity. To test this possibility, I incubated increasing
concentrations of VirB with our PicsP-lacZ. Here, with increasing VirB-His6
concentrations, large VirB:DNA complexes formed in the wells of the gel (Figure C.2A),
demonstrating that VirB binds the DNA. Next, a nuclease assay was conducted similarly
to that done with KorB (Johnson et al., 1999). Because nuclease activity for KorB was
dependent on Ca2+, increasing amounts of Ca2+ were mixed with PicsP-lacZ DNA to the
reaction with the highest VirB concentration and the reaction was allowed to incubate at
37 °C. The reactions were stopped by the addition of SDS and EDTA, and the DNA was
analyzed using agarose gel electrophoresis. VirB was unable to linearize the
supercoiled DNA, regardless of the presence or absence of Ca2+ (Figure C.2B). These
data indicate that, unlike KorB, VirB does not have nuclease activity under the
conditions tested. This result is not surprising because VirB is more closely related to
ParB of P1 plasmid, which is not known to have nuclease activity. One limitation to this
work, however, is the absence of the KorB positive control.
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Figure C.2 VirB does not have detectable nuclease activity. A) VirB-His6 binding to pHJW20 (1.96
nM). The following VirB:DNA molar ratios were used: 10:1, 25:1, 50:1, 100:1 molar ratio. B) Nuclease
assay of VirB-His6 with pHJW20. A constant VirB:DNA molar ratio of 100:1 was used. Where used,
the following increasing CaCl2 concentrations were used: 2.5, 5, 10, 25, 50 mM. Reactions were
incubated at 37 °C for 30 min. Reactions were stopped with 0.1% SDS and 5 mM EDTA.
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APPENDIX D
LIST OF BACTERIAL STRAINS AND PLASMIDS AND PRIMERS USED IN THIS
STUDY
Table D.1 Bacterial Strains and Plasmids used in this dissertation
Label
Description
Strains
S. flexneri
2457T
Wild-type S. flexneri serotype 2a
AWY3
2457T virB::Tn5; Knr
E. coli
F- [araD139]B/r Δ(argF-lac)169* &lambda- e14flhD5301 Δ(fruK-yeiR)725 (fruA25)‡ relA1
MC4100
rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1)
deoC1
MC4100 hns::Knr expresses 1 – 37 amino acids; dominant negative
MC4100 Δhns
MC4100 hns::Knr; null mutant
MC4100 ΔstpA

MC4100 stpA::Knr; null mutant
F–
endA1 deoR recA1 galE15 galK16 nupG rpsL Δ(l
ac)X74 φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcr
A Δ(mrr-hsdRMS-mcrBC) StrR λ–

Reference

(Formal et al., 1958)
(Wing et al., 2004)
(Casadaban, 1976;
Silhavy et al., 1976)
(Yamada et al., 1991)
(Barba et al., 2005)
Gift from Edmundo
Calva lab

+

DH10B

DH10B hns::Knr

(Grant et al., 1990)

DH10B with hns::Knr dominant negative locus from
(Yamada et al., 1991)

This Work

pPicsP-lacZ reporter plasmid derived from
pACYC184
pHJW20 with an Ampr cassette
PicsP-lacZ reporter plasmid derived from
pACYC184; contains λ oop transcriptional
terminator
pHJW20 carrying 1,613 bp of wild-type sequence
upstream of and 32 bp downstream of the ospZ
translation start site in the SalI and XbaI sites.
Same as pDB05 except contains λ oop
transcriptional terminator

(Wing et al., 2004)

Plasmids
pHJW20
pAFW02
pAFW04
pDB05
pJAI01

This work
(Basta et al., 2013)
(Basta et al., 2013)

(Basta et al., 2013)

pMAP07

pAFW04 lacking all promoter sequences

pBAD18

(Guzman et al., 1995)

pATM324

L-arabinose-inducible pBAD expression vector;
pBR ori; Ampr
virB expression plasmid in a pBAD18 vector

pBR322

Common cloning vector with pMB1 ori and Ampr

(Bolivar et al., 1977)

pMAP25

PicsP-lacZ from pHJW20 cloned into pBR322

This Work

pMAP28

PicsP-lacZ containing mutated VirB binding site
from pMIC18 cloned into pBR322

This Work
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(Schuch et al., 1999)

pHS06
pHS07
pHS08
pHS09
pHS10
pHS11
pHS12
pHS13
pHS16
pMAP08
pMAP09
pMAP10
pMAP11

Carries 1056 bp upstream of the TSS to 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 900 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 893 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 874 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 838 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 781 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 683 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 665 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
pAFW04 with site directed mutagenesis of BsrGI
site -1111 relative to TSS
Carries 637 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 601 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 550 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr
Carries 436 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr

This work
This work
This work
This work
This work
This work
This work
This work
This Work
This work
This work
This work
This work

pMAP12

Carries 351 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr

This work

pMAP13

Carries 254 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr

This work

pMAP15

Carries 92 bp upstream of the TSS and 48 bp
downstream of the icsP gene in pAFW04; Cmr

This work

pMAP16

pDB05 with 5’ and 3’ boundaries at -412 to -51,
respectively

This work

pMAP21

pJAI01 with mutated VirB box 2 of icsP promoter

This work

pMAP22

pJAI01 with mutated VirB box 1 of icsP promoter

This work

pCA24N

(Kitagawa et al., 2005)

pMAP23

empty IPTG-inducible expression vector; ASKA
clone
pCA24N carrying hns from 2457T

pMAP24

pCA24N carrying sfh from 2457T

pCA24N-stpA
pMAP30

This work
This work

pCA24N carrying stpA

(Kitagawa et al., 2005)

pAFW04 with Δ105 bp (from -436 relative to TSS)

This work
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pMAP31

between H-NS binding regions at PicsP
pAFW04 with Δ100 bp (from -436 relative to TSS)
between H-NS binding regions at PicsP

pMAP32

pAFW04 with Δ5 bp (from -436 relative to TSS)
between H-NS binding regions at PicsP

pMAP33

pAFW04 with Δ10 bp (from -436 relative to TSS)
between H-NS binding regions at PicsP
pHJW20 with icsP sequences downstream of -426
relative to TSS and entire lacZ gene removed;
promoter-proximal H-NS binding region and lacZ
gene excised
pMAP27 with icsP sequences downstream of -964
relative to TSS through +27 of entire lacZ gene
removed; promoter-distal and proximal H-NS
binding regions and lacZ gene excised

pMAP27

pMAP29

This work
This work
This work
This Work

This Work

pCTH03
pHJW20 truncated from the 3’ end to -32 relative to
the TSS; remove P1 and P2
pMIC18

(Hensley et al., 2011)

pHJW20 with VirB boxes 1 and 2 mutated by
transition mutations
pBluescript carrying full-length PicsP with
mutations in VirB box 2 (ATTTCAG à GCCCAGC)

(Castellanos et al.,
2009)

pMIC17

pHJW20 with VirB box 1 mutated (ATGAAAT à
CGACCCG)

(Castellanos et al.,
2009)

pMIC21

pHJW20 lacking all icsP promoter sequences

(Castellanos et al.,
2009)

pMIC10

unpublished

Table D.2 List of primers used in this dissertation.
Primer

Sequence 5’-3’

Description and Use

W54

GGGTTGAAGGCTCTCAAGGGC

W65

TGAGACGTCGACTCATTGTGCGAATAA
AGTAACGGGGGC

W68

GTGTCAGTCGACTCTGACTCTCGACTT
TAAAAGGATGGG

W73

TGAGACGTCGACCAATAAAATGGTTGG
TTGAAGGTCGTG

Reverse: used with W74 to amplify 246 bp of icsPospZ DNA containing VirB boxes 1 and 2; SalI

W74

GTGTCAGTCGACATGCTTGATAACTTA
ATTGGGGCTCCC

Forward: used with W73 to amplify 246 bp of icsPospZ DNA containing VirB boxes 1 and 2; SalI

Forward sequencing primer for pHJW20/pAFW04
derivatives; 5’ boundary at -1289 relative to icsP
TSS
Reverse sequencing primer for pHJW20/pAFW04
derivatives; 3’ boundary at -134 relative to icsP
TSS; SalI
Forward sequencing primer for pHJW20/pAFW04
derivatives; 5’ boundary at -634 relative to icsP
TSS; SalI
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W111

CTTTGCGCTCCTTCAACTGGG

W160

TTTGCGCTCCTTCAACTGGGCA

W177
W201
W309
W336
W391
W392
W393
W394

/5Phos/TATTATAAGTAAGATCTGGC
ACTGG
TTACTTCTAGACCTAAGTGGAATGTCT
CCACGG
CTACGGCTGCAGATGGCTTCAGTGCTA
AAGTGAGG
ATTTTGTCGACGAAGTATTCAATCAAA
CAATTACACC
/5Phos/GATTGAATACTTCCGGGGAT
TTCAGTATGAAATGAAGTATATTTAAT
ATACTTT
AAAGTATATTAAATATACTTCATTTCA
TACTGAAATCCCCGGAAGTATTCAATC
GATTGAATACTTCCGGGGcgggtcgTg
ctgggcGAAGTATATTTAATATACTTT
/5Phos/GATTGAATACTTCCGGGGgc
ccagcTcgacccgGAAGTATATTTAAT
ATACTTT

Reverse primer for sequencing pAFW04
derivatives; +154 downstream of PicsP TSS
Reverse sequencing primer for pHJW20/pAFW04
derivatives; 3’ boundary at +152 relative to icsP
TSS
Forward containing natural BglII; -1049 upstream
of icsP TSS; use with W405
Reverse ; 3’ boundary -51 relative to ospZ TSS;
XbaI
Forward primer for sequencing pAFW04
derivatives; -550 upstream of PicsP TSS; PstI
Forward; 5’ boundary of -412 relative to ospZ
TSS; SalI
Top strand to be annealed with W392; Target 6
wild-type VirB boxes; 54 bp
Bottom strand to be annealed with W392; Target 6
wild-type VirB boxes; 54 bp
Bottom strand to be annealed with W392; Target 6
mutated VirB boxes (lowercase); 54 bp
Top strand to be annealed with W392; Target 6
mutated VirB boxes (lowercase); 54 bp

W405

CTACGGGTCGACCAAGTACAAAGAATT
TTAcgggtcg

W428

ATTGCACAACTGAATTTAAGGC

W429

TTAAATTGTCTTAAACCG

W432

AGGCCTTCCGGAGCACTCAAATC

W433

AAGCCTTTAGATGAGGAAATCATCCAG
TG

W434

AGGCCTAGCGAAGCACTTAAAATTCTG

W435

AAGCTTTTATTGCTTGATCAGGAAATC
G

W441

CAGAATTCATTAAAGAGGAG

W442

TCACGATGAATTCCCCTAGC

Reverse sequencing primer for pCA24N
derivatives; use with W442

W602

CAAATTATCTAGAAAAGACTGCAGGTA
CAC

Reverse primer for pMAP30-33; natural XbaI; new
PstI

W603

GTACCTTAAGGCCGTGATGACAATTTA
TTGTCTTATCG

Forward primer for pMAP30 (Δ105 bp between HNS binding regions at PicsP); use with W602; AflII

GTACCTTAAGTTGCAGCCGTGATGACA
ATTTATTGTCTTATCG
GTACCTTAAGTATTGAGTCAGTTGAGA
TAC

Forward primer for pMAP31 (Δ100 bp between HNS binding regions at PicsP); use with W602; AflII
Forward primer for pMAP32 (Δ5 bp between H-NS
binding regions at PicsP); use with W602; AflII

W604
W605

Reverse; contains mutated HS 1 (lowercase); use
with W177; SalI
Forward primer for sequencing hns locus; 50 bp
upstream of start codon
Reverse primer for sequencing hns locus; 56 bp
downstream of stop codon
Forward; used with W431 to make pMAP23; 2nd
codon
Reverse; used with W432 to make pMAP23; stop
codon
Forward; used with W434 to make pMAP24; 2nd
codon
Forward; used with W433 to make pMAP24
(pCA24N-sfh); stop codon
Forward sequencing primer for pCA24N
derivatives; use with W441
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W606

GTACCTTAAGAGTCAGTTGAGATACAA
ATACATATTTATCAGC

Forward primer for pMAP33 (Δ10 bp between HNS binding regions at PicsP); use with W602; AflII

Table D.3 List of duplex DNA used for cloning
Label
Sequence 5'-3'
CATCGGTCGA CGGTATCGAT AAGCTTGATA
TCGAATTCCT GCAGGTATCA TAAACATGCT
TGATAACTTA ATTGGGGCTC CCTCTTCCTT
G-block 1 TTATGGTGTA ATTGTTTGAT TGAATACTTC
CGGGGATTTC AGTATGAAAT GAAGTATgcc
cgggATACTG TACAAAAAGT TTG

Description and Use
Duplex of icsP DNA containing mutation
in putative box A4 (lowercase); PstI
(CTGCAG) and BsrGI (TGTACA)

Duplex 1

GATCCACGTTGTGCGGCCGGGAATATGTCGAC
GAATCGGATCCCGATG

Non-specific competitor DNA used with
duplex 6 in EMSAs

Duplex 5

TCAGGATCCATGGGATTGAATACTTCCGGGGA
TTTCAGTATGAAATGAAGTATATTTAATATAC
TTTCCATGGGACT

Duplex 6

TCAGGATCCATGGGATTGAATACTTCCGGGAT
TTCAGTATGAAATGAAGTATgcccggcATACT
TTCCATGGGACT

Duplex 7

TCAGGATCCATGGGATTGAATACTTCCGGGGg
cccagcTcgacccgGAAGTATATTTAATATAC
TTTCCATGGGACT

77 bp duplex containing 54 bp of wildtype VirB boxes 1 and 2 (underlined right
to left) of icsP-ospZ DNA
77 bp duplex containing 54 bp of wildtype VirB boxes 1 and 2 (underlined right
to left) and mutated box A4 (lowercase)
of icsP-ospZ DNA
77 bp duplex containing 54 bp of wildtype VirB boxes 1 and 2 (lowercase from
right to left) of icsP-ospZ DNA
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AWARDS AND FUNDING
Aug. 2017 – Present

Hermsen Fellowship
Award Amount: $20,000

May 2017 – Aug. 2017

Summer Doctoral Research Fellowship
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Award Amount: $7,000
Aug. 2015 – May 2016

NASA Higher Education Fellowship.
Award Amount: $21,000

Aug. 2015 – May 2016

Terry D. Evans Memorial Scholarship.
Award Amount: $2,500

April 2014

Graduate and Professional Student Association Sponsorship.
Award Amount: $650

April 2012

Graduate and Professional Student Association Sponsorship.
Award Amount: $300

SCIENTIFIC PRESENTATIONS
Jun. 2016
CO

Wind River Conference on Prokaryotic Biology, Estes Park,
Talk title: Extending the role of VirB in Shigella flexneri: its
interplay with the H-NS family. Funding: GPSA Grant and Travel
Award

Apr. 2016

ASM Branch Meeting, Tempe, AZ
Talk title: Novel Effect of a Transcriptional Regulator Essential for
Virulence in Shigella flexneri. Prize: First place

Jun. 2015
CO

Wind River Conference on Prokaryotic Biology, Estes Park,
Talk title: Probing the mechanism of a transcriptional regulator
essential to virulence in the pathogen Shigella

Mar. 2015

Graduate and Profession Student Association (GPSA)
Research Forum, Las Vegas, NV
Talk title: Probing how virulence genes are turned on in the human
pathogen Shigella flexneri. Prize: Second place

Jun. 2014
CO

Wind River Conference on Prokaryotic Biology, Estes Park,
Poster title: Pursuit of the underlying mechanism of virulence gene
regulation in Shigella flexneri. Funding: GPSA Grant and Travel
Award

Apr. 2014

ASM Branch Meeting, Las Vegas, NV
Poster title: Pursuit of the underlying mechanism of virulence gene
regulation in Shigella flexneri

Apr. 2013

ASM Branch Meeting, Tucson, AZ
Talk title: Regulation of Shigella virulence by H-NS and VirB

Jun. 2012

Wind River Conference on Prokaryotic Biology, Mt.
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Charleston, NV
Poster title: NAP-mediated regulation of the icsP promoter
Funding: GPSA Grant and Travel Award
Apr. 2012

ASM Branch Meeting, Tempe, AZ
Poster title: NAP-mediated regulation of the icsP promoter

PROFESSIONAL SERVICE
Clubs and Societies
2011 – Present and
Dec. 2014 – Dec. 2015

Member, ASM UNLV Student Chapter
Secretary, American Society for Microbiology (ASM) UNLV
Student Chapter

Feb. 2011 – Feb. 2012

The Honor Society of Phi Kappa Phi

Community Outreach
Oct. 2017

Research Week at UNLV
Provided a tour of our laboratory and explained our research to
undergraduates

Mar. 2015

University of Nevada, Las Vegas Multicultural Program for
STEM and Health Sciences, University of Nevada Las Vegas
Provided a tour of our laboratory and explained our research to a
group of high school students that were interested in STEM

Feb. 2015

Mentor to elementary school students for Science Fair Challenge,
Zel and Mary Lowman Elementary School, Las Vegas, NV
As part of ASM UNLV Student Chapter, mentored elementary
school students by performing science experiments with them so
that the students could participate in a Science Fair.

Oct. 2014

Famous Scientist Scavenger Hunt Participant, Las Vegas
Natural History Museum
As part of ASM UNLV Student Chapter, dressed up as famous
scientists from the past and had children and their parents
complete a scavenger hunt while learning about each famous
scientist at each booth as they went through hunt.
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